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A B S T R A C T
Background
Many surgeons prefer to perform total knee replacement surgery with the aid of a tourniquet. A tourniquet is an occlusive device that
restricts distal blood flow to help create a bloodless field during the procedure. A tourniquet may be associated with increased risk of pain
and complications.
Objectives
To determine the benefits and harms of tourniquet use in knee replacement surgery.
Search methods
We searched MEDLINE, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) up to 26 March 2020. We searched
clinicaltrials.gov, the World Health Organization trials portal, and several international registries and joint registries up to March 2020.
Selection criteria
We included randomised controlled trials (RCTs) comparing knee replacement with use of a tourniquet versus without use of a tourniquet
and non-randomised studies with more than 1000 participants. Major outcomes included pain, function, global assessment of success,
health-related quality of life, serious adverse events (including venous thromboembolism, infection, re-operation, and mortality),
cognitive function, and survival of the implant. Minor outcomes included blood loss, economic outcomes, implant stability, and adverse
events.
Data collection and analysis
Two review authors screened abstracts and full texts, extracted data, performed risk of bias assessments, and assessed the certainty of
the evidence using the GRADE approach.
Main results
We included 41 RCTs with 2819 participants. Trials included from 20 to 199 participants. Mean age ranged between 58 and 84 years. More
than half of the RCTs had unclear risk of selection bias and unclear risk of performance and detection bias due to absence of blinding of
participants and surgeons.
Major outcomes
Tourniquet use for knee replacement surgery (Review)
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Pain: at postoperative day 1, pain (on a scale from zero to 10, with higher scores indicating worse pain) was ranked at 4.56  points
aJer surgery without a tourniquet and at 1.25  points (MD) higher (95% CI 0.32  higher to 2.19  higher) with a tourniquet (8  studies;
577 participants), for an absolute diBerence of 12.5% higher pain scores (95% CI 3.2% higher to 21.9% higher) and a relative diBerence
of 19% higher pain scores (95% CI 3.4% higher to 49% higher) with a tourniquet. Evidence for these findings was of moderate certainty,
downgraded due to risk of bias. Knee replacement with a tourniquet probably led to higher postoperative pain scores at day 1, although
this diBerence may or may not be noticeable to patients (based on a minimal clinically important diBerence (MCID) of 1.0).
Function: at 12 months, tourniquet use probably makes little or no diBerence to function, based on an MCID of 5.3 for Knee Society Score
(KSS) and 5.0 for Oxford Knee Score (OKS). Mean function (on a scale from 0 to 100, with higher scores indicating better outcomes) was
90.03 points aJer surgery without a tourniquet and was 0.29 points worse (95% CI 1.06 worse to 0.48 better) on a 0 to 100 scale, absolute
diBerence was 0.29% worse (1.06% worse to 0.48% better), with a tourniquet (5 studies; 611 participants). This evidence was downgraded
to moderate certainty due to risk of bias.
Global assessment of success:  low-certainty evidence (downgraded due to bias and imprecision) indicates that tourniquet use may
have little or no eBect on success. At six months, 47 of 50 (or 940 per 1000) reported overall successful treatment aJer surgery without a
tourniquet and 47 of 50 (or 940 per 1000) with a tourniquet (risk ratio (RR) 1.0, 95% CI 0.91 to 1.10) based on one study with 100 participants.
Health-related quality of life: at six months, tourniquet may have little or no eBect on quality of life. The 12-Item Short Form Survey
(SF-12) score (mental component from zero to 100 (100 is best)) was 54.64 aJer surgery without a tourniquet and 1.53 (MD) better (95% CI
0.85 worse to 3.91 better) with a tourniquet (1 study; 199 participants); absolute diBerence was 1.53% better (0.85% worse to 3.91% better).
Evidence was of low certainty, downgraded due to risk of bias and small number of participants.
Serious adverse events: the risk of serious adverse events was probably higher with tourniquet; 26 of 898 (29 per 1000) reported events
following surgery without a tourniquet compared to 53 of 901 (59 per 1000) with a tourniquet (RR 1.73, 95% CI 1.10 to 2.73) in 21 studies
(1799 participants). Twenty-nine more per 1000 patients (95% CI 3 to 50 more per 1000 patients) had a serious adverse event with a
tourniquet. Forty-eight (95% CI 20 to 345) participants would need to have surgery without a tourniquet to avoid one serious adverse event.
This evidence was downgraded to moderate certainty due to risk of bias.
Cognitive function: one study reported cognitive function as an outcome; however the data were incompletely reported and could not
be extracted for analysis.
Survival of implant: it is uncertain if tourniquet has an eBect on implant survival due to very low certainty evidence (downgraded for bias,
and twice due to very low event rates); 2 of 107 (19 per 1000) required revision surgery in the surgery with a tourniquet group compared to
1 of 107 (9 per 1000) without a tourniquet group at up to two years' follow-up (RR 1.44, 95% CI 0.23 to 8.92). This equates to a 0.4% (0.7%
lower to 7% more) increased absolute risk in surgery with a tourniquet.
Authors' conclusions
Moderate certainty evidence shows that knee replacement surgery with a tourniquet is probably associated with an increased risk of
serious adverse events. Surgery with a tourniquet is also probably associated with higher postoperative pain, although this diBerence may
or may not be noticeable to patients. Surgery with a tourniquet does not appear to confer any clinically meaningful benefit on function,
treatment success or quality of life. Further research is required to explore the eBects of tourniquet use on cognitive function and implant
survival, to identify any additional harms or benefits.
If a tourniquet continues to be used in knee replacement surgery, patients should be informed about the potential increased risk of serious
adverse events and postoperative pain.
P L A I N   L A N G U A G E   S U M M A R Y
What are the benefits and risks of using a tourniquet in knee replacement surgery?
Why is this question important?
Knee replacement is a common operation that involves replacing a damaged, worn, or diseased knee with an artificial joint made of metal
and plastic.
Most surgeons prefer to carry out knee replacement surgery with the aid of a tourniquet - a tight band placed around the thigh that restricts
blood flow to the knee.
Potential benefits of using a tourniquet include limiting blood loss during surgery and making it easier to conduct the operation. However,
a tourniquet may increase the risk of pain and complications for patients aJer surgery. We reviewed evidence from research studies to find
out about the benefits and risks of using a tourniquet in knee replacement surgery.
How did we identify and evaluate the evidence?
Tourniquet use for knee replacement surgery (Review)
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First, we searched for relevant, robust studies in the medical literature. We then compared the results and summarised the evidence from
all studies. Finally, we assessed how certain the evidence was. To do this, we considered factors such as the way studies were conducted,
study size, and consistency of findings across studies. Based on our assessments, we categorised the evidence as being of very low, low,
moderate, or high certainty.
What did we find?
We found 41 studies that involved 2819 people (944 men and 1777 women) who were randomly assigned to have surgery with a tourniquet,
or surgery without. This type of study, known as a randomised controlled trial, provides the most robust evidence about the eBects of a
treatment.
Studies were conducted in hospitals in Australia, Asia, Europe, and the USA. Each study involved between 20 and 166 people who were
between 58 and 84 years of age. They were followed for between one day and two years aJer surgery.
Five studies were publicly funded, and one study received funding from a medical equipment manufacturing company. The other 35 studies
did not receive specific funding or did not state who funded them.
The studies provided low to moderate evidence that:
- pain on the first day aJer surgery is probably worse with a tourniquet. On average, on a scale of 0 to 10 (higher scores = worse pain),
people operated on with a tourniquet rated their pain as 5.81. People operated on without a tourniquet rated their pain as 4.56 (average
diBerence: 1.25 points);
- knee function one year aJer surgery is probably similar with or without a tourniquet. On average, on a scale of 0 to 100 (higher scores
= better functioning), people operated on with a tourniquet rated their knee function as 89.74. People operated on without a tourniquet
rated their knee function as 90.03 (average diBerence: 0.29 points);
- satisfaction with treatment may be similar with or without a tourniquet. Six months aJer the operation, 94% of people operated on with
or without a tourniquet were 'extremely' or 'very' satisfied with their treatment;
- there may be little or no diBerence in health-related quality of life with or without a tourniquet. On average, on a scale of 0 to 100 (higher
scores = better quality of life), people operated on with a tourniquet rated their quality of life as 54.64. People who had surgery without a
tourniquet rated their quality of life as 56.17 (average diBerence: 1.53 points); and
- serious adverse events such as blood clots in the leg or lung, infection, or re-operation other than to replace the artificial joint are probably
more likely to occur with a tourniquet. Five per cent of people operated on with a tourniquet reported serious adverse events compared
to 2.9% of people operated on without a tourniquet.
We do not know if using a tourniquet aBects chances of needing a second operation to replace an artificial joint because available evidence
is of very low certainty.
No studies investigated the eBects of surgery with a tourniquet on people’s ability to process thoughts (cognitive function).
What does this mean?
Knee replacement with a tourniquet is probably slightly less beneficial, and is associated with greater risks, than surgery without a
tourniquet.
How up-to-date is this review?
Evidence in this Cochrane Review is current to March 2020.
Tourniquet use for knee replacement surgery (Review)







































































S U M M A R Y   O F   F I N D I N G S
 
Summary of findings 1.   Knee replacement with tourniquet compared to knee replacement without tourniquet 
Participants: patients undergoing knee replacement surgery
Settings: hospitals around the world performing knee replacement surgery
Intervention: surgery performed with a tourniquet for all or part of the procedure





























Visual analogue scale (VAS) for pain
from zero to 10 (higher scores indi-
cate more pain)














Knee replacement with a tourniquet led to higher postoperative pain
scores at day 1, although this difference may or may not be noticeable
to patients b
Absolute difference 12.5% worse (3.2% worse to 21.9% worse)
Relative difference 19% worse (3.4% worse to 49% worse)c
Function
Similar 0 to 100 scales (100 is best)
were used to measure the same
conceptual functional outcome:
Knee Injury and Osteoarthritis Out-
come Score Activities of Daily Liv-
ing (KOOS-ADL); Knee Society Score





















Knee replacement with tourniquet probably has little or no meaning-
ful effect on function b
Absolute difference 0.29% worse (1.06% worse to 0.48% better)
Relative difference 0.57% worse (2.07% worse to 0.94% better)c
Global assessment of success
Participants reporting overall suc-















Number of participants reporting success may not differ



































































































































  Relative difference 0% (9% worse to 10% better)
Health-related quality of life
SF-12 mental component from zero



















Knee replacement with tourniquet may have little or no meaningful
effect on health-related quality of lifeb
Absolute difference 1.53% better (0.85% worse to 3.91% better)
Relative difference 3% better (2% worse to 7% better)c














Knee replacement with tourniquet probably has a meaningful effect
on risk of serious adverse events
Absolute difference 2.1% more (0.29% more to 5.00% more)g
Relative difference 73% (10% more to 173% more)
Number needed to harm (NNTH) is 48 (20 to 345) participants to have
surgery with a tourniquet for 1 serious adverse event (venous throm-
boembolism, infection, or re-operation)
Cognitive function - - - - - No studies with adequate data
















It is uncertain if knee replacement has an effect on survival of implant
at 1 year
Absolute difference 0.4% more (0.7% less to 7% more) in the surgery
with a tourniquet group
Relative difference 44% more (77% lower to 892% more) in the surgery
with a tourniquet group
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: confidence interval; MD: mean difference; RCT: randomised controlled trial; RR: risk ratio.
GRADE Working Group grades of evidence.
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.

































































































































bWe assumed that clinically important improvement was 1 point or 10% absolute improvement for pain on a VAS (0 to 10) (Dworkin 2008; Kelly 2001; Wall 2017); 5.3 points or
5.3% absolute improvement in KSS for function (Chean Lee 2017), and 10 points or 10% absolute improvement for health-related quality of life.
cRelative changes calculated relative to baseline in the surgery with a tourniquet group (i.e. absolute change (mean diBerence) divided by mean at baseline in the surgery without
a tourniquet group from Liu 2017 b (values were 6.54 points on a 0 to 10 point VAS scale for pain and 51.3 on a 0 to 100 point KSS scale for function) and Goel 2019 (values were
54.64 on a 0 to 100 point SF-12 mental component score for continuous outcomes).
dThe mean diBerence was calculated by multiplying the SMD by the baseline SD (4.8) of the control group (Liu 2017 b).
eParticipant satisfaction was derived from one study (Huang 2017). Satisfaction was defined as the number of participants who were 'extremely' or 'very' satisfied with their
treatment.
fDowngraded by one level due to imprecision. Small total number of participants. Not enough information to calculate eBect estimate precisely.
gConfidence intervals around absolute risk demonstrated an eBect equal to or greater than 0.29%, which was deemed to be highly clinically relevant given the seriousness of
the outcome. The total number of events was low; however, this was expected, and we did not downgrade for imprecision, as this was is in line with previous literature on SAEs
(Benjamin 2016), which reported an incidence of VTE of 2.4% in patients undergoing TKR. Our results therefore do not indicate a 'low' total number of events for this outcome
of interest.
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B A C K G R O U N D
Description of the condition
Knee replacement surgery is widely regarded as an established
and eBective surgical procedure performed for relief of pain
from end-stage arthritis (Skou 2016). During knee replacement
surgery, joint surfaces are removed and are replaced with artificial
components.  All of the knee joint surface can be replaced (total
knee replacement - TKR), part of the joint can be replaced (partial
knee replacement; e.g. unicondylar, patellofemoral), or a  redo of
an existing knee replacement can be performed (revision knee
replacement). TKR is by far the most common type of knee
replacement, with more than 106,000 performed in the UK in 2018
(National Joint Registry 2018; Scottish Arthroplasty Project 2019).
A 2010 survey found that 95% of surgeons in the USA use a
tourniquet for knee replacement surgery (Zhang 2014), and the
UK's National Joint Registry (NJR) reported that 93% of knee
replacements were done with a tourniquet in 2003 (National Joint
Registry 2004). A UK-based survey conducted in 2016 demonstrated
that 90% of surgeons prefer to use a tourniquet when undertaking
TKR (Gibbs 2016). This preference is similar to that in other
European countries; the Swedish Joint Registry reported that 90%
of cases were performed with a tourniquet (The Swedish Knee
Arthroplasty Register 2012).
Description of the intervention
A thigh tourniquet is an occlusive device that squeezes the upper
leg and restricts distal blood flow.  Using a tourniquet may help
create a bloodless field during the procedure (Alcelik 2012).
Two broad types of thigh tourniquet are used for TKR surgery.
1. Inflatable/pneumatic: a cuB placed around the thigh is filled
with compressed gas. Pressure in the cuB is maintained by a
microprocessor and can be adjusted (Kumar 2016).
2. Non-inflatable: a rubber or elasticated cloth ring is placed
around the thigh. A device that achieves the required pressure is
applied and cannot be adjusted unless it is replaced with a new
device (Kumar 2016).
Before the tourniquet is applied, the leg can be elevated or
exsanguinated (using a bandage or similar device), to help reduce
the amount of pooled blood within the leg (Chiu 2012).
A thigh tourniquet can be used for the duration of the procedure
or for part of the procedure (e.g. during cementation of the
components only).
How the intervention might work
The tourniquet is designed to apply pressure to the thigh above the
internal pressure of local blood vessels (limb occlusion pressure),
thereby restricting both arterial and venous blood flow distally
(Alcelik 2012; Gibbs 2016).
Why it is important to do this review
The eBects of using a tourniquet in knee replacement surgery
have already been reported in the following four systematic
reviews:  Alcelik 2012; Smith 2010; Tai 2011;  and  Zhang 2014.
However,  21  additional randomised controlled trials have since
been published:  Alexandersson 2019;  Ayik 2020; Dong 2019 Ejaz
2014; Ejaz 2015; Ejaz 2015 b; Goel 2019; Harston 2015; Huang 2017;
Jawhar 2015; Jawhar 2020; Kumar 2015; Liu 2014; Liu 2017; Liu 2017
b; Mori 2016;  Ozkunt 2018; Vertullo 2017; Wu 2018; Zhang 2016;
Zhou 2017. These newer trials have explored additional outcomes
of interest including pain, function, and serious adverse events, and
combining data derived from these studies will help to identify the
benefits and risks of using a tourniquet.
Potential benefits of using a tourniquet
Surgical field of view
Using a tourniquet may improve the surgical field of view by limiting
intraoperative blood loss (Zhang 2014).
Cementation
Most TKR components are cemented in place to hold and stabilise
them in the correct position on the bone. Cement, which is initially
soJ when it is inserted, interdigitates into the porous bone, forming
a strong bond with the bone as it sets. Some surgeons believe that
using a tourniquet helps reduce bleeding from the porous bone
ends and allows the soJ cement to bond more eBectively, thereby
improving long-term survival of the knee implant components
(Grewal 1992; Pfitzner 2016).
Blood loss
One previous systematic review showed that intraoperative blood
loss was reduced when a tourniquet was used (Alcelik 2012).
However, when another group reviewed overall blood loss (Zhang
2014), they found no diBerence between intervention groups.
Potential risks of using a tourniquet
Pain and function
A tourniquet may  cause pain, both during and aJer surgery
(Abdel-Salem 1995). In addition to pain, a tourniquet may cause
bruising and swelling of the thigh muscles, which it squeezes.
These muscles are important for mobilisation, thus inhibiting
postoperative function and recovery.
Venous thromboembolism (VTE)
A tourniquet causes both arterial and venous stasis within the lower
leg for the duration that it is inflated (typically over an hour). Thus
it is possible that use of a surgical tourniquet might increase the
risk of postoperative venous thromboembolism (VTE) (Tai 2011;
Wauke 2002; Zhang 2014). Systematic reviews have shown that a
tourniquet may increase the risk of VTE  (Zhang 2014), although
another review found that this increased risk was not statistically
significant (Tai 2011).
Systemic emboli
VTE may not be the only thromboembolic risk associated with using
a tourniquet. Systemic emboli can occur following deflation of
a tourniquet (Berman 1998). Transoesophageal echocardiography
has demonstrated shower-like echogenic materials circulating
from the lower limbs to the right atrium, ventricle, and pulmonary
artery aJer release of a thigh tourniquet, as well as macroscopic
emboli in the central circulation (Berman 1998). As the carotid
arteries are the first branches from the aortic arch in a straight-line
orientation, some of these clots may enter the cerebral circulation.
Transcranial Doppler ultrasound studies show 60% prevalence of
echogenic material in the circle of Willis aJer a tourniquet is
Tourniquet use for knee replacement surgery (Review)
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released and have revealed that microemboli can occur even in the
absence of a patent foramen ovale (connection between leJ and
right sides of the circulation within the heart) (Sulek 1999). The
most likely route for emboli in these circumstances is through the
pulmonary capillaries or the opening of other pulmonary vessels
(Sulek 1999). The critical time is immediately aJer release of the
tourniquet, when there is potential haemodynamic instability and
evidence to suggest a five-fold increase in the amount of embolic
material (Huh 2012; Parmet 1998). The presence of cerebral emboli
that can cause cerebral damage may explain the higher than
expected prevalence of postoperative cognitive deficit following
TKR surgery, which in published reports varies from 41% to 75%
at seven days to 18% to 45% at three months postoperatively (Deo
2011).
Other e#ects
Alcelik 2012 concluded that minor complications are more
common when a tourniquet is used; similarly, Zhang 2014 showed
increased complications, including infection, blister, haematoma,
wound oozing, bruising, nerve palsy, and re-operation in the
surgery with a tourniquet group.
O B J E C T I V E S
To determine the benefits and harms  of tourniquet use in knee
replacement surgery.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised
We included studies in which participants are randomised
to intervention groups and studies in which allocation to
interventions is quasi-randomised (i.e. not strictly random, for
example, by date of birth, hospital record number, or alternation).
Non-randomised
Randomised studies, particularly in the field of this review, are
unlikely to include more than 1000 participants. To help improve
estimates of potential risks (e.g. adverse events of the intervention,
many of which may be rare events (VTE approximately < 5%
(Zhang 2014)), we aimed to include observational cohort studies
and unselected case series of 1000 or more participants, which
include concurrent comparison groups (e.g. published data from
joint replacement registries).  The minimum sample of 1000 was
based on a previous work (Gurung 2015), which recommended this
number when risks for rare events are estimated.
To minimise selection bias within non-randomised studies, we
aimed to include only studies that use statistical adjustment for
baseline case mix (e.g. multi-variable analyses to adjust for age, co-
morbidity, and type of knee replacement (total or partial, primary,
or revision)).
Types of participants
We included participants who underwent knee replacement
surgery for any indication, regardless of age. All types of knee
replacement, including total replacement, partial replacement,
and revision surgery, were included in this review.
Types of interventions
We included studies of all types of thigh tourniquet (inflatable
or non-inflatable) used for the duration or for part of knee
replacement surgery. Comparators could be:
1. placebo: this may include a sham tourniquet, for example, one
that is applied but is not inflated;
2. no tourniquet; or
3. alternative measures to improve the surgical field of view
or to reduce intraoperative blood loss (e.g. this may include
tranexamic acid).
Types of outcome measures
Major outcomes
According to the Outcome Measures in Rheumatology (OMERACT)
core outcome set (Bellamy 1997), pain, function/disability, global
assessment of success, and health-related quality of life are major
outcomes. We prioritised them according to previous evidence on
the hierarchy of patient-reported outcomes (Juhl 2012).
1. Pain
Measured using mean pain or mean change in pain on a visual
analogue scale (VAS), a numerical rating scale, or another scale.
2. Function
Measured with instruments such as Knee Society Score (KSS),
Western Ontario and McMaster Universities Arthritis Index
(WOMAC), Knee Injury and Osteoarthritis Outcome Score (KOOS),
Oxford Knee Score (OKS). We will extract all available function
scores and will present total scores in the primary analysis and
subscores as additional analyses when available.
3. Global assessment of success
As reported by the participant (e.g. proportion of participants
reporting overall successful treatment and participant
satisfaction).
4. Health-related quality of life
Measured with instruments such as the 36-Item Short Form Survey
(SF-36) or EuroQoL Group Quality of Life Questionnaire based on 5
dimensions (EQ-5D).
5. Serious adverse events (SAEs)
A serious adverse event is an adverse event that fulfils one of
more of the following criteria: results in death, is immediately life-
threatening, requires hospitalisation or prolongation of existing
hospitalisation, or is an important medical condition. We screened
studies to report the following SAEs: number of deaths, infection
(joint or wound), nerve damage, ischaemia, VTE, systemic embolic
events, and re-operation, excluding revisions for implant failure.
6. Cognitive function
Measured with instruments such as Mini-Mental State Examination
(MMSE), Oxford Cognitive Screen (OCS), and Montreal Cognitive
Assessment (MoCA).
Tourniquet use for knee replacement surgery (Review)









Cochrane Database of Systematic Reviews
7. Survival of the implant
Measured as revision rate. The preferred marker of implant failure
will be revision surgery. The outcome included in this review is
revision risk.
We prioritised the major outcomes in numerical order, as given
above.
Minor outcomes
Following discussion between the senior review authors, we
prioritised the minor outcomes in numerical order as shown below.
1. Blood loss
a. Total blood loss during surgery (intraoperative blood loss)
b. Postoperative blood loss measured from drainage systems and
blood transfusion rates
c. Overall blood loss
2. Economic outcomes
a. Resource usage: direct healthcare and societal costs to facilitate
a cost-eBectiveness analysis
b. Duration of surgery: surgery start and finish times when available
c. Length of hospital stay
3. Implant stability
Validated methods such as radiostereometric analysis (RSA).
4. Adverse events
We report adverse events that are not classified as serious adverse
events based on the criteria above.
Timing of outcome assessment
Studies are likely to report the outcomes discussed at several time
points. We therefore planned to group these assessments into
three categories: short-term (up to and including three months),
medium-term (aJer three months and up to and including 12
months), and long-term follow-up (longer than one year).
The greatest eBect of the intervention on pain was likely to be
seen in the very early postoperative phase. Therefore we have
made day 1 the time point for this primary outcome. We have also
reported pain scores at later time points up to six weeks, when we
anticipated pain levels would be lower and any diBerences would
be fewer.
The primary time point for SAE, function, health-related quality of
life, global assessment of success, and cognitive function is within
12 months of surgery, and the primary time point for revision
surgery is any revision surgery performed within the follow-up
period of the study. For studies included in this review, it was 24
months.
Search methods for identification of studies
Electronic searches
This current review includes randomised controlled trials (RCTs)
published between 1946 and 26 March 2020 and non-randomised
studies published between 1946 and 26 March 2020.
We searched the following databases for randomised trials.
1. Cochrane Central Register of Controlled Trials, via Cochrane
Library (Appendix 1).
2. OVID MEDLINE, 1946 to 26 March 2020 (Appendix 2).
3. OVID Embase, 1974 to 26 March 2020 (Appendix 3).
4. ClinicalTrials.gov for ongoing trials (Appendix 4).
5. World Heath Organization (WHO) International Clinical Trials
Registry Platform (ICTRP) search portal (www.who.int/ictrp/en/;
Appendix 5).
We also searched the following databases for non-randomised
studies.
• OVID MEDLINE, 1946 to 26 March 2020 (Appendix 6).
• OVID Embase, 1974 to 26 March 2020 (Appendix 7).
Searching other resources
We checked the reference lists of all primary studies and review
articles for additional references.
In addition, we searched the following established joint registry
programmes for relevant published reports and used the contacts
below to identify any missing joint registry programmes.
Australasia
1. Australian Orthopaedic Association National Joint Replacement
Registry (aoanjrr.sahmri.com/)
2. New Zealand National Joint Register (https://nzoa.org.nz/nzoa-
joint-registry)
Europe
1. Danish Knee Arthroplasty Register (https://www.sundhed.dk/
sundhedsfaglig/kvalitet/kliniske-kvalitetsdatabaser/planlagt-
kirugi/knaealloplastikregister/)
2. European Arthroplasty Register (https://www.efort.org/about-
us/nore/)
3. Scottish Arthroplasty Project (www.arthro.scot.nhs.uk/)
4. Slovak National Arthroplasty Register (sar.mfn.sk/the-slovak-
arthroplasty-register.348.html)
5. Swedish Knee Arthroplasty Register (www.myknee.se/en/)
6. National Joint Registry of England and Wales
(www.njrcentre.org.uk/njrcentre/default.aspx)
7. Norwegian Arthroplasty Register (nrlweb.ihelse.net/eng/)
8. Portugese Arthroplasty Register (www.rpa.spot.pt/)
9. RIPO Bologna, Italy (ripo.cineca.it/)
10.Romanian Arthroplasty Register (www.rne.ro/?lang=en)
North America
1. American Joint Replacement Registry (www.ajrr.net/)
2. Canadian Joint Replacement Register (www.cihi.ca/en/types-
of-care/specialized-services/joint-replacements/canadian-
joint-replacement-registry)
3. Health East Joint Replacement Registry (www.healtheast.org/
orthopaedics/registry.html)
4. Kaiser Permanente National Implant Registries
(www.kpimplantregistries.org/)
Tourniquet use for knee replacement surgery (Review)









Cochrane Database of Systematic Reviews
We searched for errata or retractions from included studies
published in full text on PubMed (www.ncbi.nlm.nih.gov/pubmed),
and we reported in the review the date this was done.
Data collection and analysis
Selection of studies
Two review authors (IA and PW) independently screened titles and
abstracts of all studies for potential inclusion that we identified
as a result of the search. We coded them as 'retrieve' (eligible or
potentially eligible/unclear) or 'do not retrieve'. AJer retrieving the
full-text study reports/publications, two review authors (IA and PW
for RCTs, IA and AC for non-randomised studies) independently
screened them and identified studies for inclusion; we also
identified and recorded reasons for exclusion of ineligible studies.
We resolved any disagreement through discussion, or, if required,
we consulted  a third review author (MU). We identified and
excluded duplicates and collated multiple reports of the same
study, so that each study, rather than each report, is the unit
of interest in the review. We recorded the selection process
in suBicient detail to complete a PRISMA flow diagram and
Characteristics of excluded studies section. Search strategies can
be seen in the appendices (Appendix 1; Appendix 2; Appendix 3;
Appendix 4; Appendix 5; Appendix 6; Appendix 7).
Data extraction and management
We used a data collection form for study characteristics and
outcome data that has been piloted on at least one study in
the review. One review author (IA) extracted study characteristics
from the included studies. A second review author (PW) cross-
checked study characteristics for accuracy against the trial report.
We extracted the following study characteristics.
1. Methods: study design, total duration of study, details of any
'run-in' period, number of study centres and locations, study
setting, withdrawals, and dates of study.
2. Participants: number (N), mean age, age range, sex, disease
duration, inclusion criteria, and exclusion criteria.
3. Interventions: type of surgery, number of participants in
tourniquet group, and number of participants in comparator
group (sham/no tourniquet/other).
4. Outcomes: major and minor outcomes specified and collected,
and time points reported.
5. Characteristics of the design of the trial, as outlined in the
Assessment of risk of bias in included studies section below.
6. Notes: funding for trial and notable declarations of interest of
trial authors.
Two review authors (IA and AC) independently extracted outcome
data from the included studies. We extracted the number of
events and the number of participants in each treatment group
for dichotomous outcomes, and we extracted means and standard
deviations and number of participants in each treatment group
for continuous outcomes. For non-randomised trials, we aimed to
extract adjusted outcome measures.
We aimed to use non-randomised studies to extract outcomes of
interest that are rare (e.g. VTE, implant failure rate).
We noted in the Characteristics of included studies table if outcome
data were not reported in a usable way, and when data were
transformed or estimated from a graph. We resolved disagreements
by reaching consensus or by involving a third review author (MU).
One review author (IA) transferred data into the Review Manager
5 file (RevMan 2014). We double-checked that data were entered
correctly by comparing data presented in the review with data
presented in study reports.
Our a priori decision rules to extract data in the event of multiple
outcome reporting in trials are as follows.
1. When trialists report both final values and change from baseline
values for the same outcome, we extracted change from baseline
values.
2. When trialists report both unadjusted and adjusted-for-baseline
values for the same outcome, we extracted unadjusted baseline
values.
3. When trialists report data analysed based on the intention-to
treat (ITT) sample and another sample (e.g. per protocol, as
treated), we extracted ITT-analysed data.
4. When trials do not include a measure of overall pain but include
one or more other measures of pain, for the purpose of pooling
data we combined overall pain with other types of pain in the
following hierarchy: unspecified pain, pain at rest, pain with
activity, daytime pain.
5. When trialists report multiple pain outcome measures, for the
purposes of pooling data we extracted one measure using
the following hierarchy: visual analogue scale, numerical or
cognitive rating scale, McGill Pain Questionnaire, or another
scale.
6. When trialists report multiple measures of function or disability,
for the purposes of pooling data we extracted a single measure
using the following hierarchy: Oxford Knee Score (OKS), Knee
Injury and Osteoarthritis Outcome Score (KOOS), Knee Society
Score (KSS), Western Ontario and McMaster Universities Arthritis
Index (WOMAC), or an other scale.
Assessment of risk of bias in included studies
Randomised studies
Two review authors (IA and PW) independently assessed
risks of bias for each study, using the criteria outlined in
the  Cochrane Handbook for Systematic Reviews of Interventions,
version 6.1  (Higgins 2020a). We resolved disagreements by
discussion or by consultation with another review author (MU). We
assessed risks of bias according to the following domains.
1. Random sequence generation (only for randomised studies).
2. Allocation concealment (only for randomised studies).
3. Blinding of participants and personnel.
4. Blinding of outcome assessment.
5. Incomplete outcome data.
6. Selective outcome reporting.
7. Other potential bias (e.g. discrepancies between groups for
co-morbidities that could act as confounding factors, such as
clotting disorders; diBerences in application of co-interventions,
such as postoperative rehabilitation).
We graded each potential source of bias as high, low, or unclear,
and we provided a quote from the study report together with
a justification for our judgement in the 'Risk of bias' table. We
summarised risk of bias judgements across diBerent studies for
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each of the domains listed. We considered blinding separately
for diBerent key outcomes when necessary (e.g. for unblinded
outcome assessment, risk of bias for all-cause mortality may
be diBerent than for a participant-reported pain scale). We also
considered the impact of missing data by key outcomes.
When information on risk of bias relates to unpublished data or
correspondence with a trialist, we noted this in the 'Risk of bias'
table.
When considering treatment eBects, we aimed to take into account
the risk of bias for studies that contributed to that outcome.
We presented the figures generated by the 'Risk of bias' tool to
provide summary assessments of risks of bias.
Non-randomised studies
We planned to use ROBINS-I (Risk Of Bias In Non-randomised
Studies of Interventions), a tool for assessing risk of bias in non-
randomised studies (Sterne 2016). This approach involved three
stages for each study.
Stage 1
To specify the research question, list confounding domains and
co-interventions, and specify the outcomes being examined.
Confounding factors that may influence outcome include:
1. co-morbidities such as vascular disease;
2. previous VTE disease;
3. prothrombotic conditions such as malignancy;
4. use and type of VTE prophylaxis (such as low molecular weight
heparin, aspirin, or intermittent calf pump);
5. type of implant used;
6. use of cement; and
7. basic participant demographics, including age, body mass index
(BMI), and American Society of Anesthesiologists (ASA) grade.
Stage 2
Risk of bias assessment for a specific result.
Stage 3
Overall risk of bias 'triangulated' across all studies. This tool
evaluated the following area of bias.
1. Confounding.
2. Selection bias.
3. Bias in measurement classification of interventions.
4. Bias due to deviations in intended interventions.
5. Bias due to missing data.
6. Bias in measurement of outcomes.
7. Bias in selection of the reported result.
Studies would be reported as having low risk of bias, moderate risk
of bias, serious risk of bias, or critical risk of bias. A 'no information'
category will be used to describe the risk of bias where there is
insuBicient information to permit a judgement for the study.
Assessment of bias in conducting the systematic review
We conducted the review according to the published protocol and
reported any deviations from it in the DiBerences between protocol
and review section of the review.
Measures of treatment e<ect
We used risk ratios (RRs) with 95% confidence intervals (CIs) to
report categorical outcomes. We analysed continuous data as mean
diBerences (MDs) or as standardised mean diBerences (SMDs),
depending on whether the same scale was used to measure an
outcome, along with 95% CIs. We then translated the SMD back to a
common scale by multiplying SMD by baseline standard deviation
(SD) for the control group from the most representative study
(Higgins 2020b). We entered data presented as a scale with a
consistent direction of eBect across studies.
In the EBects of interventions section under Results and in the
'Comments' column of the 'Summary of findings' table, we provide
the absolute per cent diBerence, the relative per cent change
from baseline, and the number needed to treat for an additional
beneficial outcome (NNTB); we calculated the NNTB only when the
outcome showed a clinically significant diBerence.
For dichotomous outcomes, such as serious adverse events,
we calculated the NNTB from the control group event rate
and the risk ratio, using the Visual Rx NNT calculator (Cates
2008). We will calculate the NNTB for continuous measures
using the Wells calculator (available at the CMSG Editorial oBice;
musculoskeletal.cochrane.org/).
For dichotomous outcomes, we calculated the absolute per
cent change from the diBerence in risks between intervention
and control groups using GRADEpro (GRADEpro 2015), and we
expressed this as a percentage. For continuous outcomes, we
calculated the absolute risk diBerence as improvement in the
intervention group minus improvement in the control group, in the
original units.
We calculated the relative per cent change for dichotomous data
as the RR minus 1, expressed as a percentage. For continuous
outcomes, we calculated the relative diBerence in change from
baseline as the absolute benefit divided by the baseline mean of the
control group.
Unit of analysis issues
We anticipated most studies to use a simple parallel-group design.
However, if we found any other design (e.g. cluster-randomised), we
planned to use generic inverse variance methods to combine data.
For analysis, we planned to use details of intraclass correlation
coeBicients (ICCs) and cluster sizes for trials of this type, if reported
eBects had not been adjusted for clustering.
When multiple trial arms are reported in a single trial, we included
only the relevant arms.
We preferred trials that reported a unit of analysis at the participant
level, to maintain independence of the outcome variable. When
studies reported outcomes in patients undergoing bilateral total
knee replacement surgery, the unit of analysis was presented at
a joint level (e.g. each individual knee; Kumar 2015; Liu 2017; Liu
2017 b). For these studies, we extracted outcomes only if they
were reported as specifically related to each individual knee (e.g.
Tourniquet use for knee replacement surgery (Review)









Cochrane Database of Systematic Reviews
pain, function, global assessment of success, SAEs (infection, VTE,
re-operation, nerve damage), survival of implant, intraoperative
blood loss (per knee), duration of surgery). In these studies, trial
authors made direct comparisons between one knee and the other;
as a result, outcomes were knee-specific and therefore could be
included in the meta-analysis.
Dealing with missing data
We contacted investigators or study sponsors to verify key study
characteristics and to obtain missing numerical outcome data
when possible (e.g. when a study is identified as an abstract only,
when data are not available for all participants). When this was not
possible, and when missing data were thought to introduce serious
bias, we explored the impact of including such studies in the overall
assessment of results by performing a sensitivity analysis.  We
described any assumptions and imputations for handling missing
data and we explored the eBect of imputation by conducting
sensitivity analyses.
For dichotomous outcomes (e.g. number of withdrawals due
to adverse events), we calculated the withdrawal rate using
the number of participants randomised to the group as the
denominator.
For continuous outcomes (e.g. mean change in pain score), we
calculated MD or SMD based on the number of participants
analysed at that time point. If the number of participants analysed
was not presented for each time point, we aimed to use the number
of randomised participants in each group at baseline.
When possible, we aimed to compute missing SDs from other
statistics such as standard errors, confidence intervals, or P
values, according to the methods recommended in the Cochrane
Handbook for Systematic Reviews of Interventions, version 6.1 (
Deeks 2020). If we could not estimate standard deviations, we
aimed to impute them (e.g. from other studies in the meta-
analysis).
Assessment of heterogeneity
We assessed clinical and methodological diversity in terms of
participants, interventions, outcomes, and study characteristics
for included studies, to determine whether a meta-analysis was
appropriate. We assessed statistical heterogeneity by visually
inspecting the forest plot to assess for obvious diBerences in results
between studies, and by using I2 and Chi2 statistical tests.
As recommended in the Cochrane Handbook for Systematic
Reviews of Interventions, version 6.1 (Deeks 2020), I2 value of
0% to 40% indicates 'might not be important'; 30% to 60%
may represent 'moderate heterogeneity'; 50% to 90% may
represent 'substantial heterogeneity'; and 75% to 100% represents
'considerable heterogeneity'. We considered the importance of
I2 to depend on the magnitude and direction of eBects and on
the strength of evidence for heterogeneity (e.g. P value from
Chi2 test, confidence interval for I2). If we identified substantial
heterogeneity, we reported this and investigated possible causes
by following the recommendations provided in Section 9.6 of the
Cochrane Handbook for Systematic Reviews of Interventions, version
6.1 ( Deeks 2020).
Assessment of reporting biases
We aimed to create and examine a funnel plot to explore possible
small-study biases. In interpreting funnel plots, we examined
the diBerent possible reasons for funnel plot asymmetry, as
outlined in Section 13 of the Cochrane Handbook for Systematic
Reviews of Interventions, version 6.1  ( Page 2020), and we related
this information to results of the review. If we were able to
pool more than 10 trials, we decided to undertake formal
statistical tests to investigate funnel plot asymmetry and to follow
the recommendations provided in Section 13 of the Cochrane
Handbook for Systematic Reviews of Interventions, version 6.1 (Page
2020). For continuous data, we tested asymmetry by using a
weighted linear regression of the standardised mean against its
standard error (Egger 1997). For dichotomous data, we used a
weighted linear regression based upon the odds ratio against its
variance (Harbord 2009). In both cases, we considered a P value
below 0.05 as evidence that publication bias was present. We
performed analyses using the “meta” R package (Schwarzer 2007).
To assess outcome reporting bias, we checked trial protocols
against published reports. For studies published aJer 1 July 2005,
we screened the Clinical Trial Register at the International Clinical
Trials Registry Platform of the World Health Organization for the
a priori trial protocol (apps.who.int/trialssearch). We evaluated
whether selective reporting of outcomes was present.
Data synthesis
We pooled outcomes of clinically and methodologically
homogeneous studies, when meaningful, using a random-eBects
model. We performed analysis using Review Manager 5 (RevMan
2014), and we produced forest plots for all analyses. We aimed
to pool outcomes of non-randomised studies only if the studies
were clinically homogeneous, using a random-eBects model, which
allows for diBerent study variances. We aimed to use log-RR
data (with corresponding standard errors (SEs) on the log scale)
and aimed to pool outcomes using the generic inverse variance
method. We aimed to use non-randomised studies to analyse only
outcomes that are rare (e.g. VTE, implant failure rate). We planned
to assess clinical homogeneity based on participants, interventions
(procedures performed with a tourniquet), outcomes (VTE and
implant failure), and study characteristics, including study design.
Two review authors (IA and PW) determined if at least three of these
features are matching between each study, to pool the data.
Subgroup analysis and investigation of heterogeneity
We planned to carry out the following subgroup analyses.
1. DiBerent surgical procedures that may aBect outcome (e.g.
total versus partial knee replacement, primary versus knee
replacement and revision knee replacement).
2. DiBerent types of tourniquet that may aBect outcome (e.g.
inflatable, non-inflatable).
Types of surgical procedures vary in complexity, and this may
impact both the duration of tourniquet use and the risk of
complications.
We planned to use the following outcomes in subgroup analyses.
1. Pain.
2. Function.
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3. Adverse events.
We planned to use the formal test for subgroup interactions
in Review Manager 5 (RevMan 2014), and we used caution in
interpreting subgroup analyses, as advised in Section 10 of the
Cochrane Handbook for Systematic Reviews of Interventions, version
6.1 (Deeks 2020).
Sensitivity analysis
If studies diBered markedly from most other studies (diBerent
outcomes), and if we deemed it necessary to exclude them, we
conducted sensitivity analyses to report whether the overall eBect
changed when these studies were removed.
When we identified  suBicient studies, we performed sensitivity
analyses to assess the impact of selection bias, performance bias,
and detection bias on major outcomes.
Interpreting results and reaching conclusions
We followed the guidelines provided in Chapter 15 of the Cochrane
Handbook for Systematic Reviews of Interventions, version 6.1
when interpreting results (Schunemann 2020b), and we were
aware of distinguishing lack of evidence of eBect from lack
of eBect. We based our conclusions only on findings from the
quantitative or narrative synthesis of included studies for this
review. We avoided making recommendations for practice, and our
implications for research suggest priorities for future research and
outline remaining uncertainties in this area.
Summary of findings and assessment of the certainty of the
evidence
'Summary of findings' table




3. Global assessment of success
4. Health-related quality of life
5. Serious adverse events
6. Cognitive function
7. Survival of the implant
The comparison in the SoF table was: tourniquet versus no
tourniquet.
Two review authors (IA and PW) independently assessed the quality
of the evidence. We used the five GRADE considerations (study
limitations, consistency of eBect, imprecision, indirectness and
publication bias) to assess the quality of a body of evidence
as it relates to the studies which contribute data to the meta-
analyses for the pre-specified outcomes. We used methods and
recommendations from Chapter 14 of the  Cochrane Handbook
for Systematic Reviews of Interventions, version 6.1  (Schunemann
2020a), and used GRADEpro soJware to prepare the SoF tables
(GRADEpro 2015). We justified all decisions to downgrade the
quality of studies using footnotes, and made comments to aid the
reader's understanding of the review where necessary.
The planned minimum clinically important diBerence (MCID) was
1 point or 10% absolute improvement for pain on a VAS (0-10)
(Dworkin 2008; Kelly 2001; Wall 2017); 5.3 points or 5.3% absolute
improvement in KSS for function (Chean Lee 2017) and 10 points
or 10% absolute improvement for health-related quality of life
(Karjalainen 2019).
R E S U L T S
Description of studies
Results of the search
Randomised controlled trials
The database search was performed on March 2020. Results of the
search can be seen in Figure 1. The search returned 1290 citations
through databases (CENTRAL 539; MEDLINE 340; Embase 411) and
a further 150 citations from trial registries (Clinical trials.gov 42;
WHO 108). No further citations were obtained from grey literature
(e.g. unpublished studies, registry data). AJer duplicates were
removed, title and abstracts were screened for eligibility, leaving
53 full texts for further assessment. In total, 41 studies met the
inclusion criteria of this review and were included for further
analysis: Abdel-Salem 1995; Aglietti 2000; Alexandersson 2019; Ayik
2020; Clarke 2001; Dong 2019; Ejaz 2014; Ejaz 2015; Ejaz 2015 b;
Goel 2019; Harston 2015; Huang 2017; Jawhar 2015; Jawhar 2020;
Juelsgaard 2001; Kato 2002; Kiss 2005; Kumar 2015; Ledin 2012; Li
2008; Li 2009; Liu 2014; Liu 2017; Liu 2017 b; Matziolis 2004; Molt
2014; Mori 2016; Ozkunt 2018; Pfitzner 2014; Tai 2012; Tetro 2001;
Vandenbussche 2001; Vertullo 2017; Wakankar 1999; Wauke 2002;
Wu 2018; Yavarikia 2010; Zhang 2010; Zhang 2016; Zhou 2011; Zhou
2017. Eleven  studies were excluded following full-text screening.
Reasons for exclusion were:
 
Tourniquet use for knee replacement surgery (Review)









Cochrane Database of Systematic Reviews
Figure 1.   Study flow diagram: search for randomised controlled trials.
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Figure 1.   (Continued)
 
1. wrong comparator (n = 6): Brin 2015; Dennis 2016; Friedrich 1990
Husted 2005; Nielsen 2016; Padala 2004;
2. commentary piece (n = 1): Dorr 2014;
3. wrong study design (n = 3): Harvey 1997; Huang 2015; Nicolaiciuc
2019b; and
4. supplementary piece (n = 1): Mourikis 2009.
We identified 12 ongoing studies meeting the inclusion criteria and
presented their characteristics in the Characteristics of ongoing
studies table. All of these studies were in the recruitment phase or
the follow-up period: Duncan 2019; Forsmo 2018; Gill 2018; Kange
2017; Liebensteiner 2016; Pei 2016; Pei 2016 (b); Shen 2018; Singh
2019; Vasquez 2019; Wall 2016; Wang 2016.
We identified  a study protocol or registration for 13 studies
(Alexandersson 2019; Dong 2019; Ejaz 2014; Ejaz 2015; Ejaz 2015
b; Goel 2019; Harston 2015; Huang 2017; Jawhar 2015; Jawhar
2020; Molt 2014; Wu 2018; Zhou 2017); however, despite contacting
authors, we could gather no study protocols nor registrations
for 28 studies (Abdel-Salem 1995; Aglietti 2000; Ayik 2020; Clarke
2001; Juelsgaard 2001; Kato 2002; Kiss 2005; Kumar 2015; Ledin
2012; Li 2008; Li 2009; Liu 2014; Liu 2017; Liu 2017 b; Matziolis
2004; Mori 2016; Ozkunt 2018; Pfitzner 2014; Tai 2012; Tetro 2001;
Vandenbussche 2001; Vertullo 2017; Wakankar 1999; Wauke 2002;
Yavarikia 2010; Zhang 2010; Zhang 2016; Zhou 2011).
Non-randomised studies
The search for non-randomised studies was performed in March
2020 and returned 1535 citations through database screening
(MEDLINE 656, Embase 879). No further citations were found
through searching grey literature. AJer duplicates were removed,
895 citations underwent title and abstract screening. Once
complete, 16 full texts were assessed for eligibility. All 16 were
excluded, as the sample size was less than 1000, which was a
pre-specified inclusion criterion (Ajnin 2020; Bakker 2019; Barros
2017; Burg 2009; Fakuda 2007; Hasanain 2018; Jarolem 1995;
Kheir 2018; Matziolis 2011; Mutlu 2015; Nicolaiciuc 2019; Nishiguchi
2008;  Schimizu 2016; Schnettler 2017; Stroh 2011; Zhang 2019).
We also searched registry databases; only the Swedish Registry
reported tourniquet use but provided no data on SAEs or revision
rates. The search results are summarised in Figure 2.
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Figure 2.   Study flow diagram: search for non-randomised studies.
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Included studies
We have provided a full description of the 41 included studies in
the Characteristics of included studies table; we have presented a
summary of trial features and participant characteristics in Table 1.
Trial design, settings, and characteristics
The 41 included studies were randomised controlled trials (RCTs);
no quasi-randomised studies were identified or included. Thirty-
seven studies were two-arm single-centre RCTs comparing knee
replacement  performed with a tourniquet versus without a
tourniquet (Abdel-Salem 1995; Aglietti 2000; Alexandersson 2019;
Ayik 2020; Dong 2019; Ejaz 2014; Ejaz 2015; Ejaz 2015 b; Goel
2019; Harston 2015; Jawhar 2015; Jawhar 2020; Juelsgaard 2001;
Kato 2002; Kiss 2005; Kumar 2015; Ledin 2012; Li 2008; Li 2009;
Liu 2014; Liu 2017; Liu 2017 b; Matziolis 2004; Molt 2014; Mori
2016; Pfitzner 2014; Tai 2012; Tetro 2001; Vandenbussche 2001;
Vertullo 2017; Wakankar 1999; Wauke 2002; Wu 2018; Zhang
2010; Zhang 2016; Zhou 2011; Zhou 2017). Four studies included
three arms in the study design. Clarke 2001 compared surgery
performed without a tourniquet versus surgery performed with
a tourniquet inflated at low pressure (225 mmHg) and surgery
performed with a tourniquet inflated at high pressure (300 mmHg).
Huang 2017 compared surgery performed with a tourniquet and
multiple doses of tranexamic acid against surgery performed with
a tourniquet only and surgery performed without multiple doses
of tranexamic acid and with no tourniquet. Ozkunt 2018 and
Yavarikia 2010 compared surgery performed without a tourniquet
against surgery performed with a tourniquet inflated for the entire
procedure and surgery performed with the tourniquet inflated only
for implantation of the prosthesis.
With regards to anaesthetic protocol,  14 studies used general
anaesthesia for all participants (Abdel-Salem 1995; Clarke 2001;
Dong 2019; Huang 2017; Kato 2002; Liu 2014; Liu 2017; Liu 2017
b; Ozkunt 2018; Vandenbussche 2001; Wakankar 1999; Wauke
2002; Zhou 2017; Wu 2018). Eight studies reported using spinal
anaesthesia (Aglietti 2000; Ayik 2020; Ejaz 2014; Ejaz 2015; Ejaz
2015 b; Goel 2019; Ledin 2012; Mori 2016; one study reported
using intrathecal anaesthesia (Harston 2015); one study reported
using either general anaesthesia or regional anaesthesia with
a block  (Zhang 2016);  and two studies reported using epidural
anaesthesia (Kiss 2005; Kumar 2015). Two  studies used diBerent
methods of anaesthesia between the two groups; one study
compared hypotensive epidural anaesthesia in surgery without a
tourniquet versus spinal anaesthesia in surgery with a tourniquet
(Juelsgaard 2001), and one study compared epinephrine-
augmented hypotensive epidural anaesthesia in surgery without
a tourniquet versus normotensive epidural anaesthesia in surgery
with a tourniquet (Kiss 2005). Fourteen studies did not explicitly
state the anaesthetic protocol used (Alexandersson 2019; Jawhar
2015; Jawhar 2020; Li 2008; Li 2009; Matziolis 2004; Molt 2014;
Pfitzner 2014; Tai 2012; Tetro 2001; Vertullo 2017; Yavarikia 2010;
Zhang 2010; Zhou 2011).     
Chemical thromboprophylaxis regimens were started in 25 studies,
14 studies reported using heparin-based anticoagulation (Abdel-
Salem 1995; Alexandersson 2019; Ayik 2020; Kiss 2005; Ledin 2012;
Li 2009; Molt 2014; Ozkunt 2018; Tetro 2001; Vandenbussche 2001;
Wauke 2002; Wu 2018; Yavarikia 2010; Zhang 2010), seven studies
reported using rivaroxiban (Ejaz 2014; Ejaz 2015; Ejaz 2015 b; Liu
2017; Liu 2017 b; Zhang 2016; Zhou 2017), and one study used
aspirin (Goel 2019). In three studies, the exact method was not
clearly stated (Clarke 2001; Huang 2017; Wakankar 1999).
Follow-up in the included studies ranged from within hours of the
operation, in Aglietti 2000, Ejaz 2015, Jawhar 2015, and Kato 2002,
to two years in Abdel-Salem 1995, Dong 2019, Ejaz 2015 b, Ledin
2012, and Molt 2014.
Six studies reported sources of study funding. Two were supported
by institutional grants (Harston 2015; Matziolis 2004), and one
was supported by an industrial grant (Liu 2014), Ledin 2012 was
supported by a grant from the Swedish Research Council, Wu 2018
was supported by a science and technology department of Sichaun
Province Grant, and Zhou 2017 received funding from a health
industry special scientific research projects of China grant. The
remainder of the studies did not report a source of funding or did
not receive any further financial support.
The included studies were carried out in 16 diBerent countries:
Australia (Liu 2014; Vertullo 2017), Austria (Kiss 2005), China (Dong
2019; Huang 2017; Li 2008; Li 2009; Liu 2017; Liu 2017 b; Zhang
2010; Zhang 2016; Zhou 2011; Zhou 2017), Denmark (Ejaz 2014;
Ejaz 2015; Ejaz 2015 b; Jawhar 2015; Juelsgaard 2001), France
(Vandenbussche 2001), Germany (Jawhar 2015; Jawhar 2020;
Matziolis 2004; Pfitzner 2014), India (Kumar 2015), Iran (Yavarikia
2010), Italy (Aglietti 2000), Japan (Kato 2002; Mori 2016; Wauke
2002), Kingston (Tetro 2001), Sweden (Alexandersson 2019; Harston
2015; Ledin 2012; Molt 2014), Taiwan (Tai 2012), Turkey (Ayik 2020;
Ozkunt 2018), the United Kingdom (Abdel-Salem 1995; Clarke 2001;
Wakankar 1999), and the USA (Goel 2019).
Participants
All participants were recruited from a secondary care hospital
at which orthopaedic surgeons oBered total knee replacement
surgery. In total, 2819 participants were allocated to surgery
without a tourniquet (n = 1466) or to surgery with a tourniquet (n =
1461). The number of participants per trial ranged from 20 to 199.
When studies reported age and body mass index (BMI), mean age in
the tourniquet group was 69.0 and mean age in the non-tourniquet
group was 68.2. Mean BMI in the tourniquet group was 27.7 and in
the non-tourniquet group 27.8. A total of 944 male participants and
1777 female participants were reported in the studies included in
this review.
Inclusion criteria were comparable between groups when
participants were listed for knee replacement surgery. In most
cases, surgery was performed to treat end-stage osteoarthritis;
however, in five studies, patients with rheumatoid arthritis were
also included (Li 2008; Li 2009; Tetro 2001; Zhang 2016; Zhou 2017).
The main exclusion criteria included a history of diabetes (Abdel-
Salem 1995; Ayik 2020; Ejaz 2014; Ejaz 2015; Ejaz 2015 b;  Goel
2019; Li 2008; Li 2009; Liu 2017; Liu 2017 b; Matziolis 2004;
Vandenbussche 2001; Wakankar 1999), neurovascular or peripheral
vascular disease (Abdel-Salem 1995;  Ayik 2020; Ejaz 2014; Ejaz
2015; Ejaz 2015 b; Goel 2019; Jawhar 2020; Kumar 2015; Li 2008;
Li 2009; Liu 2014; Liu 2017; Liu 2017 b; Matziolis 2004; Tai 2012;
Tetro 2001; Vertullo 2017; Zhang 2010; Zhang 2016), previous open
knee surgery (Aglietti 2000; Alexandersson 2019; Ayik 2020; Clarke
2001; Ejaz 2014; Ejaz 2015; Ejaz 2015 b;  Goel 2019;  Harston
2015; Huang 2017; Liu 2017 b; Molt 2014; Vandenbussche 2001;
Zhou 2017), neoplastic disease or malignancy (Aglietti 2000;
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Jawhar 2015;  Jawhar 2020;  Ledin 2012; Li 2008; Li 2009; Liu
2017; Molt 2014; Wakankar 1999; Zhang 2010), treatment with
anticoagulant medication (Aglietti 2000;  Ayik 2020;  Clarke 2001;
Ejaz 2014; Ejaz 2015; Ejaz 2015 b; Huang 2017; Jawhar 2015; Jawhar
2020;  Juelsgaard 2001; Liu 2017; Liu 2017 b; Mori 2016; Pfitzner
2014; Wu 2018; Zhou 2017), or coagulation disorder (Aglietti 2000;
Jawhar 2015; Jawhar 2020; Kiss 2005; Li 2008; Li 2009; Liu 2017;
Matziolis 2004; Mori 2016; Pfitzner 2014; Tai 2012; Tetro 2001;
Vandenbussche 2001; Wakankar 1999; Yavarikia 2010; Zhang 2010;
Zhang 2016; Zhou 2011; Zhou 2017). Patients were also excluded
if they had BMI greater than 35 (Alexandersson 2019; Ejaz 2014;
Ejaz 2015; Ejaz 2015 b; Molt 2014; Wu 2018), American Society
of Anesthesiologists (ASA) grade greater than IV (Huang 2017),
anaemia (defined as haemoglobin < 10) (Huang 2017; Li 2008; Li
2009; Zhang 2010), known infection within the knee (Jawhar 2020
Liu 2014; Liu 2017; Molt 2014; Tetro 2001; Wu 2018; Zhang 2010),
or a history of cardiovascular disease (Dong 2019; Jawhar 2015;
Juelsgaard 2001; Kiss 2005; Kumar 2015; Ledin 2012; Li 2009; Liu
2017; Liu 2017 b; Ozkunt 2018; Tai 2012; Wu 2018; Zhou 2017).
Fourteen studies excluded participants undergoing bilateral knee
surgery (Alexandersson 2019; Dong 2019; Ejaz 2014; Ejaz 2015; Ejaz
2015 b;  Goel 2019; Huang 2017; Ledin 2012; Li 2009; Tetro 2001;
Wakankar 1999;Vandenbussche 2001;Zhang 2016;Zhou 2017).
A postoperative antibiotic regimen was clearly provided in 13
studies and regimens were comparable amongst studies (Abdel-
Salem 1995; Alexandersson 2019; Ejaz 2014; Ejaz 2015; Ejaz 2015 b;
Goel 2019; Kumar 2015; Ledin 2012; Li 2008; Ozkunt 2018; Wakankar
1999; Yavarikia 2010; Zhang 2016). The duration of illness was
unspecified in all studies included in this review. For further details
on eligibility criteria and participant characteristics in the included
studies, see Characteristics of included studies.
Mean preoperative pain scores were reported in six studies and
were comparable between groups. Mean preoperative pain score
in the tourniquet group was 6.53 (0.75) and in the non-tourniquet
group 6.54 (0.76) in a study by Liu 2017 b. Zhang 2016  reported
mean preoperative pain score of 3.87 (1.19) in the tourniquet
group and 3.62 (0.91) in the non-tourniquet group; Alexandersson
2019 reported a mean preoperative pain score of 1.84 (2.44) in the
tourniquet group and 1.71 (1.93) in the non-tourniquet group; Ayik
2020  reported a mean preoperative pain score of 6 (0.8) in the
tourniquet group and 7 (0.75) in the non-tourniquet group; Dong
2019  reported a mean pain score of 2.14 (0.83) in the tourniquet
group and 2.22 (0.81) in the non-tourniquet group; and Goel
2019  reported a mean pain score of 5.19 (2.54) in the tourniquet
group and 5.74 (2.48) in the non-tourniquet group.
Mean preoperative knee function scores were reported in seven
studies and were comparable between the two groups. Huang
2017  reported a mean preoperative Hospital for Special Surgery
(HSS) score of 45.1 (11.8) in the surgery with a tourniquet group
and 45.9 (11.2) in the surgery without a tourniquet group.  This
is similar to Zhou 2011,  which reported preoperative figures of
47.7 (11.8) and 49.6 (12.3) for the two groups. Three studies
reported KSS scores preoperatively: Liu 2014  reported a score of
51.2 (5) in the tourniquet group and 51.3 (4.8) in the non-tourniquet
group; Ozkunt 2018 reported a preoperative KSS score of 63 (5.68)
in the surgery with a tourniquet group and 82 (6.21) in the non-
tourniquet group; and  Ayik 2020  reported a mean KSS score of
42 (16) in the tourniquet group and 43 (15) in the non-tourniquet
group. Jawhar 2020 reported a mean preoperative OKS score of 39
in the tourniquet group and 40 in the non-tourniquet group. Goel
2019 reported mean preoperative KOOS scores; the mean score for
activities of daily living was 50.69 (19.70) in the tourniquet group
and 50.59 (17.56) in the non-tourniquet group.
Interventions
Details of interventions are provided in the Characteristics of
included studies section.
Number of surgeons
Seventeen studies clearly stated that a single surgeon performed
all procedures (Abdel-Salem 1995; Aglietti 2000; Ayik 2020; Huang
2017; Kato 2002; Kumar 2015; Liu 2017; Liu 2017 b; Matziolis
2004;  Ozkunt 2018; Pfitzner 2014;  Vandenbussche 2001; Vertullo
2017; Zhang 2010; Zhang 2016;  Zhou 2017;  Wu 2018). In three
studies, two surgeons performed all procedures (Goel 2019; Molt
2014; Mori 2016); in two studies, three surgeons performed all
procedures (Juelsgaard 2001;  Ledin 2012); in one study, four
surgeons performed all procedures (Li 2009); and in one study,
seven surgeons were responsible for performing all procedures
(Alexandersson 2019).
Types of knee replacement
All procedures were primary total knee replacement surgery. None
of the included studies reported outcomes in patients undergoing
revision or partial knee replacement surgery. Although the types of
total knee replacement components diBered between studies, all
prostheses were implanted following cementation; in most studies,
a posterior cruciate retaining implant was used. When reported,
seven studies resurfaced the patella in all cases and six studies did
not resurface the patella in all cases. All surgery was open surgery
performed predominantly via a para-patellar approach.
Tourniquet pressures
Thirty-six studies reported tourniquet pressure in the protocol.
Seven studies reported tourniquet pressure of 250 mmHg (Clarke
2001; Ejaz 2014; Ejaz 2015; Ejaz 2015 b; Mori 2016; Wu 2018;
Yavarikia 2010); ten  studies reported tourniquet pressure of 100
mmHg above the patient's systolic blood pressure (Ayik 2020; Dong
2019; Harston 2015; Huang 2017; Kumar 2015; Li 2008; Li 2009; Tai
2012; Wauke 2002; Zhang 2010); three studies reported tourniquet
pressure of 125 mmHg above systolic blood pressure (Liu 2017; Liu
2017 b; Tetro 2001; and nine studies reported tourniquet pressure
of 300 to 350 mmHg (Alexandersson 2019; Juelsgaard 2001; Kato
2002; Kiss 2005; Liu 2014; Molt 2014; Vandenbussche 2001; Vertullo
2017; Pfitzner 2014). Studies reported tourniquet pressure of 0.8 bar
(Aglietti 2000), 360 to 380 mmHg (Jawhar 2015; Jawhar 2020), 275
mmHg (Ledin 2012), 400 mmHg (Matziolis 2004), 13.3 kPa (Zhang
2016, 225 or 300 mmHg (dependent on surgeon preference) (Goel
2019), and twice the systolic blood pressure (Wakankar 1999).
Rehabilitation regimens
Postoperatively, when studies specifically reported rehabilitation
regimens, participants were allowed to mobilise under supervision
on day 2  in eight studies  (Abdel-Salem 1995;  Ayik 2020;  Clarke
2001; Kiss 2005; Kumar 2015; Li 2009; Liu 2017 b;  Vandenbussche
2001) and on day 1 in six studies  (Alexandersson 2019;  Huang
2017; Tai 2012; Tetro 2001; Yavarikia 2010; Zhou 2011). Continuous
passive motion was used in five studies  (Abdel-Salem 1995; Kiss
2005; Li 2008; Liu 2017; Vandenbussche 2001).
Tourniquet use for knee replacement surgery (Review)













Eighteen studies reported pain scores as an outcome measure. All
studies reported pain using a 10-point visual analogue scale (VAS),
with higher scores indicating more pain. Eight studies reported
pain on the first postoperative day  (Abdel-Salem 1995;  Dong
2019;  Kumar 2015; Li 2008; Liu 2014; Liu 2017;  Tai 2012;
Alexandersson 2019); six studies reported pain on day 2  (Dong
2019;  Kumar 2015; Li 2008; Liu 2017; Pfitzner 2014; Tai 2012);
10 studies reported pain on day 3  (Alexandersson 2019; Dong
2019; Ejaz 2014; Kumar 2015; Ledin 2012; Liu 2014; Liu 2017;
Pfitzner 2014; Tai 2012; Zhang 2016); six studies reported pain
scores at two weeks (Dong 2019; Kumar 2015; Li 2008; Liu 2017;
Tai 2012; Zhang 2016); and seven studies reported pain scores
at four to six weeks postoperatively (Alexandersson 2019; Ayik
2020; Goel 2019; Kumar 2015; Liu 2017; Ozkunt 2018; Zhang 2016).
One study  reported a change in pain score at one and six weeks
postoperatively (Wakankar 1999; however, these investigators did
not report baseline values. One study  reported that pain was
collected as an outcome but did not include any data in the results
section (Vandenbussche 2001). One study reported pain graphically
without any raw values, and we were unable to extract the data
(Zhou 2017).
Function
Ten studies reported function scores as an outcome measure
(Abdel-Salem 1995;Ayik 2020;  Ejaz 2014; Goel 2019; Huang 2017;
Jawhar 2020; Liu 2014; Liu 2017 b; Ozkunt 2018; Zhou 2017). One
study reported HSS score at 12 months (Abdel-Salem 1995), and
two studies reported HSS score at six months (Huang 2017; Zhou
2017). Three studies  reported KOOS: one at three months (Goel
2019), and two at 12 months postoperatively (Ejaz 2014; Goel
2019). Two studies reported in the methods that OKS scores will be
collected for all participants (Jawhar 2020; Liu 2014; however, for
one study, no data were provided in the results section (Liu 2014).
Four studies reported KSS score: three at three months (Ayik 2020;
Ozkunt 2018; Liu 2017 b), and one at 12 months postoperatively (Liu
2017 b).
Global assessment of success
One study with 100 participants reported global assessment of
success in terms of patient satisfaction (Huang 2017). Investigators
reported the satisfaction level of participants based on a six-point
Likert scale ranging from extremely satisfied to very dissatisfied at
discharge and at one, three, and six months aJer surgery. Results
were reported as the number of patients who selected each option
at each time point. Goel 2019  reported participant satisfaction
based on a VAS at three months and at six months; however, study
authors did not report what a 'satisfactory' score was, and so the
data were not included in the analysis.
Health-related quality of life
One study with 122 participants reported SF-12 scores at six weeks
and at eight months postoperatively (Goel 2019). One study with
99 participants reported EQ-5D index and VAS scores at six weeks,
six months, and 12 months (Jawhar 2020; however, we did not pool
these data with data from the other study because we could not
access standard deviations of the mean scores despite contacting
study authors.
Serious adverse events
In all, 21 studies reported serious adverse events as defined in
the methods section (Abdel-Salem 1995; Alexandersson 2019; Ejaz
2015 b; Goel 2019; Huang 2017; Jawhar 2020; Kato 2002; Li 2008;
Liu 2017; Liu 2017 b; Matziolis 2004; Molt 2014; Mori 2016; Tetro
2001; Vandenbussche 2001; Wakankar 1999; Wauke 2002; Wu 2018;
Zhang 2010; Zhang 2016; Zhou 2017). 17 studies reported deep
vein thrombosis (DVT) as an SAE (Abdel-Salem 1995; Ejaz 2015
b; Goel 2019; Huang 2017; Jawhar 2020; Li 2008; Liu 2017 b; Molt
2014; Mori 2016; Tetro 2001; Vandenbussche 2001; Wakankar 1999;
Wauke 2002; Wu 2018; Zhang 2010; Zhang 2016; Zhou 2017); five
reported pulmonary embolism (PE) (Huang 2017; Kato 2002; Mori
2016; Wauke 2002; Wu 2018); one reported incidence of stroke as
an SAE (Molt 2014); two reported nerve damage (Matziolis 2004;
Vandenbussche 2001); 12 reported infection (Abdel-Salem 1995;
Alexandersson 2019;  Goel 2019;  Huang 2017;  Jawhar 2020;  Liu
2017; Liu 2017 b; Matziolis 2004; Tetro 2001; Vandenbussche 2001;
Wu 2018; Zhou 2017); four reported re-operation for reasons
other than revision surgery (Jawhar 2020; Li 2008; Matziolis 2004;
Wakankar 1999); and two reported the number of deaths (Molt
2014; Wakankar 1999).
Cognitive function
One study with 129 participants reported MoCA scores at days 1,
2, 3,  and 7  postoperatively (Dong 2019). However, investigators
reported these data only graphically, and despite contacting them,
we were unable to obtain mean and SD values.
Survival of implant
We could not estimate the risk of revision due to the small total
number of events. Studies included in this review had  follow-up
limited to between one day and two years. Two studies with 164
participants reported the risk of revision surgery up to one year
(Liu 2017; Liu 2017 b). However, investigators reported only two
revisions; all were performed in the group that had  total knee
replacement with a tourniquet. One study with 50 participants
reported risk of revision surgery up to two years (Ledin 2012).
However, only one revision was performed, and this took place in
the group that had total knee replacement without a tourniquet.
Minor outcomes
Blood loss
FiJeen studies reported intraoperative blood loss (Aglietti 2000;
Dong 2019;  Ejaz 2015 b; Harston 2015; Huang 2017; Juelsgaard
2001; Kato 2002; Li 2008; Li 2009; Tai 2012; Tetro 2001; Wu
2018; Zhang 2010; Zhang 2016; Zhou 2017), which was measured
by volume in the suction tubing and weight of the sponges.
Twelve studies reported postoperative blood loss (Aglietti 2000;
Huang 2017; Juelsgaard 2001; Li 2008; Li 2009; Liu 2014; Ozkunt
2018; Vandenbussche 2001; Wauke 2002; Wu 2018; Zhang 2010;
Zhou 2017), which was measured through volume in the drains.
Eighteen studies reported overall blood loss (Abdel-Salem 1995;
Aglietti 2000; Dong 2019; Goel 2019; Huang 2017; Juelsgaard 2001;
Ledin 2012; Li 2008; Li 2009; Mori 2016; Pfitzner 2014; Tai 2012;
Tetro 2001; Vandenbussche 2001; Wu 2018; Yavarikia 2010; Zhang
2010; Zhou 2017), which was measured as combined intraoperative
and postoperative blood loss or by the formula described in
Gross 1983. Seventeen studies reported the number of units of
blood transfused to patients in each group (Alexandersson 2019;
Clarke 2001; Ejaz 2015 b; Huang 2017; Kiss 2005; Ledin 2012;
Tourniquet use for knee replacement surgery (Review)









Cochrane Database of Systematic Reviews
Li 2008; Liu 2014; Matziolis 2004; Molt 2014; Ozkunt 2018; Tai
2012; Tetro 2001; Vandenbussche 2001; Wu 2018; Zhang 2016;
Zhou 2017); three reported the volume of blood transfused in
each group (Juelsgaard 2001; Kato 2002; Yavarikia 2010); nine
reported the change in haemoglobin concentration as the change
in concentration between the postoperative blood test and the
preoperative sample (Alexandersson 2019; Kiss 2005; Li 2008;
Matziolis 2004; Tai 2012; Tetro 2001; Yavarikia 2010; Wu 2018; Zhang
2016); and three reported a change in haematocrit concentration
between preoperative and postoperative blood samples (Tai 2012;
Yavarikia 2010; Zhou 2011).
Economic outcomes
None of the included studies reported resource usage.
Twelve studies reported length of stay measured in days from the
date of admission to the date of discharge (Abdel-Salem 1995;
Harston 2015; Huang 2017; Ledin 2012; Liu 2014; Molt 2014; Tai
2012; Tetro 2001; Vandenbussche 2001; Wu 2018; Zhang 2016;
Zhou 2017). Twenty-seven studies reported duration of surgery
measured in minutes (Aglietti 2000;  Ayik 2020; Dong 2019; Ejaz
2015 b; Goel 2019; Harston 2015; Huang 2017; Jawhar 2015; Kato
2002; Kiss 2005; Ledin 2012; Li 2008; Li 2009; Liu 2014; Liu 2017; Liu
2017 b; Matziolis 2004; Molt 2014; Mori 2016; Tai 2012; Tetro 2001;
Vandenbussche 2001; Wauke 2002; Wu 2018; Yavarikia 2010; Zhang
2016; Zhou 2017).
Implant stability
Two studies measured implant stability using
radiostereometric  (RSA)  analysis (Ejaz 2014;  Molt 2014). These
studies reported maximum  total point motion (MTPM) at
eight weeks, at six months, at one year, and at two years.
Excluded studies
Randomised studies
Twelve studies were excluded following full-text screening.
Six studies used a study comparator that did not meet our
inclusion criteria. Brin 2015  and Dennis 2016  used a tourniquet
for a reduced duration as the comparator. Friedrich 1990  used
diBerent regimens of tourniquet inflation as a comparator. Husted
2005  compared surgery with a tourniquet inflated in a straight
knee versus a tourniquet inflated in a fully flexed knee. Padala
2004 compared surgery with a tourniquet and drains versus surgery
without a drain. Nielsen 2016  compared topical versus systemic
tranexamic acid application.
Harvey 1997 Huang 2015 and Nicolaiciuc 2019b used a study design
that did not meet our inclusion criteria.
Dorr 2014 was a commentary piece.
Mourikis 2009 was a supplementary piece for a study that did not
meet our inclusion criteria.
Non-randomised studies
Sixteen non-randomised studies were excluded following full-text
screening because they had  a sample size less than 1000 (Ajnin
2020; Bakker 2019; Barros 2017; Burg 2009; Fakuda 2007; Hasanain
2018; Jarolem 1995; Kheir 2018; Matziolis 2011; Mourikis 2009;
Mutlu 2015; Nicolaiciuc 2019; Nishiguchi 2008; Schimizu 2016;
Schnettler 2017; Stroh 2011; Zhang 2019). We also searched registry
reports; however, no registry report included data specifically
related to tourniquet use and the outcomes of interest in this
review.
Further details can be seen in Characteristics of excluded studies.
Ongoing studies
Following our search of trial registries, we identified 12 ongoing
studies; for further details on study design, interventions, and
outcomes, please see the Characteristics of ongoing studies
section.
Risk of bias in included studies
The summary of risk of bias is presented in Figure 3  and  Figure
4. Three trials met all methodological criteria for low risk of bias
(Alexandersson 2019; Ayik 2020; Huang 2017). The other trials had
sources of bias including unclear risk of selection bias, performance
bias, and detection bias as blinding was not clearly stated in the
methods nor in the protocol. The assessment of each domain of risk
of bias for the included studies is summarised in the Characteristics
of included studies section.
 
Figure 3.   Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages
across all included studies.
Random sequence generation (selection bias)
Allocation concealment (selection bias)
Blinding of participants and personnel (performance bias): All outcomes
Blinding of outcome assessment - self-reported outcomes (detection bias)
Blinding of outcome assessment - assessor reported outcomes (detection bias)
Incomplete outcome data (attrition bias): All outcomes
Selective reporting (reporting bias)
Other bias
0% 25% 50% 75% 100%
Low risk of bias Unclear risk of bias High risk of bias
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Abdel-Salem 1995 ? ? ? ? ? ? ? +
Aglietti 2000 ? ? ? + ? + ? +
Alexandersson 2019 + + + + + + + +
Ayik 2020 + + + + ? + + +
Clarke 2001 ? + ? + ? ? ? +
Dong 2019 ? ? ? ? ? + + +
Ejaz 2014 + + + + ? + + +
Ejaz 2015 + + + + ? + + +
Ejaz 2015 b + + + + ? + + +
Goel 2019 + + + + + + + +
Harston 2015 + + - - + + + +
Huang 2017 + + + + + + + +
Jawhar 2015 + ? ? ? ? ? - +
Jawhar 2020 + ? ? ? ? + + +
Juelsgaard 2001 ? ? + + ? ? ? -
Kato 2002 ? ? ? ? ? ? ? +
Kiss 2005 ? ? ? + + + + -
Kumar 2015 + ? ? ? + ? ? +
Ledin 2012 + + + + + + ? +
Li 2008 ? ? + + + + ? +
Li 2009 + - + + + ? ? +
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Figure 4.   (Continued)
Li 2008 ? ? + + + + ? +
Li 2009 + - + + + ? ? +
Liu 2014 + ? + + + + ? +
Liu 2017 + ? ? ? + ? ? +
Liu 2017 b + ? ? + + ? ? +
Matziolis 2004 + - ? + ? ? ? +
Molt 2014 ? + ? ? ? + + +
Mori 2016 + ? ? ? ? + ? +
Ozkunt 2018 ? ? ? ? ? + ? +
Pfitzner 2014 ? + ? ? ? + ? +
Tai 2012 ? + + + + + ? +
Tetro 2001 ? + + + - + ? +
Vandenbussche 2001 ? + + + + + ? +
Vertullo 2017 + ? ? + + + ? +
Wakankar 1999 + ? ? ? ? + ? +
Wauke 2002 ? ? ? ? ? + ? +
Wu 2018 + + + + - + + +
Yavarikia 2010 ? + ? + ? ? ? +
Zhang 2010 + - ? ? ? ? ? +
Zhang 2016 ? ? ? ? ? + ? +
Zhou 2011 + + ? ? + + ? +
Zhou 2017 + + ? ? ? + + +
 
Allocation
Overall, 12 studies (29%) had low risk of selection bias due to
both random sequence generation and allocation concealment
(Alexandersson 2019; Ayik 2020; Ejaz 2014; Ejaz 2015; Ejaz 2015 b;
Goel 2019; Harston 2015; Huang 2017; Ledin 2012; Wu 2018; Zhou
2011; Zhou 2017). The remainder of studies (29 studies (71%)) had
either unclear or high risk of bias for one of the two domains (Abdel-
Salem 1995; Aglietti 2000; Clarke 2001; Dong 2019; Jawhar 2015;
Jawhar 2020; Juelsgaard 2001; Kato 2002; Kiss 2005; Kumar 2015;
Li 2008; Li 2009; Liu 2014; Liu 2017; Liu 2017 b; Matziolis 2004; Molt
2014; Mori 2016; Ozkunt 2018; Pfitzner 2014; Tai 2012; Tetro 2001;
Vandenbussche 2001; Vertullo 2017; Wakankar 1999; Wauke 2002;
Yavarikia 2010; Zhang 2010; Zhang 2016). Further details can be
found below.
A total of 24 studies (59%) had low risk of selection bias as
the random sequence generation was clearly stated as computer
generated  (Alexandersson 2019; Goel 2019; Harston 2015; Huang
2017; Jawhar 2015; Jawhar 2020; Liu 2014; Matziolis 2004; Vertullo
2017; Wu 2018; Zhou 2011; Zhou 2017) or block randomised (Ayik
2020; Ejaz 2014; Ejaz 2015; Ejaz 2015 b; Ledin 2012), or based
on a random number list (Li 2009; Liu 2017; Liu 2017 b; Mori
2016; Wakankar 1999; Zhang 2010) or a coin toss (Kumar 2015).
The remaining studies were deemed to have unclear risk due to
failure to explicitly state their randomisation method (Abdel-Salem
1995; Aglietti 2000; Clarke 2001; Dong 2019; Juelsgaard 2001; Kato
2002; Kiss 2005; Li 2008; Mori 2016; Ozkunt 2018; Pfitzner 2014; Tai
2012; Tetro 2001; Vandenbussche 2001; Wauke 2002; Yavarikia 2010;
Zhang 2016).
Nineteen of 41 studies (46%) were deemed to have low risk
of selection bias due to allocation concealment. These studies
used sealed envelopes (Alexandersson 2019; Ayik 2020; Clarke
2001; Ejaz 2014; Ejaz 2015; Ejaz 2015 b; Goel 2019; Harston
2015; Huang 2017; Ledin 2012; Molt 2014; Pfitzner 2014; Tai 2012;
Tetro 2001; Vandenbussche 2001; Wu 2018; Yavarikia 2010; Zhou
2011; Zhou 2017). Three studies were deemed at high risk due
to an open random allocation schedule (Li 2009; Matziolis 2004;
Zhang 2010); the remainder were deemed to have unclear risk
due to failure to explicitly state allocation concealment methods
(Abdel-Salem 1995; Aglietti 2000; Dong 2019; Jawhar 2015; Jawhar
2020; Juelsgaard 2001; Kato 2002; Kiss 2005; Kumar 2015; Li 2008;
Liu 2014; Liu 2017; Liu 2017 b; Mori 2016; Ozkunt 2018; Vertullo 2017;
Wakankar 1999; Wauke 2002; Zhang 2016).
Blinding
Performance bias
Due to the nature of the intervention, it was not possible for
studies to blind the surgeons delivering the intervention. Despite
this, it is unlikely that surgeons would want or would be able
to alter their performance in these studies for main outcomes of
interest. Duration of surgery is the most vulnerable outcome in this
context. Sixteen studies (39%) were deemed to have low risk of
performance bias as participants were blinded to the intervention
(Alexandersson 2019; Ayik 2020; Goel 2019; Ejaz 2014; Ejaz 2015;
Ejaz 2015 b; Huang 2017;  Juelsgaard 2001; Ledin 2012; Li 2008;
Li 2009; Liu 2014; Tai 2012; Tetro 2001; Vandenbussche 2001;
Wu 2018). One study (4%) was deemed to have high risk as
participants were aware of their treatment intervention (Harston
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2015). Remaining studies (57%) were deemed to have unclear risk
as blinding was not explicitly stated in the methods (Abdel-Salem
1995; Aglietti 2000; Clarke 2001; Dong 2019; Jawhar 2015; Jawhar
2020; Kato 2002; Kiss 2005; Kumar 2015; Liu 2017; Liu 2017 b;
Matziolis 2004; Molt 2014; Mori 2016; Ozkunt 2018; Pfitzner 2014;
Vertullo 2017; Wakankar 1999; Wauke 2002; Yavarikia 2010; Zhang
2010; Zhang 2016; Zhou 2011; Zhou 2017).
Detection bias
Detection bias was assessed for both self-reported outcomes (e.g.
pain, function, global assessment of success, SAEs) and assessor-
reported outcomes (e.g. implant stability, blood loss). Twenty-three
(56%) studies were deemed to have low risk of detection bias
for self-reported outcomes due to blinding of participants (Aglietti
2000; Alexandersson 2019; Ayik 2020; Clarke 2001; Ejaz 2014; Ejaz
2015; Ejaz 2015 b; Goel 2019; Huang 2017; Juelsgaard 2001; Kiss
2005; Ledin 2012; Li 2008; Li 2009; Liu 2014; Liu 2017 b; Matziolis
2004; Tai 2012; Tetro 2001; Vandenbussche 2001; Vertullo 2017; Wu
2018; Yavarikia 2010); one study (2%) was deemed to have high
risk as participants were not blinded and were responsible for self-
reported outcomes (Harston 2015), Seventeen studies (42%) were
deemed to have unclear risk of detection bias as how outcomes
were reported was not explicitly stated in the methods (Abdel-
Salem 1995; Dong 2019; Jawhar 2015; Jawhar 2020; Kato 2002;
Kumar 2015; Liu 2017; Molt 2014; Mori 2016; Ozkunt 2018; Pfitzner
2014; Wakankar 1999; Wauke 2002; Zhang 2010; Zhang 2016; Zhou
2011; Zhou 2017).
Sixteen studies (39%) had low risk of detection bias for assessor-
reported outcomes (e.g. duration of surgery, length of hospital
stay, blood loss, RSA analysis) as the methods clearly stated
that outcome assessors were blinded (Alexandersson 2019; Goel
2019; Harston 2015; Huang 2017; Kiss 2005; Kumar 2015; Ledin
2012; Li 2008; Li 2009; Liu 2014; Liu 2017; Liu 2017 b; Tai 2012;
Vandenbussche 2001; Vertullo 2017; Zhou 2011). Twenty-three
studies (56%) had unclear risk of detection bias for assessor-
reported outcomes as it was not explicitly stated in the methods
whether outcome assessors were blinded (Abdel-Salem 1995;
Aglietti 2000; Ayik 2020; Clarke 2001; Dong 2019; Ejaz 2014; Ejaz
2015; Ejaz 2015 b; Jawhar 2015; Jawhar 2020; Juelsgaard 2001; Kato
2002; Matziolis 2004; Molt 2014; Mori 2016; Ozkunt 2018; Pfitzner
2014; Wakankar 1999; Wauke 2002; Yavarikia 2010; Zhang 2010;
Zhang 2016; Zhou 2017). Two studies (5%) were deemed to have
high risk as outcome assessors were not blinded (Tetro 2001; Wu
2018).
Incomplete outcome data
Twelve (29%) studies were deemed to have unclear risk of attrition
bias due to incomplete reporting of attrition (Abdel-Salem 1995;
Clarke 2001;  Jawhar 2015; Juelsgaard 2001; Kato 2002;  Kumar
2015; Li 2009; Liu 2017 Liu 2017 b; Matziolis 2004; Yavarikia 2010;
Zhang 2010). These studies did not include CONSORT diagrams and
did not clearly state the reasons for missing outcome data. The
remainder of studies were deemed as having low risk of attrition
bias. In these studies, no outcome data were missing or the missing
outcome data were balanced in number across intervention groups
with similar reasons for missing data across groups.
Selective reporting
Fourteen (34%) studies were deemed to have low risk of reporting
bias (Alexandersson 2019; Ayik 2020; Dong 2019; Ejaz 2014; Ejaz
2015; Ejaz 2015 b; Goel 2019; Harston 2015; Huang 2017; Jawhar
2020; Kiss 2005; Molt 2014; Wu 2018; Zhou 2017). These studies
reported all outcomes clearly specified in the trial registration
document, protocol, or methods. The remaining studies were
deemed to have unclear risk due to insuBicient information to
permit judgement. These studies were not registered at a clinical
trials registry and had no accessible protocol. One study (3%) was
deemed to have high risk as outcomes clearly stated in the protocol
were not reported in the final study report (Jawhar 2015).
Other potential sources of bias
Two studies (5%) were deemed to have an additional source
of bias related to  study design. In both these studies, the
comparators were diBerent methods of anaesthesia used in
the group that had a  tourniquet and in the group that did
not. Measured outcomes therefore could have been biased by
additional diBerences in interventions other than those of interest.
Juelsgaard 2001  investigated surgery with epidural anaesthesia
without a tourniquet versus spinal anaesthesia with a tourniquet;
blood loss and transfusion rate were the outcomes of interest. Kiss
2005  compared epinephrine-augmented hypotensive epidural
anaesthesia without a tourniquet versus  normotensive epidural
anaesthesia with a tourniquet.
E<ects of interventions
See: Summary of findings 1 Knee replacement with tourniquet
compared to knee replacement without tourniquet
The results described were derived when knee replacement
with a tourniquet was compared to knee replacement  without
a tourniquet. None of the included studies reported the eBect
of tourniquet use  on unicondylar or revision knee replacement
surgery. All studies reported the eBects of an inflatable tourniquet;
no studies reported eBects of a non-inflatable tourniquet.
Major outcomes
Pain
The primary endpoint for pain was day 1 postoperative pain scores,
as this is the point at which the intervention is likely to have the
greatest eBect. Moderate-quality evidence based on eight studies
of 577 participants shows that postoperative pain scores were
statistically significantly higher on day 1 postoperatively  in the
surgery with a tourniquet group compared to the surgery without
a tourniquet group (Abdel-Salem 1995; Alexandersson 2019; Dong
2019; Kumar 2015; Li 2008; Liu 2014; Liu 2017; Tai 2012). The mean
pain score in the surgery without a tourniquet group was 4.56,
and the mean pain score in the surgery with a tourniquet group
was 5.81. The mean diBerence was 1.25 (95% confidence interval
(CI) 0.32 to  2.19) (with higher pain scores in the surgery with a
tourniquet group). The I2  value was 94%; the most likely reason
for this considerable heterogeneity is clinical diversity, which is
explored in the discussion. Further details of the analysis can be
seen in Analysis 1.1. Although the mean diBerence is above the
threshold for clinical significance based on a minimum clinically
important diBerence (MCID) for VAS for pain of one  (Dworkin
2008; Kelly 2001; Wall 2017), the lower boundary of the confidence
interval indicates that the results may or may not be clinical
noticeable to the patient. The relative per cent change was 19%
worse (3.4% worse to 49% worse) for pain scores in the surgery with
a tourniquet group.
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Postoperative pain levels can fluctuate and are likely to be higher in
the the early postoperative phase; therefore, we analysed the data
on diBerent postoperative days.
Six studies involving 394 participants reported pain two  days
postoperatively (Dong 2019; Kumar 2015; Li 2008; Liu 2014; Pfitzner
2014; Tai 2012). Tourniquet use  was associated with a mean
diBerence of 0.37 (95% CI -0.03 to 0.76; I2 = 48%) for higher pain
scores compared to not using a tourniquet; however, this diBerence
was not statistically significant.
Ten studies involving 807 participants reported postoperative pain
at day 3 (Alexandersson 2019; Dong 2019; Ejaz 2014; Kumar 2015;
Ledin 2012; Liu 2014;  Liu 2017;  Pfitzner 2014;  Tai 2012; Zhang
2016). Using a tourniquet was associated with a significantly higher
pain score  when compared to not using a tourniquet. A mean
diBerence  of 0.78 (95% CI 0.34 to 1.23; I2 = 87%) was noted for
higher pain scores when a tourniquet was used compared to when
a tourniquet was not used.
Six studies involving 562 participants reported postoperative pain
at two weeks (Dong 2019;  Kumar 2015; Li 2008; Liu 2017;  Tai
2012;  Zhang 2016).  Using a tourniquet was associated with a
statistically significantly higher postoperative mean pain score
when compared to not using a tourniquet (mean diBerence (MD)
0.32, 95% CI 0.12 to 0.53; I2 = 72%).
Six studies involving 637 participants reported postoperative pain
at the six-week stage (Alexandersson 2019; Goel 2019; Kumar 2015;
Liu 2017; Ozkunt 2018; Zhang 2016). There was no significant
diBerence in pain scores between the two groups (MD 0.38, 95% CI
-0.48 to 1.23; I2 = 98%).
Four other studies reported pain as an outcome; however, these
data were not included in the pooled results as we could not
accurately extract the data from graphical plots, or because
raw data were not available despite contact with study authors.
Vandenbussche 2001 and Zhou 2017 reported pain scores that were
significantly lower in the group without a tourniquet compared to
the group with a tourniquet. Wakankar 1999 reported no significant
diBerence between treatment groups.  Wu 2018  reported that
surgery with a tourniquet was associated with significantly higher
pain scores at days 1, 2, and 3 postoperatively. There was no
significant diBerence between the two groups at one month and at
six months postoperatively.
Function
Nine studies investigated the eBects of tourniquet use on knee
function scores (Abdel-Salem 1995;  Ayik 2020;  Ejaz 2015 b;  Goel
2019;  Huang 2017; Jawhar 2015;  Liu 2017 b; Ozkunt 2018; Zhou
2017). For all reported outcomes measuring function, higher score
indicates better function.
Three studies reported change in HSS score.  Abdel-Salem
1995  found no diBerence between the tourniquet group and the
control group in HSS at one year postoperatively (mean HHS 23
in the tourniquet group versus 26 in the control group). Huang
2017 reported change in HSS at six months postoperatively with no
significant diBerence between the two groups (mean HSS 45 in the
tourniquet group versus 44.7 in the group without a tourniquet).
Zhou 2017 reported no significant diBerence in change in HSS score
at six months (mean HSS 43 in the tourniquet group versus 40.2 in
the group without a tourniquet).
Liu 2017 b reported 12-month KSS scores and found no significant
diBerences between the two groups. The mean KSS score in the
surgery with a tourniquet group was 93.2, and it was 93.3 in the
surgery without a tourniquet group. Investigators also  found no
significant diBerences in KSS score between the two groups at
three  months (90.3 in the tourniquet group and 90.2 in the no
tourniquet group). Ozkunt 2018 found that using a tourniquet was
associated with a significantly lower KSS score at three months
compared to not using a tourniquet (mean KSS score in the surgery
with a tourniquet group was 63, and it was 82 in the group without a
tourniquet; P = 0.02). Ayik 2020 found no diBerence in KSS scores at
three months between the two groups, with a mean KSS score of 79
in the tourniquet group and 76 in the group without a tourniquet.
Ejaz 2015 b reported the change in KOOS score up to 12 months
postoperatively between the group with a tourniquet and the group
without a tourniquet. These investigators found no significant
diBerence between the two groups at 12 months postoperatively
in any of the KOOS domains (pain, symptoms, activities of
daily living, sports/recreation, and quality of life). However, at
two months postoperatively, the group without a tourniquet was
associated with significantly higher KOOS scores in all domains.
Goel 2019  found no diBerence in KOOS scores between the
two groups at three  months postoperatively. In particular, the
KOOS activities of daily living (ADL) mean score was 69.15 in the
tourniquet group and 69.06 in the group without a tourniquet.
Four studies involving 425 participants reported three-month
patient-reported functional outcome scores (Ayik 2020; Goel 2019;
Liu 2017 b; Ozkunt 2018). There was no significant diBerence
in these scores at three  months between the two groups. The
standardised mean diBerence between the two groups was a
0.64 lower function score in the tourniquet group (95% CI 1.52
lower to 0.25 higher) compared to the group without a tourniquet
(standardised mean diBerence (SMD) -0.64, 95% CI -1.52 to 0.25; I2
= 94%) (Analysis 1.2). The mean diBerence was calculated using a
reference standard deviation (SD) from a selected study (Liu 2017
b); the mean diBerence was found to be 3.07 (95% CI 7.30 lower to
1.2 higher) lower function scores at three months (7.30 to 1.2) in the
surgery with a tourniquet group. The absolute diBerence is 3.07%
lower (7.3% lower to 1.2% higher) function scores at three months
in the surgery with a tourniquet group. The relative diBerence
is 5.98% (14.2% lower to 2.34% higher) lower function scores in the
surgery with a tourniquet group.
Five studies involving 611 participants reported 12-month patient-
reported functional outcome scores (Abdel-Salem 1995; Goel 2019;
Huang 2017; Liu 2017 b; Zhou 2017). There was no significant
diBerence in these scores at 12 months. The mean score in the
tourniquet group was 89.5, and the mean score in the group
without a tourniquet was 90.0. The standardised mean diBerence
was 0.06 lower (95% CI 0.22 lower to 0.10 higher; I2 = 0%) in the
surgery with a tourniquet group compared to the group without
a tourniquet (Analysis 1.3). The mean diBerence was translated
back from the baseline SD in the control group of a selected paper
(Liu 2017 b).  The mean diBerence was found to be 0.29  points
worse (1.06  worse to 0.48  better) in the tourniquet group. The
absolute diBerence between the two groups was 0.29% worse
for scores in the tourniquet group (1.06% worse to 0.48% better)
than for scores in the surgery with a tourniquet group. Relative
changes were calculated relative to baseline in the surgery with a
tourniquet group (i.e. absolute change (mean diBerence) divided
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by the mean at baseline in the surgery without a tourniquet group)
from Liu 2017 b (values were 51.3 on a 0 to 100 point KSS score
scale for function). The relative diBerence was 0.57% worse scores
(2.07% worse to 0.94% better) in the surgery with a tourniquet
group. The I2 was reported as 0%, and the evidence was graded as
low quality due to risk of bias and imprecision. All patient-reported
functional outcome scores  included were measured on a 0 to
100 scale, with higher scores indicating better outcomes. Previous
studies have demonstrated an MCID of 5.9 for KSS and 5.0 for OKS,
respectively (Chean Lee 2017; Clement 2014).  Therefore none of
the diBerences in patient-reported function were deemed to be
clinically significant, as the minimum diBerence did not exceed the
MCID.
We did not include Ejaz 2015 b in the meta-analysis as no raw
data were available despite contact with study authors. We did not
include Jawhar 2020 in the meta-analysis as study authors reported
OKS and WOMAC scores. Both were diBerent scales from those
used for patient-reported functional scores included in the meta-
analysis. Jawhar 2020  found no significant diBerence in OKS or
WOMAC scores at six weeks or at six months.
Global assessment of success
Based on a single study, we found no evidence of clinically
important between-group diBerences in the proportion of
participants who were satisfied with their treatment. Huang
2017 reported the number of patients satisfied with their procedure
at discharge, at one month, at three months, and at six months.
We grouped the patients reporting that they were 'very satisfied'
or 'extremely satisfied' with their procedure for this review. At
three months, 47 out of 50 participants were satisfied with their
procedure in the surgery with a tourniquet group and 46 out
of 50 participants were satisfied with their procedure in the
group without a tourniquet. The risk ratio was 1.02 (95% CI 0.92 to
1.14) (Analysis 1.4).
At six months, there was no significant diBerence in the number of
participants satisfied with their procedure. At six months, 47 out of
50 participants were satisfied with their procedure in the surgery
with a tourniquet group and 47 out of 50 participants were satisfied
with their procedure in the group without a  tourniquet. The risk
ratio was 1.0 (95% CI 0.91 to 1.10) (Analysis 1.5). The relative per
cent change was 0% (95% CI 10 fewer to 9.4 more) fewer satisfied
following surgery with a tourniquet. The evidence was graded as
moderate quality and was downgraded due to the low total number
of events.
Health-related quality of life
Goel 2019 reported mean SF-12 scores at six  months
postoperatively. There was no significant diBerence in SF-12 scores
between the two groups. The mean SF-12 mental component score
in the tourniquet group was 54.64 (9.33). The mean score in the non-
tourniquet group was 1.53 higher (95% CI 0.85 lower to 3.91 higher).
This led to an absolute eBect of 1.53% better (0.85% worse to 3.91%
better) scores in the non-tourniquet group. Evidence was graded as
low quality due to risk of bias and imprecision (Analysis 1.7).
There was no significant diBerence in SF-12 mental component
scores at six weeks between the two groups. The mean diBerence
was 2.58 (95% CI -0.09 to 5.25) higher scores in the non-tourniquet
group (Analysis 1.6).
Jawhar 2020 reported EQ-5D at six weeks and at six months and
found no significant diBerences between the two groups. The six-
week EQ-5D score was 70 in both groups, and the six-month EQ-5D
score was 74 in the surgery with a tourniquet group and 75 in the
group without a tourniquet. We did not include this in the meta-
analysis, as we could not access the standard deviations of mean
scores despite contact with authors.
Serious adverse events
Based upon moderate-quality evidence from 21 studies involving
1799 participants, the risk of serious adverse events was
significantly greater in the group that had surgery with a tourniquet
compared to the group without a tourniquet  (risk ratio (RR)
1.73, 95% CI 1.10 to 2.73) (Analysis 1.8)  (Abdel-Salem 1995;
Alexandersson 2019; Ejaz 2015 b; Goel 2019; Huang 2017; Jawhar
2020; Kato 2002; Li 2008; Liu 2017; Liu 2017 b; Matziolis 2004;
Molt 2014; Mori 2016; Tetro 2001; Vandenbussche 2001; Wakankar
1999; Wauke 2002; Wu 2018; Zhang 2010; Zhang 2016; Zhou 2011).
The absolute diBerence was 2.99% (0.29% more to 5.00% more)
more SAEs in the surgery with a tourniquet group with a relative
diBerence of 73% (10% more to 173% more) greater risk of SAE in
the tourniquet group. The number needed to treat for additional
harm (NNTH) is 48 (20 to 345) participants to have surgery with
a tourniquet for one SAE. Confidence intervals around absolute
risk demonstrate an eBect equal or greater than 0.29%, which was
deemed to be highly clinically relevant given the seriousness of the
outcome.
Study authors consulted with key stakeholders including patients,
lay members of the public, and surgeons and concluded that an RR
of 1.73 and the precision of this estimate (95% confidence interval
1.1 to 2.73) were highly clinically relevant given the seriousness
of the outcome; therefore this evidence was deemed clinically
significant. The serious adverse events reported included deep
vein thrombosis, pulmonary embolism, infection, re-operation,
and mortality. When studies reported more than one SAE, we would
include the results from only one SAE, as it is unclear whether
one SAE led to the development of another. For example, Wauke
2002 reported two instances of DVT and one of PE in the surgery
with tourniquet group. For the purposes of the meta-analysis, we
reported this as two SAEs.
Two studies reported mortality at 30 days postoperatively (Molt
2014; Wakankar 1999). Molt 2014 reported that there was one death
in the group that had surgery without a tourniquet and no deaths
in the group with a tourniquet. Wakankar 1999 reported two deaths
in the group without a tourniquet and one death in the tourniquet
group. In both these studies, study authors concluded that the
cause of mortality was not related to the treatment interventions.
Seventeen studies involving 1575 participants reported the
incidence of venous thromboembolic events (VTEs) (pulmonary
embolism and deep vein thrombosis) following total knee
replacement surgery (Abdel-Salem 1995;  Ejaz 2015 b;  Goel
2019; Huang 2017; Jawhar 2015; Kato 2002; Li 2008; Liu 2017 b; Molt
2014; Tetro 2001;  Vandenbussche 2001; Wakankar 1999;  Wauke
2002; Wu 2018; Zhang 2016; Zhang 2010; Zhou 2011). Tourniquet
use was associated with significantly higher risk of VTE compared
to surgery without a tourniquet (RR 1.95, 95% CI 0.99 to 3.82; I2 =
0%) (Analysis 1.9).
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Sixteen studies involving 1499 participants reported incidences
of symptomatic deep vein thrombosis following total knee
replacement surgery (Abdel-Salem 1995;  Ejaz 2015 b;  Goel
2019;  Huang 2017;  Jawhar 2020;  Li 2008;  Liu 2017 b; Molt 2014;
Tetro 2001;  Vandenbussche 2001; Wakankar 1999;  Wauke 2002;
Wu 2018;  Zhang 2016;  Zhang 2010; Zhou 2011). Tourniquet use
was associated with higher risk of symptomatic DVT; however, this
diBerence was not significant (RR 1.83, 95% CI 0.92 to 3.65; I2
= 0%). Mori 2016 reported both symptomatic and asymptomatic
DVTs. When data from Mori 2016 were combined with data from
the sixteen studies reporting symptomatic  DVT, a significantly
increased risk of DVT was evident in the group having surgery with
a tourniquet (RR 2.05, 95% CI 1.35 to 3.13; I2 = 0%) (Analysis 1.10).
Five studies involving 416 participants reported the incidence of
pulmonary embolism following total knee replacement surgery
(Huang 2017; Kato 2002; Mori 2016; Wauke 2002; Wu 2018).
There was no significant diBerence in risk of pulmonary
embolism between the two groups (RR 4.51, 95% CI 0.49 to 41.81;
I2 = 0%) (Analysis 1.11).
Three studies involving 157 participants reported the incidence
of re-operation (without revision of components) following total
knee replacement surgery (Li 2008; Matziolis 2004; Wakankar 1999).
There was no significant diBerence in risk of re-operation between
the two groups. Reasons for re-operation included revision of a
superficial wound disorder and manipulation under anaesthesia to
improve flexion and range of motion (RR 1.63, 95% CI 0.61 to 4.34;
I2 = 0%) (Analysis 1.13).
Nine studies involving 846 participants reported the incidence of
wound infection following total knee replacement surgery (Abdel-
Salem 1995; Goel 2019; Huang 2017; Liu 2017; Liu 2017 b; Matziolis
2004; Tetro 2001; Vandenbussche 2001; Zhou 2011). Tourniquet
use was associated with significantly higher risk of developing
wound infection when compared to use of control. The authors of
these studies did not state whether these were superficial or deep
infections, nor did they present the criteria used to diagnose the
infection (RR 2.72, 95% CI 1.15 to 6.42; I2 = 0%) (Analysis 1.12).
Cognitive function
One study involving 122 participants reported MoCA scores at days
1, 2, 3,  and 7  postoperatively (Dong 2019). However, data were
visible only graphically. We were unable to extract data accurately
or to obtain data by contacting study authors. Study authors
reported no diBerence in MoCA scores at day 7  postoperatively
between the two groups.
Survival of the implant
Two studies involving 164 participants reported the risk of revision
surgery up to one year  (Liu 2017; Liu 2017 b), and one study
involving 50 participants reported the risk of revision surgery up to
two years (Ledin 2012). It is uncertain if knee replacement with a
tourniquet has an eBect on survival of the implant up to two years
(RR 1.44, 95% CI 0.23 to 8.92; I2 = 0%) (Analysis 1.14). There was
an absolute diBerence of 0.4% more (0.7% lower to 7% more). The
relative diBerence was 44% higher (77% lower to 892% higher) in
the surgery with a tourniquet group. This evidence was graded as




FiJeen studies involving 1187 participants reported intraoperative
blood loss in patients who underwent knee replacement surgery
with and without a tourniquet (Aglietti 2000; Dong 2019; Ejaz 2015
b; Harston 2015; Huang 2017; Juelsgaard 2001; Kato 2002; Li 2008; Li
2009; Tai 2012; Tetro 2001; Wu 2018; Zhang 2010; Zhang 2016; Zhou
2011). Surgery with a tourniquet was associated with significantly
less intraoperative blood loss when compared to the control. The
mean diBerence between the two groups was 147.05 mL (95% CI
-190.97 to -103.12; I2 = 99%) (Analysis 1.16).
Postoperative blood loss
Twelve studies involving 776 participants reported postoperative
blood loss in patients who underwent knee replacement surgery
with and without a tourniquet (Aglietti 2000; Huang 2017;
Juelsgaard 2001; Li 2008; Li 2009; Liu 2014; Ozkunt 2018;
Vandenbussche 2001; Wauke 2002; Wu 2018; Zhang 2010; Zhou
2011). Surgery with a tourniquet was associated with significantly
greater postoperative blood loss when compared to the control.
The mean diBerence between the two groups was 57.72 mL (95% CI
13.58 to 101.87; I2 = 93%) (Analysis 1.17).
Overall blood loss
Eighteen studies involving 1500 participants reported overall blood
loss in the two treatment groups (Abdel-Salem 1995; Aglietti
2000; Dong 2019; Goel 2019; Huang 2017; Juelsgaard 2001; Ledin
2012; Li 2008; Li 2009; Mori 2016; Pfitzner 2014; Tai 2012; Tetro
2001; Vandenbussche 2001; Wu 2018; Yavarikia 2010; Zhang 2010;
Zhou 2011). There was no significant diBerence in overall blood
loss among patients who underwent knee replacement surgery
with a tourniquet and patients who underwent surgery without
a tourniquet. The mean diBerence was 8.61 mL (95% CI -83.76 to
100.97; 18 studies; I2 = 96%) (Analysis 1.18).
Blood transfusion risk
Eighteen studies involving 1285 participants reported blood
transfusion risk  in patients undergoing total knee replacement
surgery with and without a tourniquet (Alexandersson 2019; Clarke
2001; Ejaz 2015 b; Huang 2017; Juelsgaard 2001; Kiss 2005; Ledin
2012; Li 2008; Liu 2014; Matziolis 2004; Molt 2014; Ozkunt 2018; Tai
2012; Tetro 2001; Vandenbussche 2001; Wu 2018; Zhang 2016; Zhou
2011). Although the risk of blood transfusion was higher in the
tourniquet group compared to the control group, this diBerence
was not significant (RR 1.20, 95% CI 0.86 to 1.67; I2 = 29%) (Analysis
1.15).
Blood transfusion volume
Two studies reported blood transfusion volume rather than
the number of patients receiving a blood transfusion (Kato
2002;  Yavarikia 2010). Kato 2002  found that although the
transfusion volume was greater in the control group, this diBerence
was not significant (409 mL (150) versus 54 mL (151)). Yavarikia
2010  found no significant diBerence in blood transfusion volume
between the two groups (248 mL (201) versus 239 mL (144 mL)).
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Change in haemoglobin
Nine studies involving 713 participants reported change in
haemoglobin among patients undergoing knee replacement
surgery with and without a tourniquet (Alexandersson 2019; Kiss
2005; Li 2008; Matziolis 2004; Tai 2012; Tetro 2001; Wu 2018;
Yavarikia 2010; Zhang 2016). There was no significant diBerence in
change in haemoglobin (g/dL) between the two groups (MD -0.14,
95% CI -0.48 to 0.19; I2 = 85%) (Analysis 1.19).
Economic outcomes
Duration of surgery
Twenty-seven studies involving 2070 participants reported
duration of surgery in patients undergoing knee replacement with a
tourniquet and without a tourniquet (Aglietti 2000; Ayik 2020; Dong
2019; Ejaz 2015 b; Goel 2019; Harston 2015; Huang 2017; Jawhar
2015; Kato 2002; Kiss 2005; Ledin 2012; Li 2008; Li 2009; Liu 2014;
Liu 2017; Liu 2017 b; Matziolis 2004; Molt 2014; Mori 2016; Tai 2012;
Tetro 2001; Vandenbussche 2001; Wauke 2002; Wu 2018; Yavarikia
2010; Zhang 2016; Zhou 2011). Tourniquets were associated with
significantly reduced length of surgery when compared to the
control. The mean diBerence was 3.7 minutes less in the surgery
with a tourniquet group (95% CI -5.53 to -1.87; I2 = 82%) (Analysis
1.21).
Length of hospital stay
Twelve studies involving 995 participants reported length of stay for
patients undergoing knee replacement surgery with and without
a tourniquet (Abdel-Salem 1995; Harston 2015; Huang 2017; Ledin
2012; Liu 2014; Molt 2014;  Tai 2012; Tetro 2001; Vandenbussche
2001; Wu 2018; Zhang 2016; Zhou 2011). Surgery with a tourniquet
was associated with significantly greater length of hospital stay
when compared to surgery without a tourniquet. The mean
diBerence was 0.34 days longer in the surgery with a tourniquet
group (95% CI 0.03 to 0.64; I2 = 78%) (Analysis 1.20).
Adverse events
None of the included studies reported any adverse events
additional to those already described in the section on SAEs.
Implant stability
Two studies involving 130 participants assessed implant stability
based on maximum  total point motion (MTPM; higher values
indicating greater implant movement and less stability) using
radiostereometric analysis (RSA) (Ejaz 2014; Molt 2014). There was
no significant diBerence in MTPM between the two groups at eight
weeks (MD -0.06, 95% CI -0.13 to 0.01), at 12 months (MD 0.05, 95%
CI -0.09 to 0.18) and at 24 months (MD 0.06, 95% CI -0.08 to 0.19)
(Analysis 1.22; Analysis 1.23; Analysis 1.24).
Sensitivity analysis and assessment of heterogeneity
Heterogeneous study sensitivity analysis
Seven of the included studies were substantially diBerent
from the remainder. Huang 2017 compared the eBects of
tranexamic acid and tourniquet use in knee replacement.
Both Juelsgaard 2001 and Kiss 2005 had diBerent types of
anaesthesia in in their comparator groups. Juelsgaard 2001
compared hypotensive epidural anaesthesia without a tourniquet
versus spinal anaesthesia with a tourniquet. Kiss 2005 compared
normotensive epidural anaesthesia with a tourniquet versus
hypotensive epidural anaesthesia without a tourniquet. Kumar
2015, Liu 2017, and Liu 2017 b all included participants undergoing
bilateral knee replacement surgery, with each knee acting as
the unit of analysis. Mori 2016 reported the risk of deep vein
thrombosis; however, these investigators performed an ultrasound
on all participants, thereby potentially including patients with
asymptomatic deep vein thrombosis.
A formal sensitivity analysis was performed by removing each of
these studies from the outcomes included in this review.
Pain
With all studies included, the mean diBerence in day 1 pain scores
was 1.25 (95% CI 0.32 to 2.19; I2 = 94%).
AJer removal of Liu 2017, the diBerence between the two groups
remained significant. Surgery with a tourniquet was associated
with 1.32 (95% CI 0.20 to 2.43; I2 = 95%) points higher on a 10-point
scale.
AJer removal of Kumar 2015, the diBerence between the two
groups remained significant. Surgery with a tourniquet was
associated with 1.18 (95% CI 0.16 to 2.19; I2 = 95%) points higher on
a 10-point scale.
Function
With all studies included, the standardised mean diBerence for
short-term function scores was -0.64 (95% CI -1.52 to 0.25; I2 = 94%).
Removal of Liu 2017 led to no significant change in the results for
short-term function scores. The SMD was -0.93 (95% CI -2.38 to 0.48;
I2 = 96%).
With all studies included, the standardised mean diBerence for
medium-term function scores was -0.06 (95% CI -0.22 to 0.10; I2 =
0%).
Removal of Liu 2017 led to no significant change in results for
medium-term function scores. The SMD was -0.06 (95% CI -0.26 to
0.13; I2 = 15%). Similarly, removal of Huang 2017 had no significant
eBect (SMD -0.03, 95% CI -0.2 to 0.14; I2 = 0%).
Global assessment of success
Huang 2017 was the only study that reported global assessment of
success.
Health-related quality of life
None of the above studies reported health-related quality of life.
Serious adverse events
With all studies included, the RR was 1.73 (95% CI 1.10 to 2.73; I2
= 0%). When studies were removed, there remained a statistically
significantly higher risk of SAEs in the group that had surgery with
a tourniquet compared to the group that had surgery without a
tourniquet. With removal of Huang 2017, the risk was 1.71 (95% CI
1.08 to 2.71; I2 = 0%). Removal of Liu 2017 led to risk of 1.71 (95% CI
1.08 to 2.71; I2 = 0%). Removal of Liu 2017 b led to risk of 1.86 (95%
CI 1.14 to 3.02; I2 = 0%). Finally, removal of Mori 2016 led to risk of
1.73 (95% CI 1.1 to 2.73; I2 = 0%).
When the results of Mori 2016 (included asymptomatic DVTs) were
included, the risk of developing a DVT was significantly higher in the
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tourniquet group compared to the control group (RR 2.11, 95% CI
1.37 to 3.23; I2 = 0%) compared to 2.05 (95% CI 1.35 to 3.13; I2 = 0%)
when this study was not included.
Cognitive function
None of the studies above reported cognitive function.
Survival of the implant
With all studies included, the risk ratio was 1.44 (95% CI 0.23 to 8.92;
I2 = 0%). Removal of Liu 2017 and Liu 2017 b led to no change in the
overall significance of the results. The risk was 0.99 (95% CI 0.11 to
9.30; I2 = 0%) when Liu 2017 was removed and 1.00 (95% CI 0.11 to
9.30; I2 = 0%) when Liu 2017 b was removed.
Outcome analysis, which had 'substantial' or 'considerable'
heterogeneity, included 'postoperative pain: day 1', 'postoperative
pain: week 2', 'postoperative pain: week 6', 'blood loss:
intraoperative', 'blood loss: postoperative', 'blood loss: overall',
'blood loss: change in haemoglobin', 'economic: length of hospital
stay', and 'economic: duration of surgery'. The reasons for this
heterogeneity are explored in the discussion.
Risk of bias sensitivity analysis
Pain
Selection bias sensitivity analysis
With all studies included, the mean diBerence in pain scores was
1.25 points (95% CI 0.32 to 2.19; I2 = 94%) higher for pain scores
in the surgery with a tourniquet group. When the seven  studies
with unclear risk of selection bias were removed (Abdel-Salem
1995; Dong 2019; Kumar 2015; Li 2008; Liu 2014; Liu 2017; Tai 2012),
pain scores were still significantly higher in the surgery with a
tourniquet group compared to the surgery without a tourniquet
group (MD 1.65, 95% CI 0.93 to 2.37).
Performance bias sensitivity analysis
When four  studies with unclear risk of performance bias were
removed (Abdel-Salem 1995; Dong 2019;  Kumar 2015;  Liu 2017),
pain scores remained significantly higher in the surgery with a
tourniquet group (MD 0.79, 95% CI 0.01 to 1.56; I2 = 66%) compared
to a mean diBerence of 1.25 (95% CI 0.32 to 2.19; I2 = 94%) when all
studies were included.
Detection bias sensitivity analysis
When four studies with unclear risk of detection bias were removed
(Abdel-Salem 1995; Dong 2019; Kumar 2015; Liu 2017), pain scores
remained significantly higher in the surgery with a tourniquet group
(MD 0.79,  95% CI 0.01 to 1.56; I2 = 66%) compared to a mean




When studies with unclear or high risk of selection bias at 12
months were removed (Abdel-Salem 1995; Liu 2017), there was still
no significant diBerence in function (SMD -0.02, 95% CI -0.24 to 0.2;
I2 = 22%) compared to an SMD of -0.06 (95% CI -0.22 to 0.10; I2 = 0%)
when no studies were excluded.
Performance bias sensitivity analysis
When studies with unclear or high risk of performance bias were
removed (Abdel-Salem 1995; Liu 2017; Zhou 2017), there was no
significant diBerence in function at 12 months (SMD -0.13, 95% CI
-0.36 to 0.11; I2 = 0%) compared to an SMD of -0.06 (95% CI -0.22 to
0.10; I2 = 0%) when no studies were excluded.
Detection bias sensitivity analysis
When studies with  unclear or high risk of detection bias were
removed (Abdel-Salem 1995; Liu 2017; Zhou 2017), there was no
significant diBerence in function at 12 months (SMD -0.13, 95% CI
-0.36 to 0.11; I2 = 0%) compared to an SMD of -0.06 (95% CI -0.22 to
0.10; I2 = 0%) when no studies were excluded.
Global assessment of success
Huang 2017 was the only study that reported this outcome.
This study did not have unclear or high risk of detection bias,
performance bias, or selection bias.
Health-related quality of life
Goel 2019 was the only study that reported this outcome. This study
did not have unclear or high risk of detection bias, performance
bias, or selection bias.
Serious adverse events
Selection bias sensitivity analysis
When 15 studies with unclear or high risk of selection bias were
removed (Abdel-Salem 1995; Jawhar 2020; Kato 2002; Li 2008; Liu
2017;  Liu 2017 b;  Matziolis 2004;  Molt 2014;  Mori 2016;  Tetro
2001;  Vandenbussche 2001; Wakankar 1999; Wauke 2002;  Zhang
2010; Zhang 2016), the risk of SAEs between groups was no longer
statistically significant (RR 1.64, 95% CI 0.68 to 3.92; I2 = 0%). When
all studies were included, the RR was 1.73 (95% CI 1.10 to 2.73; I2 =
0%).
Performance bias sensitivity analysis
When 13 studies with unclear or high risk of performance bias were
removed (Abdel-Salem 1995; Jawhar 2020; Kato 2002; Liu 2017; Liu
2017 b; Matziolis 2004; Molt 2014; Mori 2016; Wakankar 1999; Wauke
2002; Zhang 2010; Zhang 2016; Zhou 2011), the diBerence in risk
of SAEs between groups was no longer statistically significant (RR
1.78, 95% CI 0.74 to 4.26; I2 = 0%). This diBered from the results
when all studies were included, which produced an RR of 1.73 (95%
CI 1.10 to 2.73; I2 = 0%).
Detection bias sensitivity analysis
When 13 studies with unclear or high risk of detection bias were
removed (Abdel-Salem 1995; Ejaz 2015 b; Jawhar 2020; Kato 2002;
Matziolis 2004; Molt 2014; Mori 2016; Tetro 2001; Wakankar 1999;
Wauke 2002; Wu 2018; Zhang 2010; Zhang 2016), the diBerence in
risk between groups was no longer statistically significant (RR 1.40,
95% CI 0.70 to 2.79; I2 = 0%). Again, this diBered from the results
when all studies were included, which produced an RR of 1.73 (95%
CI 1.10 to 2.73; I2 = 0%).
Cognitive function
No data for this outcome were collected.
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Survival of implant
Selection bias sensitivity analysis
When studies at high or unclear risk of selection bias were removed
(Liu 2017; Liu 2017 b), there remained no significant diBerence in
risk of revision surgery between the two groups (RR 0.33, 95% CI
0.01 to 7.81; I2 = 0%). When all studies were included, the risk of
revision surgery was found to be 1.44 (95% CI 0.23 to 8.92; I2 = 0%).
Performance bias sensitivity analysis
When studies at high or unclear risk of performance bias were
removed (Liu 2017; Liu 2017 b), there remained no significant
diBerence in risk of revision surgery between the two groups (RR
0.33, 95% CI 0.01 to 7.81; I2 = 0%). When all studies were included,
the risk of revision surgery was found to be 1.44 (95% CI 0.23 to 8.92;
I2 = 0%).
Detection bias sensitivity analysis
When all studies were included, the risk of revision surgery was
found to be 1.44 (95% CI 0.23 to 8.92; I2 = 0%). No included studies
were at high or unclear risk of detection bias.
Publication bias
Publication bias was assessed with the aid of funnel plots for all
major outcomes. Funnel plots were symmetrical for postoperative
pain, function, and survival of the implant. Formal statistical tests
were performed when more than 10 trials were pooled (SAEs, blood
loss, duration of surgery, length of hospital stay). There was no
statistically significant sign of publication bias for serious adverse
events, length of stay, or postoperative and overall blood loss (P >
0.05). There was evidence of publication bias for studies reporting
intraoperative blood loss and duration of surgery (P < 0.05). Table
2 shows the results of publication bias testing.
D I S C U S S I O N
Summary of main results
This review includes 41 randomised controlled trials involving 2819
participants, which investigated the eBects of tourniquet use on
total knee replacement surgery.
Eight  studies reporting day 1 postoperative pain scores  were
included in this review. Moderate-quality evidence shows that
surgery with a tourniquet was associated with statistically
significantly higher pain scores when compared to surgery without
a tourniquet. This diBerence may or may not be noticeable to
patients, as the lower boundary of the confidence interval is
below the minimum clinically important diBerence (MCID) for
pain (Dworkin 2008). The evidence was downgraded due to risk
of bias, as many studies had high or unclear risk of allocation
concealment, blinding, and selection and detection bias. Five
studies reported medium-term function scores. Moderate-quality
evidence shows that surgery with a tourniquet confers little or
no clinically important diBerence in knee function. Evidence was
downgraded due to risk of bias, again because many studies
had unclear or high risk of allocation concealment and blinding,
leading to potential for selection and detection bias and likely
overestimation of the eBect. Low-quality evidence suggests that
surgery with a tourniquet was associated with little or no clinically
important diBerence in global assessment of success and health-
related quality of life. The evidence was downgraded due to risk
of bias and imprecision, as the studies included small numbers of
participants.
Twenty-one studies reported serious adverse events. Moderate-
quality evidence shows that surgery with a tourniquet was
probably associated with higher risk of serious adverse events
when compared to surgery without a tourniquet. Evidence was
downgraded due to risk of bias. Serious adverse events included
deep vein thrombosis, pulmonary embolism, infection, and re-
operation for reasons other than implant loosening. Surgery with
a tourniquet was associated with a significantly higher risk of deep
vein thrombosis and infection when compared to surgery without
a tourniquet. Studies found that surgery with a tourniquet was
not associated with increased risk of pulmonary embolism and re-
operation when compared to surgery without a tourniquet.
Very low-quality evidence suggests an uncertain eBect of surgery
with a tourniquet on risk of revision surgery when compared to
surgery without a tourniquet. Evidence was downgraded due to risk
of bias and serious imprecision, as total numbers in each arm were
low (only three revision surgeries across both arms over two years).
No data on cognitive function were extracted.
We also reported minor outcomes in this review, which were
not included in our 'Summary of findings' table. This review
found that surgery with a tourniquet was not associated with
a significant eBect on  overall blood loss when compared to
surgery without a tourniquet. Surgery with a tourniquet was
associated with significantly increased length of hospital stay
and a reduced duration of surgery when compared to surgery
without a tourniquet. Use of a tourniquet was not associated
with any meaningful diBerence in implant stability at two years.
Studies reported no diBerence on radiostereometric analysis (RSA)
analysis at eight weeks, at one year, and at two years. RSA
analysis was utilised as a surrogate marker of implant stability; all
included studies reported implant stability in patients undergoing
cemented total knee replacement (TKR). None of the included
studies reported any additional adverse events.
A sensitivity analysis was performed when studies that were
substantially diBerent from other studies were removed. Removal
of these studies led to no diBerence in overall results for the major
outcomes included in this review. When studies with unclear or high
risk of bias were removed, there were no diBerences in the results
reported for pain, function, global assessment of success, health-
related quality of life, and survival of the implant. However, when
these studies were removed, there was no longer a statistically
significant diBerence in the risk of serious adverse events between
the two groups.
Overall completeness and applicability of evidence
This review included 41 studies reporting outcomes for participants
undergoing primary TKR surgery. Thirty-seven of these studies
were single-centre studies that compared surgery with a tourniquet
versus surgery without a tourniquet. More than 50% of the studies
had high or unclear risk of bias. Reasons for increased risk of
bias included unclear surgeon blinding and unclear allocation
concealment and randomisation. Studies were conducted in
15 diBerent countries, and all participants had features of
osteoarthritis or rheumatoid arthritis requiring TKR. Participants in
both groups were similar in terms of mean age, mean body mass
index (BMI), gender distribution, and baseline pain and function
scores. All included studies reported similar anticoagulation and
anaesthetic regimens. Given that the inclusion criteria were similar
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across all studies, the results of this review are applicable to similar
patients undergoing primary TKR in clinical practice.
Measurement of pain varied across trials, with studies reporting
pain from day 1 through six weeks. Our primary endpoint for
pain was postoperative day 1, as this was when the intervention
had the greatest eBect. We also reported pain scores up to six
weeks postoperatively. Regarding function, studies used diBerent
outcome measures. Given that function scores used similar
scales in the same direction, we reported the standardised
mean diBerence between the two groups. No data for cognitive
function could be accurately extracted from the studies included
in this review; as a result, no conclusions could be reached for
this outcome. None of the included studies reported outcomes
for patients undergoing revision surgery or unicondylar knee
replacement with a tourniquet; therefore these results are not
directly applicable to patients in clinical practice.
Many of the included studies reported only the minor outcomes
included in this review (e.g. blood loss, economic outcomes). As
a result, these studies were included in this review but were not
included in the 'Summary of findings' table. This explains why out
of 41 studies, only 21  studies were included in the 'Summary of
findings' table.
It would have been interesting to explore the relationship between
duration of tourniquet use and outcomes; however, the studies
included in this review provided insuBicient details on duration of
tourniquet use and were not designed to measure a dose-response
eBect.
The included studies did not explore relationships between high-
and low-risk patients for deep vein thrombosis (DVT) and surgery
with a tourniquet. Twenty-five studies reported regimens for DVT
prevention that included use of chemical thromboprophylaxis;
however, the remaining studies did not. Therefore, an evidence gap
is apparent when the association between DVT and surgery with
a tourniquet in high- or low-risk patients and the impact of DVT
prevention are explored.
Quality of the evidence
The quality of evidence for the outcomes included in this review
was graded ‘high’ to ‘low’ based on the GRADE criteria.
Moderate quality
Pain, function, and serious adverse events were graded as
moderate-quality evidence; they were downgraded due to risk
of bias.  Considerable heterogeneity was noted for pain scores
at day 1; however this is likely to be due to diBerences in
the types of anaesthetic and analgesic regimens used and in
the exact timing of assessment, all of which led to clinical
diversity. Furthermore, the direction of the clinical eBect on pain
was consistent across all studies and at other time points. We
did not downgrade this outcome for inconsistency because the
heterogeneity was expected. A random-eBects model was used to
incorporate heterogeneity amongst studies (Deeks 2020).
Low quality
Health-related quality of life and global assessment of success were
graded as low-quality evidence. The reasons for downgrading were
risk of bias and imprecision due to low total study numbers.
Very low quality
Implant survival was graded as very low-quality evidence. The
reasons for downgrading were risk of bias and serious imprecision
due to low total numbers of events in each arm. A total of three
revision surgeries were reported across both arms over two years;
as a result, the evidence was downgraded twice for imprecision.
Potential biases in the review process
Our review was based on an extensive electronic literature search
and a search for unpublished trials; therefore it is unlikely that
relevant trials were missing from this review, provided that they
were published as full-text articles or were accessible in trial
registries (Egger 2003). Two review authors independently selected
studies, extracted data, and assessed ‘risk of bias’ to reduce bias
and transcription errors. As a result, we believe potential biases
were minimised during the review process.
Limitations
Considerable statistical heterogeneity was observed for pain at day
1 (94%). Through consultation with the Cochrane Handbook for
Systematic Reviews of Interventions, the review authors believe this
was secondary to clinical diversity. Although all studies used
the same scale to measure outcomes, participants could have
experienced diBerences including in the amount and type of
analgesia, the type of anaesthesia, or the duration of tourniquet
use. The amount and type of analgesia were not clearly stated
amongst the studies. In addition, pain measurements could have
been taken at diBerent times of the day, including before or
aJer physiotherapy; this could explain the clinical heterogeneity.
Considerable heterogeneity was also noted for knee function
at three months; again this could be explained by clinical
heterogeneity, as diBerent tools were used to assess function.
Medium-term knee function scores presented in the 'Summary of
findings' table showed no heterogeneity (Deeks 2020).
There was also heterogeneity in the following minor outcomes -
duration of surgery, length of hospital stay, and blood loss - due
to methodological diBerences in study design and in ways each
outcome was measured. For example, intraoperative blood loss
was measured through suction drainage or by the change in weight
of swabs used during the operation. Both of these methods are
surrogate measures of intraoperative blood loss, and heterogeneity
could influence the final results. Many studies did not report the
criteria used for diagnosis of wound infection; this may have
diBered across the included studies.
We included studies with small total numbers of participants
and studies with small total numbers of events, which can cause
problems with precision of estimated treatment eBects. However,
in the absence of large multi-centre trials or registry data, meta-
analysis of data from multiple small trials may be the only way to
obtain reliable evidence of an eBect for rare but serious outcomes.
The impact of the duration of tourniquet use was not measured,
as most studies provided insuBicient detail to allow this. However,
previous research has demonstrated comparable pain scores and
knee function scores between surgery with a tourniquet for the
whole procedure versus tourniquet used for part of the procedure
(Viashya 2018), but findings show that longer duration of tourniquet
use is associated with increased risk of complications.
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No published registry data reported outcomes following tourniquet
use, and we did not attempt to seek unpublished data from
registries, as this was beyond the scope of the review.
Publication bias was formally tested using funnel plots and
statistical tests. Statistical evidence of publication bias was noted
for intraoperative blood loss and duration of surgery. However,
a tourniquet by design restricts intraoperative blood flow and
therefore intraoperative blood loss. As a result, there are unlikely
to be studies that demonstrate a non-significant result  for this
outcome. It is likely that even if studies reported non-significant
results, this would not aBect the overall study findings.
Agreements and disagreements with other studies or
reviews
Four previous non-Cochrane reviews have been performed, most
of which have focused on blood loss with little focus on risk of pain
and complications.
Smith 2010  reviewed 15 studies (nine  randomised controlled
trials (RCTs) and six  observational studies) with 991 participants
and found that tourniquet use was associated with significantly
greater intraoperative blood loss; however, review authors noted
no diBerence in total blood loss or complications.
Tai 2011  included eight RCTs and three prospective studies with
634 participants. Review authors reported that tourniquet use
was associated with significantly reduced intraoperative blood
loss and increased risk of thromboembolic events (risk ratio (RR)
1.91, 95% confidence interval (CI) 1.05 to 3.49). There was no
significant diBerence in postoperative blood loss or in total blood
loss. Tourniquet use was associated with significantly reduced
duration of surgery.
Alcelik 2012  reported on 10  RCTs with 493 participants. Review
authors reported that tourniquet use was associated with
significantly reduced intraoperative and postoperative blood loss.
There was no diBerence in deep vein thrombosis (DVT) or in
pulmonary embolism (PE); however, tourniquet use was associated
with significantly greater numbers of complications.
Zhang 2014 performed a meta-analysis of 13 RCTs involving 689
participants. Tourniquet use was associated with significantly
reduced intraoperative blood loss (weighted mean diBerence
-198.21 mL, 95% CI -279.82 to -116.60) and reduced duration of
surgery (weighted mean diBerence -4.57 minutes, 95% CI -7.59 to
-1.56). However there was no significant diBerence in total blood
loss or in blood transfusion rate. Tourniquets were associated with
significantly higher risk of thrombotic events (RR 5.0, 95% CI 1.31
to 19.10) and non-thrombotic complications (RR 2.03, 95% CI 1.12
to 3.67).
Our review is the largest to date (41 RCTs; 2819 participants). Our
findings are consistent with those of previous reviews for blood
loss and  duration of surgery. Previous reviews have alluded to
greater risk of complications, which is consistent with our finding
that risk of serious adverse events is significantly increased when
a tourniquet is used. Previous reviews have not reported on pain,
patient-reported function, health-reported quality of life, survival
of the implant, length of hospital stay, and implant stability, making
our review the most comprehensive review completed to date.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
Moderate-certainty evidence shows that tourniquet use was
probably associated with an increased risk of serious adverse
events, little or no diBerence in function and higher postoperative
pain scores; however, the diBerence in pain may or not be clinically
noticeable.  Low-certainty evidence shows that surgery with a
tourniquet may have little or no eBect on health-related quality of
life and global assessment of success. Very low-certainty evidence
shows that it is uncertain if tourniquet has an eBect on implant
survival.
When total knee replacement with the aid of a tourniquet
continues to be performed, patients should be informed about the
potential risks, in particular, potentially increased pain and risk of
developing serious adverse events.
In 2018, 106,000 total knee replacements were performed in the UK
(National Joint Registry 2018; Scottish Arthroplasty Project 2019).
Based on estimates showing that more than 90% of UK surgeons
use a tourniquet (Gibbs 2016; National Joint Registry 2004), along
with reports of a number needed to treat for additional harmful
outcomes (NNTH) of 48, a change in practice could potentially avoid
up to 1987 serious adverse events per year in the UK alone.
Implications for research
Large high-quality multi-centre blinded trials including all types
of knee replacement surgery and evaluating cognitive function,
health-related quality of life, knee function, and resource use
would improve the external validity, quality, and range of outcomes
assessed in the existing evidence base. Based on moderate-
certainty evidence and previous reviews, the risk of serious adverse
events following surgery with a tourniquet is probably higher,
which is clinically relevant to patients. Further research is unlikely
to change this conclusion and will only improve the confidence
limits of the eBect estimate. Additional studies of higher quality are
required to assess the impact of tourniquet use on implant stability
or survival and to assess the quality of cementation and revision
risk. This could potentially be the main benefit of tourniquet use,
which is currently associated with very low-certainty evidence.
Prospective registry data may facilitate improved precision in
estimating implant survival.
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Study characteristics
Methods Two groups: surgery with a tourniquet; surgery without a tourniquet
Follow-up: 2 years
Study design: single-centre randomised controlled trial
Abdel-Salem 1995 
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Participants 80 participants in total
Male:Female: 17:23; 15:25
Age, years (range): 72 (65 to 80); 74 (64 to 82)
Inclusion criteria: non-diabetic patients who had no previous knee surgery; normal neurovascular sup-
ply to the leg (proved by Doppler)
Duration of illness: unspecified
Interventions Group A (n = 50): total knee replacement surgery performed with a tourniquet
Group B (n = 50): total knee replacement surgery performed without a tourniquet
All operations were performed under general anaesthesia by one surgeon. For all patients, cefuroxime
1.5 g was given intravenously at the time of induction of anaesthesia and two further doses of 750 mg
were given postoperatively. Anticoagulant prophylaxis was with Fragmin, started 2 hours preoperative-
ly and continued postoperatively until the patient was fully mobile. A pneumatic tourniquet was placed
around the thigh in both groups but was inflated only for patients in group A. The limb was first exsan-
guinated by elevation for 2 minutes, and the tourniquet was inflated to twice the systolic blood pres-
sure (in group A)
Outcomes 1. Hospital for Special Surgery knee score: knee-related score assessing pain, stability (measured as total
varus-valgus arc, extension), motion (measured as total passive arc), quadriceps strength (measured
as 10% of normal for age and gender), and subtractions for contractures or fixed varus/valgus. Score
ranges from 0 to 100. The higher the score, the better the outcome
2. Postoperative pain on a linear analogue scale between 0 and 10. A score of 10 is the highest pain score;
therefore the lower the score, the better the outcome
3. Analgesia consumption: measures as the total amount of opiate injected, measured in milligrams de-
livered to the patient. A higher score indicates a worse outcome. This was measured over the first 24
hours postoperatively
4. Duration of surgery: measured in minutes
5. Overall blood loss: measured in millilitres on day 1 postoperatively. The higher the score, the worse
the outcome
6. Range of knee movement at 5 days, 10 days, and 6 weeks. Measured as time to straight leg raised,
measured in days, with higher scores indicating worse outcomes, Knee extension and flexion mea-
sured in degrees with higher scores indicating better outcomes. These scores were measured at days
5 and 10, at week 6, and 1 year postoperatively
Identification Contact information: A Abdel-Salem, Consultant orthopaedic surgeon, George Elliot Hospital NHS
Trust, Nuneaton, CV10 7DJ
Notes Country: UK
Language: English
Study author contacted: no contact details given
Trial registry record or protocol available: none found
Funding source/declaration of interest: none reported
Adverse events:
In group A: 5 patients had wound infection; 3 patients had confirmed venous thrombosis
In group B: no adverse events were reported
Risk of bias
Abdel-Salem 1995  (Continued)
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Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Card system
Allocation concealment
(selection bias)





Unclear risk Insufficient information to permit judgement
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Unclear risk HSS, pain, analgesia consumption
Not stated if patients were blinded; therefore unclear risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)




Unclear risk Insufficient reporting of attrition; no CONSORT diagram
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement; no protocol reported or identi-
fied





Methods Two groups: surgery with a tourniquet; surgery without a tourniquet
Follow-up: up to 24 hours post surgery
Study design: single-centre randomised controlled trial
Participants 20 participants in total
Male:Female: 3:10; 4:6
Age, years (SD): 70(8); 68 (4.5)
BMI, years (SD): 27.9; 27.3
Inclusion criteria: patients undergoing total knee replacement surgery for osteoarthritis
Exclusion criteria: disturbances of coagulation, history of deep vein thrombosis, previous surgery of the
knee, neoplastic disease, inflammatory disease, had received anticoagulant therapy or drugs that af-
fected the haemostatic system during the last 2 weeks
Duration of illness: unspecified
Interventions Group I (n = 10): total knee replacement surgery performed with a tourniquet
Aglietti 2000 
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Group II (n = 10): total knee replacement surgery performed without a tourniquet
Anaesthetic techniques were standardised. All patients received subarachnoid spinal anaesthesia by
injection of 4 mL of 0.5% bupivacaine at the L2-L3 interspace approximately 1 hour before surgery and
were sedated with midazolam and fentanyl intravenously. Ringer’s lactate solution was infused as
needed to maintain haernodynamic stability. Patients did not receive blood transfusions during the ob-
servation period. Autologous blood was transfused postoperatively as needed after the study was com-
pleted. Unilateral primary cemented total knee replacements (M.B.K. prosthesis, Zimmer, Warsaw, IN,
USA) were performed on all patients by the same surgeon at approximately the same time of the morn-
ing. Patients were assigned randomly to either Group I or Group II. Group I comprised 10 patients who
underwent total knee replacement with a tourniquet inflated at the root of the limb. Group II consist-
ed of 10 patients who underwent total knee replacement without the tourniquet. Before the surgical
incision was begun in patients in Group I, the limb was exsanguinated with an elastic bandage and the
tourniquet inflated at the pressure of 0.8 bar
Outcomes 1. Duration of surgery: measured in minutes
2. Intraoperative blood loss: measured in millilitres. The higher the score, the worse the outcome
3. Postoperative blood loss: measured in millilitres. The higher the score, the worse the outcome
4. Overall blood loss: measured in millilitres. The higher the score, the worse the outcome
5. Intravenous fluid usage: measured in millilitres. The higher the score, the worse the outcome
6. Prothrombin time, activated partial thromboplastin time, and fibrinogen level: venous blood samples
were drawn after 4 mL of blood was discarded to clear the venous line and to prevent haemodilu-
tion. Samples were collected via a 3-way stopcock from a 14-gauge antecubital vein cannula at the
following 4 times: 1 hour before anaesthesia (Sample Tl); after bone cuts (Sample T2); 2 minutes after
tourniquet deflation (Group I) or after cementing the prosthesis (Group 11) (Sample T3); and 1 hour
after the end of the operation (Sample T4). Samples were collected in citrated tubes (9:1 volume to
volume), immediately placed in ice, and centrifuged at 2000 g for 10 minutes at 4° C. Plasma samples
were stored immediately at -70°C until assay
Identification Contact information: P Aglietti, MD, Second Orthopaedic Clinic, Largo P. Palagi 1, 50139, Florence, Italy
Notes Country: Italy
Language: English
Study author contacted: yes, however, received no reply
Trial registry record or protocol available: none found
Funding source/declaration of interest: none reported
Adverse events: none reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Insufficient information to permit judgement
Allocation concealment
(selection bias)





Unclear risk Insufficient information to permit judgement
Aglietti 2000  (Continued)
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Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Low risk Self-reported outcomes: none
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)




Low risk No missing outcome data
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
No protocol reported or identified





Methods Two groups: surgery with a tourniquet; surgery without a tourniquet
Follow-up: 3 months
Study design: single-centre randomised controlled trial
Participants 81 participants in total
Male:Female: 18:20; 22:21
Age, years (SD): 68 (7.4); 69.7 (6.4)
BMI (SD): 28.6 (3.4); 27.9 (3.5)
Inclusion criteria: patients between 50 and 80 years of age undergoing total knee replacement surgery
for treatment of primary osteoarthritis
Exclusion criteria: revision surgery, valgus deformity > 30°, 1-stage bilateral procedures, rheumatoid
arthritis, BMI > 35
Duration of illness: unspecified
Interventions Group A (n = 38): total knee replacement surgery performed with a tourniquet
Group B (n = 41): total knee replacement surgery performed without a tourniquet
One group underwent surgery with a tourniquet (34 in., single bladder, dual port, Zimmer) around the
thigh that applied pressure of 300 mmHg; the other group underwent surgery without a tourniquet. No
femoral nerve block was used. A standard medial parapatellar incision was used
The cemented NexGen CR- or PS-Flex fixed bearing knee (Zimmer) prosthesis was used without patel-
lar resurfacing. Infiltration with 150 mL of ropivacaine-supplemented ketorolac and adrenaline was ap-
plied during surgery. If a tourniquet was used, it was released after the bandages were applied. Tranex-
amic acid (1 g) was given intravenously, 10 minutes before surgery in the non-tourniquet group, and
10 minutes before tourniquet release in the tourniquet group. 2 g of cloxacillin was administered intra-
venously just before and twice after surgery. Low-molecular-weight heparin (Fragmin, 5000 IE subcu-
taneously) was used for the first 14 postoperative days. Postoperative pain management included oxy-
Alexandersson 2019 
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codone 5 to 10 mg (controlled-release oral formulation) twice a day, paracetamol 1 g 4 times a day, and
oxycodone 5 mg when needed
Outcomes Primary outcome
Active range of motion (AROM) in the knee is measured before surgery, at day 3, and at 3-month control
with a goniometer, with the patient lying supine
Secondary outcomes:
1. Timed up and go (TUG) is carried out before surgery, at day 3, and at 3-month control. TUG is a func-
tional test in which the time taken for the patient to get up from a chair, walk 3 metres, turn, and sit
down again is measured
2. Visual analogue scale (VAS) is used for pain assessment. The patient answers the question, “How
painful is your leg?” according to a 0 to 10 scale. This is done before surgery, 24 hours after surgery, 72
hours after surgery (± 2 hrs), and at 3-month control. The question is asked before training while the
patient is at rest, and any additional analgesia given is noted
3. Swelling is assessed by measuring the circumference 10 cm proximal to the superior border of the
patella, at the superior border of the patella, and 10 cm distal to the superior border of the patella
with the patient lying supine. This is done before surgery, at day 3, and at 3-month control
4. Quadriceps function is tested by asking the patient to perform a straight leg raise while lying supine
with the other leg in flexion with the foot on the base of support. The result is noted as able to/not
able to perform the action. This is carried out before surgery, at day 3, and at 3-month control
5. Gait speed is assessed using the 10-metre walk test. Patients are asked to walk as quickly and safely
as possible for 14 metres, of which the middle 10 metres are timed
6. Patients are asked to fill in the Oxford 12-Item Knee Score, which is a well-validated outcome ques-
tionnaire designed for use with knee arthroplasty patients
Identification Contact information: StaBan Eriksson, Centre for Clinical Research Sormland, Uppsala University,
Kungsgatan 1, 531 88 Eskilstuna, Sweden, Staffankarldavid.eriksson@dll.se
Notes Country: Sweden
Language: English
Study author contacted: no
Trial registry record or protocol available: clinical trial number ISRCTN85166072
Funding source/declaration of interest: none reported
Adverse events:
In non-tourniquet group: 1 patient had a urinary tract infection
In tourniquet group: 2 patients had a wound infection
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer generated
Allocation concealment
(selection bias)





Low risk Participants blinded; surgeons not blinded
However surgeons would be able to influence/alter their performance only for
intraoperative outcomes such as intraoperative blood loss, operative time, or
Alexandersson 2019  (Continued)
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quality of cementation. It is unlikely that a surgeon would alter his or her per-
formance to influence these outcomes for fear of damaging the overall quality
and safety of the surgery
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Low risk Self-reported outcomes: TUG, VAS, and OKS
Patients blinded; therefore low risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)
Low risk Assessor-reported outcomes: swelling, quadriceps function, and gait speed




Low risk Missing outcome data balanced in numbers across intervention groups, with
similar reasons for missing data across groups
Selective reporting (re-
porting bias)
Low risk All outcome measures reported





Methods Two groups: surgery with a tourniquet; surgery without a tourniquet
Follow-up: 3 months
Study design: single-centre randomised controlled trial
Participants 70 participants randomised
Mean age in tourniquet group: 65.39% 7.25; mean age in control group: 4.90% 6.58
Male:Female: 14:18; 14:19
Mean BMI in tourniquet group: 31.38 ± 4.72; mean BMI in control group: 30.31 ±.10
Inclusion criteria: patients undergoing total knee replacement surgery with a diagnosis of osteoarthri-
tis (stage 3 to 5 on Ahlback rating), BMI < 35, and ASA score of I or II
Exclusion criteria: ASA > III, BMI > 40, diagnosis of secondary gonarthrosis, preoperative range of mo-
tion < 90 degrees in affected knee, concomitant neuromuscular or orthopaedic disorders that can af-
fect recovery of the lower limb, concomitant rheumatological disorder, concomitant peripheral vascu-
lar disease, diabetes mellitus, history of previous knee surgery, use of anticoagulant medication, and
unwillingness to participate in the study
Duration of illness unspecified
Interventions Intervention:
In Group A, exsanguination was accomplished by wrapping the limb with an elastic bandage approxi-
mately 10 cm wide, starting at the toes and continuing to just distal to the tourniquet. Next, cuB pres-
sure was inflated to 100 mmHg above systolic blood pressure
In Group B, a tourniquet was applied; however, it was not inflated
All TKAs were performed by the same surgeon (O.A.), who specialised in hip and knee replacement ac-
cording to a standard protocol, which included spinal anaesthesia, an appropriate perioperative an-
tibiotic regimen for infection prophylaxis, thrombosis prophylaxis, postoperative pain management,
and rehabilitation. Low-molecular-weight heparin was started 12 hours before spinal anaesthesia
for thrombosis prophylaxis and was concluded when patients were completely mobile. The surgical
course involved a midline skin incision made via a standard medial parapatellar approach. All patients
in both groups received the GENESIS II cemented, posterior cruciate ligament-retaining, fixed-bearing
total knee endoprosthesis with ultra-high-molecular-weight polyethylene (Smith & Nephew Orthope-
Ayik 2020 
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dics, Inc., Memphis, TN, USA). An intramedullary guide was utilised for the femur and an external guide
for the tibia. The patella was not replaced in any case, and only marginal osteophytes were removed.
Dressings were applied after wound closure, and the cuB was rapidly deflated in Group A
Outcomes 1. Isokinetic muscle strength of knee extensors (quadriceps) and flexors (hamstrings) was measured in
Newton meters (Nm) by a CYBEX 350 isokinetic dynamometer (- HUMAC/CYBEX 2009, Stoughton, MA,
USA). In both groups, peak torque and total work were evaluated preoperatively and at 1 and 3 months
postoperatively
2. Knee Society score measured at 1 and 3 months postoperatively
3. Pain measured on a visual analogue score at 1 and 3 months postoperatively
4. Knee range of motion measured at 1 and 3 months postoperatively
Identification Contact information: Mehmet Demirel, MD, Department of Orthopaedics and Traumatology, Istanbul
University, Istanbul School of Medicine, Istanbul, Turkey, dr88.mehmet.demirel@gmail.com
Notes Country: Turkey
Language: English
Study author contacted: no
Trial registry record or protocol available: study was approved by the local ethics committee (1127-Is-
tanbul University)
Funding source/declaration of interest: no source of funding reported or identified
Adverse events: no adverse events reported in groups
Number in each group 35:35
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Block randomised
Allocation concealment
(selection bias)





Low risk Patients blinded; surgeons not blinded 
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Low risk Participants were blinded; therefore low risk of bias
Self-reported outcomes: KSS, pain
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)




Low risk Missing outcome data balanced in numbers across intervention groups with
similar reasons for missing data across groups
Selective reporting (re-
porting bias)
Low risk All outcome measures reported
Other bias Low risk No other sources identified
Ayik 2020  (Continued)
 
Tourniquet use for knee replacement surgery (Review)









Cochrane Database of Systematic Reviews
 
Study characteristics
Methods Three groups: surgery without a tourniquet; surgery with a tourniquet at low pressure (225 mmHg);
surgery with a tourniquet at high pressure (350 mmHg)
Follow-up: 7 days
Study design: single-centre randomised controlled trial
Participants 31 participants in total
Male:Female: not reported
Age, years (SD): not reported
BMI (SD): not reported
31 participants
Inclusion criteria: patients undergoing total knee replacement surgery
Exclusion criteria: patients with non-osteoarthritic disease, previous open knee surgery, systemic or lo-
cal hypoxia, receiving anticoagulant or antiplatelet agents or steroid, with significant varus or valgus
deformity or preoperative lateral release
Duration of illness: unspecified
Interventions Group A: surgery without a tourniquet (n = 10)
Group B: surgery with a tourniquet at low pressure (225 mmHg) (n = 10)
Group C: surgery with a tourniquet at high pressure (350 mmHg) (n = 11)
A standard protocol was followed utilising a tourniquet 11.5 cm wide, with an effective pressurising
width of 9 cm (DePuy UK Ltd, Leeds, UK), with exsanguination in extension via a Rhys-Davies device
where appropriate. All patients had general (non-halothane) anaesthesia, a midline skin incision, a me-
dial parapatellar approach, insertion of a cemented Insall-Burnstein II TKR (Zimmer, Warsaw, IN, USA),
and skin closure using continuous Vicryl (Ethicon Ltd, Somerville, NJ, USA) over a single drain. All were
mobilised on the second postoperative day. No patient received thromboembolic prophylaxis or used a
continuous passive motion machine
Outcomes 1. Blood transfusion use: defined as the number of units delivered to the patient. The higher the number
of units, the worse the outcome
2. Wound hypoxia: measurement of tissue oxygenation was performed with transcutaneous oxygen
pressure electrodes (Radiometer Ltd, Crawley, UK) placed on the skin. Electrodes were placed on each
wound flap with a reference electrode sited in the infraclavicular region to determine intrapatient and
interpatient differences in systemic oxygen delivery both before and after operation. Electrodes were
attached to 2 Radiometer TCM3 TINA units (Radiometer Ltd). Measurements were taken before oper-
ation and on each day after surgery for 1 week or until discharge from hospital
3. Return to preoperative levels of oxygenation
4. Subjective assessment of wound healing: assessed by 2 observers for haematoma, infection, skin
necrosis, dehiscence, or contusion




Study author contacted: yes, no reply from author.
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Trial registry record or protocol available: none reported
Funding source/declaration of interest: funded by grants from the Wishbone Trust and from the re-
search and development fund of West Suffolk Hospital
Adverse events: none reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Insufficient information to permit judgement
Allocation concealment
(selection bias)





Unclear risk Insufficient information to permit judgement
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Low risk Self-reported outcomes: none
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)




Unclear risk Insufficient reporting of attrition
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
No protocol reported or identified





Methods 2 groups: surgery performed with a tourniquet inflated; surgery performed without a tourniquet inflat-
ed
Follow-up: 1 year
Study design: single-centre randomised controlled trial
Participants 129 participants randomised
Mean age in tourniquet group 68.2 ± 17.1; mean age in non-tourniquet group 69.5 ± 15.9
Male:Female: 20:38; 23:41
Mean weight in tourniquet group 67.7 ± 17.6; mean weight in non-tourniquet group 65.9 ± 15.9
Inclusion criteria: patients who were 60 to 85 years old, undergoing unilateral total knee replacement
surgery, NYHA classification I to III, ASA physical status I and II
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Exclusion criteria: severe cardiovascular or cerebrovascular disease, illiteracy, mental illness, cognitive
impairment, refusal to participate in the study
Duration of illness: unspecified
Interventions Patients in both groups were anaesthetised by general anaesthesia. General anaesthesia induction
drugs included midazolam 0.5 mg/kg, propofol 1.5 mg/kg, sulfentanyl 0.5 μg/kg, and rocuronium 0.8
mg/kg by intravenous bolus injection. Intermittent injection of rocuronium 10 mg per 40 to 60 min-
utes, continuous intravenous infusion of remifentanil 0.1 to 0.3 μg/kg/min, and propofol 2 to 4 mg/kg/
h; continuous inhalation of sevoflurane was used for anaesthesia maintenance. All patients underwent
TKA via a standardised technique and process
Patients in group T underwent surgery with a tourniquet inflated to 100 mmHg above systolic blood
pressure; patients in group H underwent surgery without a tourniquet
The orthopaedic surgeon injected 20 mL of a ‘cocktail mixture’ into the posterior capsular ligament,
peripheral capsular ligament, and ligamentum patellae before the artificial prosthesis was embed-
ded to relieve pain and inflammation. The formula for the ‘cocktail’ is as follows: ropivacaine 100 mg,
tranexamic acid 3 g, adrenaline 3 drops, methylprednisolone 40 mg, in a total volume of 20 mL with the
addition of normal saline
Outcomes 1. Pain assessed via a numerical rating scale from 0 (no pain) to 10 (worst pain imaginable). Collected on
days 1, 2, 3, and 7 and 1 year after the operation
2. Active range of motion measured in degrees; collected on days 1, 2, 3, and 7 and 1 year after the op-
eration
3. Intraoperative blood loss
4. Total blood loss
5. Circumferences of the lower and middle thighs of patients were measured before the operation and
on day 1, day 2, and day 3 after the operation, to judge swelling of the operative side thigh
6. A Montreal Cognitive Assessment Scale (MoCA) with a total score of 30 points was used to analyse the
cognitive function of patients on day 1, day 2, day 3, and day 7 after the operation. MoCA value < 26
points was considered to show cognitive impairment
7. Serum creatinine
8. Glomerular filtration rate collected on days 1, 2, and 3 postoperatively
9. C-reactive protein collected on days 1, 2, 3, and 7 postoperatively
Identification Contact information: Jun Dong, dongjun441@163.com, Department of Anesthesiology, The First Affili-
ated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, China
Notes Country: China
Language: English
Study author contacted: no
Trial registry record or protocol available: protocol was approved by the ethics committee of the First
Affiliated Hospital of Chongqing Medical University (2012-2-21) and was registered at ClinicalTrials.com
(NCT02576015)
Funding source/declaration of interest: no source of funding reported or identified
Adverse events: no adverse events reported in groups
Number in each group: 66:63
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Insufficient information to permit judgement
Allocation concealment
(selection bias)
Unclear risk Insufficient information to permit judgement
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Unclear risk Insufficient information to permit judgement
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Unclear risk Insufficient information to permit judgement
Self-reported outcomes: pain, Montreal Cognitive Assessment Scale
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)
Unclear risk Insufficient information to permit judgement
Assessor-reported outcomes: range of motion, blood loss, thigh swelling,




Low risk No missing outcome data
Selective reporting (re-
porting bias)
Low risk All outcome measures reported





Methods Two groups: surgery with a tourniquet; surgery without a tourniquet
Follow-up: 12 months
Study design: single-centre randomised controlled trial
Participants 64 participants in total
Male:Female: 18:15; 17:14
Age, years (SD): 68 (8.4); 68 (7.8)
BMI (SD): 25 (2.0); 25 (2.5)
Inclusion criteria: patients aged 50-85 undergoing an elective unilateral total knee replacement be-
cause of arthritis
Exclusion criteria: rheumatoid arthritis, peripheral vascular disease, diabetes, prior knee surgery, use of
anticoagulant medication, BMI > 35
Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet (n = 33)
Group B: surgery performed without a tourniquet (n = 31)
All procedures were standardised with regard to preoperative tranexamic acid, spinal anaesthesia,
postoperative pain treatment, and rehabilitation regimen. Before surgery, tranexamic acid (1 g) was
administered orally, and cefuroxime (1.5 g) was administered intravenously immediately before skin
incision. In addition, tranexamic acid (0.5 g) was given 3 hours after surgery, and cefuroxime (750
mg) was given 6 and 12 hours postoperatively. Thrombosis prophylaxis was achieved with the use
of rivaroxaban (10 mg/d) throughout the hospital stay. Both groups had an appropriately sized thigh
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tourniquet applied, but it was inflated only in the Tq group; in the non-Tq group, it was placed on the
thigh but was not inflated, thereby serving as a safety device in case of uncontrollable bleeding. In the
Tq group, limb exsanguination was done by elevation for 2 minutes, and the cuB was inflated to 250
mmHg
Outcomes 1. Knee Outcome and Osteoarthritis Severity score (KOOS) at 12 months: validated knee-specific pa-
tient-reported outcome measure consisting of 42 items in 5 subsets (pain, symptoms, activities of dai-
ly living, sports/recreation, quality of life); score ranges from 0 to 100; zero indicates extreme knee
problems, and 100 represents no knee problems
2. Pain score on days 1 and 3 postoperatively. Assessed as a visual analogue scale between 0 and 10;
zero indicates no pain, and 10 indicates extreme pain
3. Analgesia consumption was expressed as a mean morphine equivalent during hospitalisation; con-
sumption was standardised with 10 mg of morphine used as reference analgesic dose
4. Duration of surgery: measured in minutes
5. Intraoperative blood loss: measured in millilitres. The higher the score, the worse the outcome
6. Blood transfusion rate: defined as the number of units delivered to the patient. The higher the number
of units, the worse the outcome
7. Deep vein thrombosis
Identification Contact information: Ashir Ejaz, Department of Orthopaedic Surgery, Aslborg University Hospital, Aal-
borg, Denmark, Asej@m.dk
No source of funding identified
Notes Country: Denmark
Language: English
Study author contacted: yes, no reply from author
Trial registry record or protocol available: clinical trials number NCT1209035
Funding source/declaration of interest: none reported
Adverse events:
In the tourniquet group: 2 patients had confirmed DVT, and 2 patients required further operations on
the index knee
In the non-tourniquet group: 1 patient had confirmed DVT
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Block randomised
Allocation concealment
(selection bias)





Low risk Patients blinded; surgeons not blinded
However surgeons would be able to influence/alter their performance only for
intraoperative outcomes such as intraoperative blood loss, operative time,
or quality of cementation. It is unlikely that surgeons would alter their perfor-
mance to influence these outcomes for fear of damaging the overall quality
and safety of the surgery
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Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Low risk Self-reported outcomes: KOOS, pain, analgesia consumption, DVT
Patients blinded; therefore low risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)




Low risk Missing outcome data balanced in numbers across interventions
Selective reporting (re-
porting bias)
Low risk All outcome measures reported





Methods Two groups: surgery with a tourniquet; surgery without a tourniquet
Follow-up: 5 hours
Study design: single-centre randomised controlled trial
Participants 62 participants in total
Male:Female: 16:15; 17:14
Age, years (SD): 68.3 (8.4); 68.2 (7.8)
BMI (SD): 25.1(2.0); 25.2 (2.5)
Inclusion criteria: patients aged 50 to 85 undergoing elective unilateral cemented total knee replace-
ment because of arthritis
Exclusion criteria: rheumatoid arthritis, peripheral vascular disease, diabetes, prior knee surgery, use of
anticoagulant medication, BMI > 35
Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet (n = 31)
Group B: surgery performed without a tourniquet (n = 31)
All procedures were standardised with regard to preoperative tranexamic acid, spinal anaesthesia,
postoperative pain treatment, and rehabilitation regimen. Before surgery, tranexamic acid (1 g) was
administered orally and cefuroxime (1.5 g) was administered intravenously immediately before skin
incision. In addition, tranexamic acid (0.5 g) was given 3 hours after surgery, and cefuroxime (750
mg) was given 6 and 12 hours postoperatively. Thrombosis prophylaxis was achieved with the use
of rivaroxaban (10 mg/d) throughout the hospital stay. Both groups had an appropriately sized thigh
tourniquet applied, but it was inflated only in the Tq group. In the non-Tq group, it was placed on the
thigh but was not inflated, thereby serving as a safety device in case of uncontrollable bleeding. In the
Tq group, limb exsanguination was done by elevation for 2 minutes and the cuB was inflated to 250
mmHg
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Outcomes 1. Change in pyruvate, glucose, lactate, and glycerol concentrations. Samples were taken from the
dialysate fluid. Microdialysis catheters were inserted into the gastrocnemius muscle at the time of
surgery. Samples were collected every 20 minutes postoperatively until 5 hours
2. Duration of surgery: measured in minutes
Identification Contact information: Ashir Ejaz, Department of Orthopaedic Surgery, Aslborg University Hospital, Aal-
borg, Denmark, Asej@m.dk
No source of funding identified
Notes Country: Denmark
Language: English
Study author contacted: yes, no reply from author
Trial registry record or protocol available: clinical trials number NCT1209035
Funding source/declaration of interest: none reported
Adverse events: none reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Block randomised
Allocation concealment
(selection bias)





Low risk Participants blinded; surgeons not blinded
However surgeons would be able to influence/alter their performance only for
intraoperative outcomes such as intraoperative blood loss, operative time,
or quality of cementation. It is unlikely that surgeons would alter their perfor-
mance to influence these outcomes for fear of damaging the overall quality
and safety of the surgery
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Low risk Self-reported outcomes: none
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)




Low risk Missing outcome data balanced in numbers across intervention groups with
similar reasons for missing data
Selective reporting (re-
porting bias)
Low risk All outcome measures reported
Other bias Low risk No other sources of bias identified
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Study characteristics
Methods Two groups: surgery with a tourniquet; surgery without a tourniquet
Follow-up: 24 months
Study design: single-centre randomised controlled trial
Participants 57 participants in total
Male:Female: 13:16; 15:13
Age, years (SD): 68.3 (8.0); 68.2 (7.8)
BMI (SD): 25.1 (2.0); 25.2 (2.5)
Inclusion criteria: patients aged 50 to 85 undergoing elective unilateral total knee replacement because
of arthritis
Exclusion criteria: rheumatoid arthritis, peripheral vascular disease, diabetes, prior knee surgery, use of
anticoagulant medication, BMI > 35
Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet (n = 29)
Group B: surgery performed without a tourniquet (n = 28)
All procedures were standardised with regard to preoperative tranexamic acid, spinal anaesthesia,
postoperative pain treatment, and rehabilitation regimen. Before surgery, tranexamic acid (1 g) was
administered orally, and cefuroxime (1.5 g) was administered intravenously immediately before skin
incision. In addition, tranexamic acid (0.5 g) was given 3 hours after surgery, and cefuroxime (750
mg) was given 6 and 12 hours postoperatively. Thrombosis prophylaxis was achieved with the use
of rivaroxaban (10 mg/d) throughout the hospital stay. Both groups had an appropriately sized thigh
tourniquet applied, but it was inflated only in the Tq group. In the non-Tq group, it was placed on the
thigh but was not inflated, thereby serving as a safety device in case of uncontrollable bleeding. In the
Tq group, limb exsanguination was done by elevation for 2 minutes and the cuB was inflated to 250
mmHg
Outcomes 1. Radiosterometric analysis (maximum total point motion) at 8 weeks, 6 months, 12 months, and 24
months. MTPM represents the vector length of a marker in the rigid body that has the longest trans-
lational motion, not considering direction, and always has a positive value. Translations along the
axes were given as x-translation (medial–lateral movement), y-translation (superior/liJ-oB and infe-
rior/subsidence movement), and z-translation (anterior and posterior movements). Rotations around
the axes were expressed as x-rotation, y-rotation, and z-rotation, which represent anterior-posterior
tilt, internal-external rotation, and varus–valgus tilt, respectively
Identification Contact information: Ashir Ejaz, Department of Orthopaedic Surgery, Aslborg University Hospital, Aal-
borg, Denmark, Asej@m.dk
No source of funding identified
Notes Country: Denmark
Language: English
Study author contacted: yes, no reply from author.
Trial registry record or protocol available: clinical trials number NCT1209035
Funding source/declaration of interest: none reported
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Adverse events: none reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Block randomised
Allocation concealment
(selection bias)





Low risk Participants blinded; surgeons not blinded
However surgeons would be able to influence/alter their performance only for
intraoperative outcomes such as intraoperative blood loss, operative time,
or quality of cementation. It is unlikely that surgeons would alter their perfor-
mance to influence these outcomes for fear of damaging the overall quality
and safety of the surgery
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Low risk Self-reported outcomes: none
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)
Unclear risk Assessor-reported outcomes: RSA analysis




Low risk Missing outcome data balanced in numbers across intervention groups with
similar reasons for missing data
Selective reporting (re-
porting bias)
Low risk All outcome measures reported





Methods 2 groups: surgery with a tourniquet; surgery performed without a tourniquet
Follow-up: 8 months
Study design: randomised controlled trial performed at an academic university hospital and a private
orthopaedic hospital
Participants 200 participants randomised
Mean age in the tourniquet group 66 (7); mean age in the non-tourniquet group 65.5 (7.8)
Male:Female ratio: 50:50; 48:52
Mean BMI in the tourniquet group 30.9 (4.6); mean BMI in the non-tourniquet group 31.3 (4.5)
Inclusion criteria: all unilateral primary knee arthroplasties performed by investigators participating in
this study will be eligible for inclusion and diagnosis of osteoarthritis
Exclusion criteria: revision surgery, bilateral knee surgery, age < 18 or > 80, BMI > 40, baseline lower ex-
tremity strength < 5/5, vascular calcifications, history of chronic narcotic use defined as more than 5 mg
of oxycodone q4 hours, functionally limiting spine disease, other functionally limiting lower extremi-
ty disorder (i.e. symptomatic ipsilateral hip disease), patients who cannot perform baseline functional
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tests, allergy/contraindication to protocol medications, post-traumatic arthritis, Inflammatory arthritis,
pregnancy, prisoners and patients receiving care as part of a workers' compensation injury
Duration of illness: unspecified
Interventions In the tourniquet group, surgery was performed with a tourniquet inflated at 225 mmHg or 300 mmHg
depending on surgeon preference. In the non-tourniquet group, surgery was performed without a
tourniquet
All total knee replacements were done with the patient under sedation and spinal anaesthesia utilising
bupivacaine without an opioid. All patients received an adductor canal block, and a pneumatic tourni-
quet was applied to all patients. Patients received 1 g of intravenous tranexamic acid 30 minutes be-
fore the incision when it was deemed appropriate by the anaesthesiologist. A standard midline incision
and a medial parapatellar approach were utilised for all surgical procedures. For patients randomised
to tourniquet inflation, the tourniquet was inflated at the start of the procedure and was deflated after
application of sterile dressings. Either the DePuy Synthes P.F.C. SIGMA or the Zimmer Biomet Persona
implant system was used. The tourniquet system used was the Stryker Color CuB Dual Port inflated to
either 300 or 225 mmHg, depending on surgeon preference
Outcomes 1. Duration of surgery
2. Overall blood loss
3. Surgeon-rated difficulty in visualisation
4. Pain measured on a visual analogue scale at 4 to 6 weeks and at 6 to 8 months
5. Stair climb test measured at 4 to 6 weeks and at 6 to 8 months
6. Time to up and go test measured at 4 to 6 weeks and at 6 to 8 months
7. KOOS score measured at 4 to 6 weeks and at 6 to 8 months
8. SF-12 measured at 4 to 6 weeks and at 6 to 8 months
9. Wound complications
10.Deep vein thrombosis
Identification Contact information: Rahul Goel, Department of Orthopaedic Surgery, Emory University, Atlanta, Geor-
gia, USA
ORCID ID for R Goel: 0000-0002-0515-0361
Notes Country: USA
Language: English
Study author contacted: no
Trial registry record or protocol available: study was registered at ClinicalTrials.gov (NCT02907047)
Funding source/declaration of interest: no source of funding reported or identified
Adverse events:
1 person in the tourniquet group had a wound complication requiring antibiotics
1 patient in each group had postoperative wound blistering
1 patient in the non-tourniquet group developed symptomatic DVT
Number in each group 100;100
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random number generator
Allocation concealment
(selection bias)
Low risk Envelopes with allocation opened before incision
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Low risk Patients blinded; surgeons not blinded
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Low risk Self-reported outcomes: pain, satisfaction, SF-12, KOOS
Patients blinded
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)
Low risk Outcome assessors blinded
Assessor-reported scores: blood loss, duration of surgery, range of motion,




Low risk Missing outcome data balanced in numbers across intervention groups with
similar reasons for missing data across groups
Selective reporting (re-
porting bias)
Low risk All outcome measures reported





Methods Two groups: surgery with a tourniquet; surgery without a tourniquet
Follow-up: 48 hours
Study design: single-centre randomised controlled trial
Participants 64 participants in total
Male:Female: 17:15; 18:14
Age, years (SD): 68 (8.0); 66 (8)
BMI (SD): 27.4; 28.4
Inclusion criteria: ASA I to III, able to understand given information, 45 to 85 years of age
Exclusion criteria: previous major knee surgery to the same knee, preoperative inability to flex the knee
> 90 degrees, rheumatoid arthritis, allergy to any of the drugs used in the study
Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet (n = 32)
Group B: surgery performed without a tourniquet (n = 32)
As premedication, all patients received oral celecoxib 400 mg and acetaminophen 1 g; thereafter 12-
hourly (celecoxib 200 mg) and 6-hourly (acetaminophen 1 g). No subjects received an indwelling uri-
nary catheter, and no drains were used. A low-volume fluid regimen was used with 2000 mL of Ringer's
solution during the first 24 hours. All subjects were given 1 g of tranexamic acid i.v. Oxycodone 5 mg
i.v. was used as postoperative rescue pain medication. No femoral nerve blocks were used. All patients
were anaesthetized using intrathecal administration of hyperbaric bupivacaine 0.5%, 3 mL. An infusion
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of propofol 10 mg mL−1 was given to induce light sedation during surgery. All patients breathed spon-
taneously with supplemental oxygen 2 L min−1
Outcomes 1. Knee extension strength: measured from pre-surgery to 48 hours after surgery in the operated leg.
Knee extension strength was measured isometrically at 60° knee flexion using an isokinetic dy-
namometer (Biodex) and was expressed as Newtons per kilo body mass
2. Pain: assessed as a visual analogue scale between 0 and 10; zero indicates no pain, and 10 indicates
extreme pain
3. Swelling: not reported how this was collected.
4. Nausea: not reported how this was collected.
5. Duration of surgery: measured in minutes




Study author contacted: author not contacted
Trial registry record or protocol available: clinical trials number NCT01808859
Funding source/declaration of interest: study was supported by institutional grants
Adverse events: no adverse events reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer generated
Allocation concealment
(selection bias)





High risk Patients and surgeons not blinded
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
High risk Self-reported outcomes: pain and nausea
Patients not blinded; therefore high risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)
Low risk Assessor-reported outcomes: knee extension strength, swelling, duration of
surgery




Low risk No missing outcome data
Selective reporting (re-
porting bias)
Low risk All outcome measures reported
Other bias Low risk No other sources of bias identified
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Methods Three groups: surgery with a tourniquet as well as multiple doses of intravenous tranexamic acid (TXA);
surgery with no tourniquet and multiple doses of TXA; surgery with a tourniquet and no TXA
Follow-up: 6 months
Study design: single-centre randomised controlled trial
Participants 150 participants in total
Male:Female: 18:32; 16:34
Age, years (SD): 66.2 (8.3); 65.1 (6.8)
BMI (SD): 25.1 (1.5); 24.4 (1.5)
Inclusion criteria: patients older than 18 scheduled for primary total knee arthroplasty for end stage-os-
teoarthritis
Exclusion criteria: revision procedures, bilateral procedures, previous knee surgery, flexion deformity >
30 degrees, anaemia, contraindication for TXA, ASA grade IV, coagulation disorder
Duration of illness: unspecified
Interventions Group A: surgery with a tourniquet and multiple doses of TXA (n = 50)
Group B: surgery without a tourniquet and multiple doses of TXA (n = 50)
Group C: surgery with a tourniquet and no TXA (n = 50)
A surgeon-selected cemented posterior-stabilised prosthetic design was used. Vacuum wound
drainage was used for every patient and was removed the next morning. An intraoperative periarticu-
lar injection of ropivacaine and postoperative oral diclofenac sodium (Voltaren; 50 mg twice daily) were
administered for pain. On the day of the surgery and 3 times daily thereafter until hospital discharge,
all patients were evaluated by a physical therapist and began walking with partial weight-bearing and
wearing a knee brace to protect the surgical site
Outcomes 1. HSS score at 6 months: knee-related score assessing pain, stability (measured as total varus-valgus
arc, extension), motion (measured as total passive arc), quadriceps strength (measured as 10% of
normal for age and gender), and subtractions for contractures or fixed varus/valgus. Score ranges from
0 to 100. The higher the score, the better the outcome
2. Duration of surgery: measured in minutes
3. Intraoperative blood loss: measured in millilitres
4. Total blood loss: measured in millilitres
5. Transfusion rate: defined as the number of units delivered to the patient. The higher the number of
units, the worse the outcome
6. Length of hospital stay: measured in number of days
7. Patient satisfaction: all patients completed a satisfaction questionnaire regarding outcomes of
surgery, which asked them to rate their satisfaction on a 7-point scale ranging from very dissatisfied
to extremely satisfied
8. Deep vein thrombosis
9. Pulmonary embolism
10.Swelling ratio: the swelling ratio was defined as the knee circumference of the operatively treated limb
divided by the circumference of the contralateral limb, with the knee circumference encompassing
the upper and lower poles of the patella
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Identification Contact information: ZeYu Huang, MD, PhD, Department of Orthopaedic Surgery, West China Hospital,




Study author contacted: no
Trial registry record or protocol available: registered on Chinese clinical trials registry ChiC-
TR-INR-16009762
Funding source/declaration of interest: none reported
Adverse events:
Group A: 1 patient had a superficial wound infection
Group B: no adverse events were reported
Group C: 3 patients developed a superficial wound infection and 3 patients reported blistering
We reported groups A and B in our analysis
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer generated
Allocation concealment
(selection bias)





Low risk Participants blinded; surgeons blinded only until the morning of the operation
However surgeons would be able to influence/alter their performance only for
intraoperative outcomes such as intraoperative blood loss, operative time,
or quality of cementation. It is unlikely that surgeons would alter their perfor-
mance to influence these outcomes for fear of damaging the overall quality
and safety of the surgery
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Low risk Self-reported outcomes: HSS score, patient satisfaction, DVT, PE
Patients blinded; therefore low risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)
Low risk Assessor-reported outcomes: duration of surgery, intraoperative blood loss,
total blood loss, transfusion rate, length of hospital stay, swelling




Low risk No missing outcome data
Selective reporting (re-
porting bias)
Low risk All outcome measures reported
Other bias Low risk No other sources of bias identified
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Methods Two groups: surgery with a tourniquet; surgery without a tourniquet
Follow-up: 60 minutes postoperatively
Study design: single-centre randomised controlled trial
Participants 34 participants in total
Male:Female: 8:15; 8:15
Age, years (SD): 70.6 (7); 70.6 (6)
BMI (SD): 32.1 (5); 33.8 (5)
Inclusion criteria: 55 to 85 years of age, osteoarthritis of the knee joint (degree III or IV), physical status
(ASA I or II), BMI < 45, able to provide written informed consent
Exclusion criteria: < 55 or > 85 years of age, osteoarthritis of the knee joint (degree I or II), ASA physical
status III or IV, BMI > 45, unable to provide written consent, malignant disease, rheumatoid disease, in-
fectious disease, coagulation disorder, history of deep vein thrombosis or pulmonary embolism, pe-
ripheral arterial disease, immune deficiency, medication (glucocorticoid, aspirin, heparin, cumarin,
warfarin), neurological dysfunction, liver insufficiency, coronary heart disease, immobility
Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet (n = 17)
Group B: surgery performed without a tourniquet (n = 17)
After accomplishment of the anaesthesia, a pneumatic tourniquet was applied at the proximal third of
the thigh. Thereafter, a standard sterilisation procedure was performed. The tourniquet was inflated
(380 mmHg) immediately before the skin incision. The standard medial parapatellar approach was per-
formed in all cases. For each of these groups, 2 biopsies were taken from the vastus medialis. The first
muscle biopsy was obtained immediately after surgery was performed; this was followed by the second
muscle biopsy exactly 60 minutes later (before tourniquet deflation). Biopsy volume was set to be 5 × 5
× 5 mm (125 mm3) with distance between biopsies > 10 mm. Muscle extracts were frozen in liquid nitro-
gen until further analyses
Outcomes Primary outcome:
Measurement of intracellular proteolytic activity: the total ubiquitination, as a result of total ubiqui-
tin-protein ligase activity (tUbPL), was determined as biotinylated ubiquitin incorporation into the sum
of the cytosolic proteins. The ubiquitination was expressed in katal, which is defined as 1 mol biotiny-
lated ubiquitin incorporated into cytosolic proteins per second
Secondary outcomes:
1. Blood loss (1 week postoperative): measured in millimetres
2. Complication (within 6 months of operation date)
3. WOMAC score (6 months postoperatively): consists of 24 items divided into 3 subscales (pain, stiffness,
and physical function). Total score is 96, with 0 indicating no problems with the knee and 98 repre-
senting extreme problems with the knee
4. Prosthesis position on radiograph (1 week postoperatively): not stated in protocol how this was to be
measured
5. Nerve function analysis: not stated in protocol how this was to be measured
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Identification Contact information: Ahmed Jawhar, Department of Orthopaedics and Trauma Surgery, University
Medical Centre Mannheim of University Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Ger-
many, Jawhar_ahmed@yahoo.de
No conflicts of interest
Notes Country: Germany
Language: English
Study author contacted: yes, no reply from author
Trial registry record or protocol available: clinical trials ID NCT02475603
Funding source/declaration of interest: no sources of funding stated
Adverse events: no adverse events reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer generated
Allocation concealment
(selection bias)





Unclear risk Insufficient information to permit judgement
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Unclear risk Not stated if patients were blinded; therefore unclear risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)




Unclear risk No missing outcome data
Selective reporting (re-
porting bias)
High risk Outcomes in registration/protocol not reported





Methods 2 groups: surgery performed with a tourniquet; surgery performed without a tourniquet
Follow-up: 6 months
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Study design: single-centre randomised controlled trial
Participants 99 participants included in this study
Mean age in the tourniquet group 69.3 (7.4); mean age in the non-tourniquet group 68.3 (7.3)
Mean BMI in the tourniquet group 31.9 (6); mean BMI in the non-tourniquet group 31.4 (5.5)
Male:Female ratio: 17:33; 19:30
Inclusion criteria: 50 to 85 years of age; Osteoarthritis Kellgren and Lawrence score III or IV; ASA score I,
II, III; BMI < 45 kg/m2; able to provide written consent
Exclusion criteria: < 50 years or > 85 years of age, Osteoarthritis Kellgren and Lawrence score I or II, ASA
IV, 
BMI > 45 kg/m2, unable to provide written consent, other implant designs, unicondylar knee arthro-
plasty, malignant disease, rheumatoid disease,
infectious disease, coronary heart disease, neurological dysfunction, immobility - not able to walk
, liver insufficiency, 
coagulation disorder, glucocorticoids, aspirin, heparin, coumadin, warfarin, history of DVT or pul-
monary embolism
Duration of illness: unspecified
Interventions All TKAs were performed at the Department of Orthopaedics and Trauma Surgery according to institu-
tional standard operating procedure. Medial parapatellar approach and femur first surgical technique
were performed to implant a cemented prosthesis design (SmartSet Bone cement, DePuy Synthes,
Warsaw, IN, USA) (PFC® SIGMA®). After introduction of anaesthesia, a pneumatic tourniquet (Balbina™,
Ulrich Medical, Ulm, Germany) was placed on the proximal thigh and was inflated only in the tourni-
quet group to 360 mmHg, immediately before skin incision. The tourniquet was released on comple-
tion of wound closure and after application of an elastic–compressive bandage. In the non-tourniquet
group, the same surgery was performed without a tourniquet
Outcomes 1. Oxford Knee Score collected at 6 weeks and 6 months
2. WOMAC score collected at 6 weeks and 6 months
3. Mancuso score collected at 6 weeks and 6 months
4. EQ-5D (VAS and Index) collected at 6 weeks and 6 months
5. Hospital Anxiety and Depression score collected at 6 weeks and 6 months
6. Muscle strength (muscle peak force (Newton), workload (Joule), total workload (Joule), power (Watt))
collected at 6 weeks and 6 months
7. Complications such as postoperative haematoma, DVT/PE, surgical site infection, and vascular/nerve
injury
Identification Ahmed Jawhar, ahmed.jawhar@umm.de, Department of Orthopaedics and Trauma Surgery, Universi-




Study author contacted: no
Trial registry record or protocol available: the protocol was registered at clinicaltrials.gov (ClinicalTrial-
s.gov NCT02475603). The Institutional Ethics Committee approved the protocol (file reference 2012-334
N-MA/University Medical Center Mannheim of University Heidelberg)
Funding source/declaration of interest: no source of funding reported or identified
Adverse events:
In the tourniquet group, 1 deep vein thrombosis occurred, 1 patient underwent revision surgery due
to surgical site infection, 2 patients underwent revision surgery due to haematoma in the tourniquet
groups
In the non-tourniquet group, 1 patient had revision surgery due to surgical site infection, 2 patients had
delayed wound healing, 1 patient with delayed wound healing needed revision surgery
Number in each group 50:49
Risk of bias
Jawhar 2020  (Continued)
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Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer generated
Allocation concealment
(selection bias)





Unclear risk Insufficient information to permit judgement
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Unclear risk Insufficient information to permit judgement
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)




Low risk Missing outcome data balanced in numbers across intervention groups with
similar reasons for missing data across groups
Selective reporting (re-
porting bias)
Low risk All outcome measures reported





Methods Two groups: surgery with a tourniquet; surgery without a tourniquet
Follow-up: 2 days
Study design: single-centre randomised controlled trial
Participants 30 participants in total
Male:Female: 7:9; 4:10
Age, years (range): 69 (52 to 89); 64 (46 to 86)
BMI (SD): not reported
Inclusion criteria: patients undergoing primary cemented TKR
Exclusion criteria: patients younger than 18 years, recent (< 6 months) myocardial infarction, unstable
angina, severe aortic or mitral valve stenosis, previous stroke, unmedicated hypertension, treatment
with beta-antagonist or anticoagulant
Duration of illness: unspecified
Interventions Group A: surgery performed with epidural anaesthesia without a tourniquet (n = 14)
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Group B: surgery performed with spinal anaesthesia and a tourniquet (n = 16)
In all cases, the leg planned for operation was exsanguinated with an Esmarch bandage before the
tourniquet was inflated around the upper femur; tourniquet inflation pressure was maintained at 350
to 400 mmHg during the operation. At the end of surgery, the surgeon deflated the tourniquet to enable
establishment of haemostasis; during surgery, sedation was adjusted to a level where communication
was possible. Oxygen was delivered at 3L/min on a nasal catheter. All patients had urine output moni-
tored via a urinary bladder catheter
Outcomes 1. Mean arterial pressure: measured intraoperatively calculated as (cardiac output multiplied by sys-
temic vascular resistance) added to central venous pressure
2. Intraoperative blood loss: measured in millilitres through volume in the suction apparatus and weigh-
ing of towels
3. Postoperative blood loss: measured in millilitres through volume in postoperative drains
4. Total blood loss: measured in millilitres
5. Intravenous fluid usage: measured in millilitres as the amount of colloid or crystalloid administered
in the first 24 hours
6. Blood transfusion rate: defined as the number of units delivered to the patient. The higher the number
of units, the worse the outcome
7. Blood hematocrit, creatinine, APTT, and platelet level at 1, 3, and 7 days postoperatively
8. Postoperative arterial pH and base excess
Identification Contact information: Palle Juelsgaard, MD, Tokkerbakken 20, DK-8240, Risskov, Denmark, juels-
gaard@dadlnet.dk
No source of funding stated
Notes Country: Denmark
Language: English
Study author contacted: not contacted
Trial registry record or protocol available: none stated or identified
Funding source/declaration of interest: no sources of funding stated
Adverse events: no adverse events reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Insufficient information to permit judgement
Allocation concealment
(selection bias)





Low risk Participants blinded; insufficient information on whether surgeons were blind-
ed
However surgeons would be able to influence/alter their performance only for
intraoperative outcomes such as intraoperative blood loss, operative time,
or quality of cementation. It is unlikely that surgeons would alter their perfor-
mance to influence these outcomes for fear of damaging the overall quality
and safety of the surgery
Juelsgaard 2001  (Continued)
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Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Low risk Self-reported outcomes: none
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)




Unclear risk Insufficient reporting of attrition
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
No protocol reported or identified






Methods Two groups: surgery with a tourniquet; surgery without a tourniquet
Follow-up: no follow-up beyond operation
Study design: single-centre randomised controlled trial
Participants 46 participants in total
Male:Female: 2:20; 2:23
Age, years (SD): 65 (10); 63 (8)
BMI (SD): not reported
Inclusion criteria: patients due to undergo primary total knee replacement surgery
Exclusion criteria: none stated
Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet (n = 22)
Group B: surgery performed without a tourniquet (n = 24)
Anaesthesia was induced with intravenous propofol (1.5 mg/kg) and fentanyl citrate (0.1 mg). Tracheal
intubation was facilitated with vecuronium bromide (0.1 mg/kg); anaesthesia was maintained with
66% nitrous oxide in 33% oxygen and sevoflurane. During the operation, all patients were ventilated
with a tidal volume of 10 mL/kg and had a respiratory rate of 10 breaths/min. In the tourniquet group,
the involved limb was exsanguinated by elevation and an Esmarch bandage, after which a pneumatic
thigh tourniquet was applied to the limb and was inflated to pressure of 350 mmHg. No tourniquet was
applied to the legs of control patients. The same surgeon performed all procedures; a similar surgical
technique was used in each patient
Outcomes 1. Number of embolic events: measured via ultrasound. To identify the residue, it was Sudan-stained
to detect fat and Giemsa-stained to detect thrombus and bone marrow. Echogenic materials were
Kato 2002 
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graded as follows: Grade 0 no emboli, Grade 1 few fine emboli, Grade 2 a cascade of fine emboli or
embolic masses < 5 mm, Grade 3 fine emboli mixed with large embolic masses > 5 mm
2. Duration of surgery: measured in minutes
3. Pulmonary embolism
4. Mean arterial pressure: measured intraoperatively, calculated as (cardiac output multiplied by sys-
temic vascular resistance) added to central venous pressure
5. Blood loss: measured in millilitres
6. Tranfusion volume: measured as total volume of blood transfused to all patients in millilitres
Identification Contact information: Dr. Kato, Department of Anesthesia, Chiba Hokusoh Hospital, Nippon Medical
School, 1715 Kamakari, Inba-mura, Inba-gun, Chiba 270-1694, Japan, n-kato@mva.biglobe.ne.jp
No sources of funding mentioned for this study
Notes Country: Japan
Language: English
Study author contacted: yes, no reply from the author
Trial registry record or protocol available: none stated or identified
Funding source/declaration of interest: no sources of funding stated
Adverse events: no adverse events reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Insufficient information to permit judgement
Allocation concealment
(selection bias)





Unclear risk Insufficient information to permit judgment
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Unclear risk Not stated if patients were blinded; therefore unclear risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)




Unclear risk Insufficient reporting of attrition
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
No protocol reported or identified
Other bias Low risk No other sources of bias identified
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Methods Two groups: surgery with epinephrine-augmented hypotensive anaesthesia without use of a tourni-
quet; normotensive epidural anaesthesia with a tourniquet
Follow-up: 6 days
Study design: single-centre randomised controlled trial
Participants 100 participants in total
Male:Female: 13:36; 10:41
Age, years (SD): 74.7 (7.4); 72.6 (7.1)
BMI (SD): 28.5 (3.3); 28.8 (3.9)
Inclusion criteria: patients listed for total knee replacement surgery, ASA grade I and II
Exclusion criteria: patients with history of myocardial infarction with angina, severe aortic or mitral
valve stenosis, untreated hypertension, renal disease, preoperative bleeding disorders
Duration of illness: unspecified
Interventions Group A: surgery performed with epinephrine-augmented hypotensive epidural anaesthesia and no
tourniquet group (n = 49)
Group B: surgery performed with normotensive epidural anaesthesia with tourniquet group (n = 51)
All patients were given oral premedication of 7.5 mg midazolam. Arterial blood pressure was monitored
by inserting a 20-gauge cannula into the radial artery. In all patients, a central venous catheter was
placed into the right internal jugular vein to measure central venous pressure. The catheter also was
used to administer the epinephrine infusion to the group of patients who received EAHEA (Group A)
In Group A, patients received 100 to 200 mL Ringer’s solution (Fresenius Kabi Austria GmbH, Graz, Aus-
tria) before the epidural dose as a fluid preload. Epidural anaesthesia was done at the Th12-L1 and L1-
L2 interspace by a paramedian approach with ropivacaine 1% (20 to 30 mL) and fentanyl (50 micro-
grams)
In Group B, patients received 500 mL Ringer’s solution (Fresenius Kabi Austria GmbH) before the
epidural dose as fluid preload. Epidural anaesthesia was administered at the L3-L4 and L4-L5 inter-
spaces through a paramedian approach with ropivacaine 1% (15 mL) and fentanyl (50 micrograms)
Outcomes 1. Change in haemoglobin: haemoglobin measured in grams/dL was taken via blood sample at 6 hours
and days 1 to 6 postoperatively
2. Blood transfusion rate: defined as the number of units delivered to the patient. The higher the number
of units, the worse the outcome
3. Duration of surgery: measured in minutes
Identification Contact information: Martin Raffl, MD, Clinic for Anesthesiology and Intensive Care, Paracelsus
Medical Private School, Salzburg, Muellner Hauptstrasse 48, A-5020, Salzburg, Austria Phone
0043-662-4482-2701; Fax 0043-662-4482-2703; m.raffl@salk.a
Notes Country: Austria
Language: English
Study author contacted: yes, no reply from the author
Trial registry record or protocol available: none stated or identified
Kiss 2005 
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Funding source/declaration of interest: no sources of funding stated
Adverse events: no adverse events reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Insufficient information to permit judgement
Allocation concealment
(selection bias)





Unclear risk Insufficient information to permit judgment
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Low risk Self-reported outcomes: none
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)
Low risk Assessor-reported outcomes: change in haemoglobin, blood transfusion rate,
duration of surgery




Low risk No missing outcome data
Selective reporting (re-
porting bias)
Low risk All outcome measures reported





Methods Two groups: surgery performed with a tourniquet; surgery performed without a tourniquet
Follow-up: 6 weeks
Study design: single-centre randomised controlled trial
Participants 30 participants in total
Male:Female: 9:21
Age, years (range): 58 (45 to 69)
BMI (SD): not reported
Inclusion criteria: patients undergoing bilateral total knee replacement
Exclusion criteria: patients with severe cardiac comorbidities or neurological problems
Kumar 2015 
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Duration of illness: unspecified
Interventions 30 patients undergoing bilateral knee replacement surgery
Group A: surgery performed with a tourniquet (n = 30)
Group B: surgery performed without a tourniquet (n = 30)
All surgeries were performed by the same surgical team with standard technique. Epidural anaesthe-
sia was used in all patients given with epidural morphine 50 mg/kg along with 0.1% bupivacaine in 10
mL normal saline. Along with that, IV diclofenac sodium was used twice daily for 5 days postoperatively
and then was shifted to oral formulation accordingly. Both knees were prepared at the same time, and
a single set of instruments were used. One knee was operated first and then the other by senior author
[CSY]. All patients received perioperative antibiotics (amoxicillin-clavulanic acid 1.2 grams intravenous-
ly).
The thigh that will receive the tourniquet pressure will be randomised according to a coin toss just be-
fore the start of surgery. The tourniquet cuB used was 85 cm long and 8.5 cm wide One soJ roll pad was
applied between the skin and the cuB
In thigh 1, tourniquet used side was inflated to systolic blood pressure plus 100 mmHg and was re-
leased after the first quadriceps stitch. Haemostasis was achieved before closure. The wound was
closed after wound irrigation, then elastic bandages were applied. In thigh 2, the tourniquet was
wrapped around the thigh but was not inflated during surgery
Outcomes 1. Pain score at days 1, 2, 3, weeks 2 and 6 postoperatively: assessed on a visual analogue scale between
0 and 10; zero indicates no pain, and 10 indicates extreme pain
Identification Corresponding author: c/o Bipin Kumar, Sector-4/D, Quarter No. 1038, Bokarosteel City, Jharkhand, In-
dia, knishikant@ymail.com (N. Kumar)
Notes Country: India
Language: English
Study author contacted: no
Trial registry record or protocol available: none stated or identified
Funding source/declaration of interest: no sources of funding stated
Adverse events: no adverse events reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Coin toss
Allocation concealment
(selection bias)





Unclear risk Insufficient information to permit judgement
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Unclear risk Self-reported outcome: pain
Not stated if patients were blinded; therefore unclear risk of bias
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Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)




Unclear risk Insufficient reporting of attrition
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
No protocol reported or identified





Methods Two groups: surgery performed with a tourniquet; surgery performed without a tourniquet
Follow-up: 2 years
Study design: single centre randomised controlled trial
Participants 50 participants in total
Male:Female: 10:15; 9:14
Age, years (SD): 70 (8); 71 (6)
BMI (SD): 29 (4.8); 28 (4.8)
Inclusion criteria: patients on the waiting list for elective primary total knee surgery due to arthritis,
ASA I or II
Exclusion criteria: Inability to give informed consent, rheumatic arthritis, malignancy, coagulation dis-
order or medical treatment influencing coagulation, liver disease, severe heart disease, bilateral opera-
tion
Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet (n = 25)
Group B: surgery performed without a tourniquet (n = 25)
All operations were done under spinal anaesthesia. The Nexgen CR all-poly tibia knee prosthesis (Zim-
mer) was inserted after pulsed lavage and was cemented with Palacos R + G (Heraeus Medical Nordic,
Sollentuna, Sweden) (40 g Palacos and 0.5 g gentamicin). 2 g cloxacillin was given intravenously just
before and 3 times after the operation Low–molecular-weight heparin (Innohep, 4500 IE subcutaneous-
ly) was used for the first 14 postoperative days
Outcomes 1. Maximum total point motion at 6 months, 12 months, and 24 months: MTPM represents vector length
of a marker in the rigid body that has the longest translational motion, not considering direction, and
always has a positive value. Translations along the axes were given as x-translation (medial–lateral
movement), y-translation (superior/liJ-oB and inferior/subsidence movement), and z-translation (an-
terior and posterior movements). Rotations around the axes were expressed as x-rotation, y-rotation,
and z-rotation, which represent anterior-posterior tilt, internal-external rotation, and varus–valgus
tilt, respectively
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2. Pain: assessed as a visual analogue scale between 0 and 10; zero indicates no pain, and 10 indicates
extreme pain
3. Blood loss: measured during surgery by weighing the surgical sponges and by subtracting the amount
of irrigation fluid used from the content of the suction drain. Postoperative overt bleeding volume (in
the drains) was estimated by measuring the haemoglobin content of the drains in relation to the blood
haemoglobin concentration. Total blood loss was estimated by the haemoglobin dilution method
based on blood volume
4. Range of motion: ROM was measured before surgery and after 3 days, 4 days, 6 weeks, 3 months, 6
months, 1 year, and 2 years. These measurements were performed by a physiotherapist who did not
know whether a tourniquet had been used
Identification Contact information: Department of Orthopedics, Aleris Specialist Care Motala; Department of Ortho-




Study author contacted: no
Trial registry record or protocol available: none stated or identified
Funding source/declaration of interest: the study was funded by Swedish Research Council
(VR-2009-6725)
Adverse events: no adverse events reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Block randomised
Allocation concealment
(selection bias)





Low risk Patients blinded; surgeons not blinded
However surgeons would be able to influence/alter their performance only for
intraoperative outcomes such as intraoperative blood loss, operative time,
or quality of cementation. It is unlikely that surgeons would alter their perfor-
mance to influence these outcomes for fear of damaging the overall quality
and safety of the surgery
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Low risk Self-reported outcome: pain
Patients blinded; therefore low risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)
Low risk Assessor-reported outcomes: MTPM, blood loss, range of motion




Low risk No missing outcome data
Ledin 2012  (Continued)
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Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
No protocol reported or identified





Methods Two groups: surgery performed with a tourniquet; surgery performed without a tourniquet
Follow-up: 7 days
Study design: single-centre randomised controlled trial
Participants 60 participants in total
Male:Female: 9:21; 10:20
Age, years (SD): 71 (7); 70 (7)
BMI (SD): 24 (5); 24 (5)
Inclusion criteria: patients with initial unilateral TKA osteoarthritis (OA), rheumatoid arthritis (RA)
Exclusion criteria: patients with diabetes, haemorrhagic haematological disease, haemoglobin (Hb) <
100 g/L, peripheral neurovascular disease, malignant tumour, history of vascular embolism, history of
infection in the affected lower limb
Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet (n = 30)
Group B: surgery performed without a tourniquet (n = 30)
All surgical prostheses were replaced with posterior cruciate ligament instead of a cemented artifi-
cial knee joint (GENES II, Smith & Nephew, Andover, MA, USA). Surgery was performed by the same
group of physicians using the midvastus route. 3 g of haemostatic powder was sprayed on the surface
of the joint cavity and soJ tissue before the incision was sutured. Tourniquet pressure in the tourniquet
group was the patient's own arterial systolic pressure + 100 mmHg (1 mmHg = 0.133 kPa); the wound
was closed, and the tourniquet was loosened with standard dressing. Operation of the non-haemosta-
tic group was the same as above, but the anaesthetist reduced basal blood pressure by 30 to 40 mmHg
during the period from osteotomy to the bone cement-covered bone bed to reduce bleeding and found
that the active bleeding point was electrocoagulated in time. All patients had no drainage in the inci-
sion [6]. Low-molecular-weight heparin calcium and plantar pump were routinely used postoperative-
ly for anti-deep vein thrombosis. The wound dressing was replaced when it was oozing out or when the
dressing of the incision was slightly tight to prevent distal blood flow. The knee joint was not passively
exercised after CPM, and the affected limb was lifted higher than the heart plane
Outcomes 1. Hb and haematocrit (HCT) values: all patients were treated with blood tests 24 hours after surgery;
patients with haemoglobin values < 90 g/L were treated with blood transfusion. The number of trans-
fused patients in the 2 groups was recorded
2. Surgical time: record operating time from cutting the skin to suturing the skin measured in minutes
3. Intraoperative blood loss (IBL): calculation of intraoperative blood loss includes liquid in the aspirator
bottle minus flushing fluid used in the procedure, plus net weight of the gauze pad
4. Postoperative wound blood loss (PWBL): postoperative blood loss is mainly the increase in net weight
after the dressing is weighted; the amount of wound exudation is obtained and converted into vol-
ume. Exudate in the dressing has a certain volatilisation before the dressing change, so there is a cer-
Li 2008 
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tain error between the calculated amount of exudation and the actual amount. To minimise errors
caused by volatilisation, we have increased the thickness of the dressing and increased the frequency
of dressing changes
5. Total measured blood loss (TMBL): IBL + PWBL
6. Periarticular circumference and contusion: the circumference of the knee was measured on the 3rd
and 14th days after surgery, and the increase in rate compared with preoperative rate was calculated.
The maximum extent of soJ tissue plaque around the joint was measured, and the percentage of sur-
face area of the plaque was calculated by the palm method
7. Pain: patients were routinely given analgesia after surgery, intramuscular injection of morphine 10
mg within 6 hours after surgery, oral celecoxib 200 mg twice daily. If the patient feels unbearable pain
after the operation, the morphine 10 mg intramuscular injection is given at any time on the premise
of ensuring safety of the anaesthetic. Postoperative anaesthetic use was compared between the 2
groups. The patient's femoral pain was recorded and pain scores were obtained on 6th, 24th, 48th, and
7th postoperative days on a 10-degree scale. The number of patients with straight leg elevations at
24 hours and 7 days after operation was observed and recorded. The maximum angle of spontaneous
flexion of the knee joints at 1, 3, and 7 days after surgery was recorded
8. Adverse events included deep vein thrombosis
Identification Contact information: 200003 Shanghai, Changzheng Hospital, Second Military Medical University, De-
partment of Orthopedics
Corresponding author: Qian Qi Rong, qianqr @ 163. corn
No funding mentioned for this study
Notes Country: China
Language: Chinese
Study author contacted: yes, no reply from study author
Trial registry record or protocol available: none stated or identified
Funding source/declaration of interest: none stated or identified
Adverse events: no adverse events reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Insufficient information to permit judgement
Allocation concealment
(selection bias)





Low risk Patients blinded; surgeons not blinded
However surgeons would be able to influence/alter their performance only for
intraoperative outcomes such as intraoperative blood loss, operative time,
or quality of cementation. It is unlikely that surgeons would alter their perfor-
mance to influence these outcomes for fear of damaging the overall quality
and safety of the surgery
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Low risk Self-reported outcomes: pain, adverse events
Patients blinded; therefore low risk of bias
Blinding of outcome as-
sessment - assessor re-
Low risk Assessor-reported outcomes: change in haemoglobin and haematocrit, dura-
tion of surgery, blood loss, periarticular circumference
Li 2008  (Continued)
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ported outcomes (detec-
tion bias)




Low risk No missing outcome data
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
No protocol reported or identified





Methods Two groups: surgery performed with a tourniquet; surgery performed without a tourniquet
Follow-up: 14 days
Study design: single-centre randomised controlled trial
Participants 80 participants in total
Male:Female: 11:29; 13:27
Age, years (SD): 71 (6); 70 (7)
BMI (SD): 27.3 (6.3); 26.8 (5.1)
Inclusion criteria: patients with primary osteoarthritis or rheumatoid arthritis undergoing primary total
knee replacement
Exclusion criteria: bilateral total knee replacement either simultaneously or staged at less than 3-
month intervals, diabetes, haemostatic defect, history of peripheral vascular disease, presence of ma-
lignant tumour, preoperative level of Hb < 10 g/L, previous thromboembolism
Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet (n = 40)
Group B: surgery performed without a tourniquet (n = 40)
All procedures were performed by 4 similar staB surgeons. The implant used was the type of posterior
cruciate ligament substituting total knee prosthetic components (Genesis II, Smith & Nephew, Mem-
phis, TN, USA). In group A, the tourniquet was inflated to 100 mmHg above systolic blood pressure after
the leg was elevated and exsanguinated, and deflation was performed after the wound was closed and
the compressive dressing applied. The tourniquet was not used in group B, and active bleeding points
were promptly sealed with electrical coagulation. A uniform perioperative regimen was used in all cas-
es. Antibiotic treatment with second-generation cephalosporin was infused intravenously (1 dose pre-
operatively and for the next 2 days). The quantity of saline transfused intravenously within 24 hours
postoperatively was 2500 to 3000 mL
Outcomes 1. Postoperative range of motion: measured in degrees of active knee flexion. Assessed at days 1, 3, and 7
2. Number of people conducting self-leg raise: measured at days 1, 3, and 7
3. Circumference length of the knee: on postoperative days 3 and 14, the circumference length of the
knee was measured through the superior patellar pole, and the increased rate compared with the
preoperative result was calculated
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4. Duration of surgery
5. Intraoperative blood loss: assessed by adding the volume in suction bottles after reduction of wound
irrigation fluid and the net blood weight of sponges used during the procedure
6. Postoperative blood loss: soaked dressings were weighed and converted to volume. Due to evapora-
tion from soaked dressings before changing, there was an error between calculated volume and ac-
tual volume. So we increased the thickness of the dressings and the frequency of changing
7. Total blood loss: measurement of overall blood loss in millimetres
Identification Contact details: B Li: H Wu; Q Qian; X Lin; H Zhao, Department of Orthopaedic Surgery, Arthritis Insti-




Study author contacted: yes, no reply from study author
Trial registry record or protocol available: none stated or identified
Funding source/declaration of interest: none stated or identified
Adverse events: no adverse events reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random number list was used
Allocation concealment
(selection bias)





Low risk Patients blinded; surgeons not blinded
However surgeons would be able to influence/alter their performance only for
intraoperative outcomes such as intraoperative blood loss, operative time,
or quality of cementation. It is unlikely that surgeons would alter their perfor-
mance to influence these outcomes for fear of damaging the overall quality
and safety of the surgery
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Low risk Self-reported outcomes: number of people conducting straight leg raise
Patients blinded; therefore low risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)
Low risk Assessor-reported outcomes: range of motion, circumference of knee, dura-
tion of surgery, intraoperative blood loss, postoperative blood loss, total blood
loss




Unclear risk Insufficient reporting of attrition
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
No protocol reported or identified
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Methods Two groups: surgery performed with a tourniquet; surgery performed without a tourniquet
Follow-up: 12 months
Study design: single-centre randomised controlled trial
Participants 20 participants in total
Male:Female: 7:3; 9:1
Age, years (SD): 67; 70
BMI (SD): 25.6; 27.1
Inclusion criteria: patients undergoing total knee replacement for osteoarthritis
Exclusion criteria: patients with symptomatic peripheral vascular disease or contraindication to tourni-
quet use
Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet (n = 10)
Group B: surgery performed without a tourniquet (n = 10)
All patients underwent TKA by the senior surgeon (Liu) through a standardised technique and prosthe-
sis. All patients received a general anaesthetic without regional blocks or local anaesthesia, in an effort
to minimise confounding variables that may influence pain scores. A medial parapatellar approach was
used with eversion of the patella. An intra-articular drain on low suction was inserted before wound
closure and was removed day 1 postoperatively. All patients received patient-controlled analgesia with
morphine sulphate for the first 24 hours. Patients were mobilised day 1 postoperatively and were dis-
charged home when mobilising safely. The same standardised physiotherapy protocol was undertaken
in all patients postoperatively. Active and passive range of motion was encouraged without the use of
continuous passive motion
Outcomes 1. Pain: a score from 1 to 10 was recorded 4 times daily up to discharge and was averaged for each day.
Pain scores were recorded at 600, 1200, 1800, and 2200 with the patient at rest for 5 consecutive days.
These times coincided with the timing of routine panadol administration by the nurses
2. Blood transfusion rate: defined as the number of units delivered to the patient. The higher the number
of units, the worse the outcome
3. Thigh and knee swelling: thigh and knee swelling was recorded with use of a tape measure at the
midpoint of the patella and 10 cm above the superior pole of the patella
4. Length of hospital stay: measured in days
5. Range of motion: measured as range of flexion
6. Oxford Knee Score: 12-item patient-reported outcome measure used to report outcomes following
knee replacement. Scores range from 0 to 60. 0 indicates extreme knee problems, and 60 indicates a
normal knee. Not stated when OKS was collected
7. Quadriceps function: measured during active knee extension against gravity using surface EMG. Sur-
face EMG data were recorded (Pocket EMG; BTS S.p.A., Milano, Italy) for each participant on the day
of surgery preoperatively, and at 6 weeks and 6 and 12 months postoperatively. The vastus medialis,
rectus femoris, and vastus lateralis muscles for both treated and control knees were recorded. Sur-
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face EMG electrodes (3M Red Dot; 3M Australia, Sydney, Australia) were placed on the skin surface of
the muscle
8. Cement penetration: measured on the femur and tibia as the depth in centimetres the cement pen-
etrates
Identification Contact details: David Liu, FRACS Gold Coast Centre for Bone and Joint Surgery, John Flynn Private
Hospital, Suite 8A, Fred McKay House, 42 Inland Dr, Tugun Queensland 4224, Australia
Tel: +61-7-5598-0205, fax: +61-7-5598-0205, dliu01@bigpond.com
Smith & Nephew Australia provided financial support
Notes Country: Australia
Language: English
Study author contacted: yes, no reply from study author
Trial registry record or protocol available: none stated or identified
Funding source/declaration of interest: Smith & Nephew Australia provided financial support
Adverse events: no adverse events reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer generated
Allocation concealment
(selection bias)





Low risk Patients blinded; insufficient information on whether surgeons were blinded
However surgeons would be able to influence/alter their performance only for
intraoperative outcomes such as intraoperative blood loss, operative time,
or quality of cementation. It is unlikely that surgeons would alter their perfor-
mance to influence these outcomes for fear of damaging the overall quality
and safety of the surgery
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Low risk Self-reported outcomes: pain, OKS
Patients blinded; therefore low risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)




Low risk No missing outcome data
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
No protocol reported or identified
Other bias Low risk No other sources of bias identified
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Methods Two groups: surgery performed with a tourniquet; surgery performed without a tourniquet
Follow-up: 12 months
Study design: single-centre randomised controlled trial
Participants 56 participants in total
Male:Female: 16:36
Age, years (SD): 67 (8)
BMI (SD): 28.1 (5.5)
Inclusion criteria: bilateral severe osteoarthritis with pain, accompanied with or without significant de-
formity, failure of conservative treatment
Exclusion criteria: recent or current knee sepsis, extensor mechanism discontinuity or severe dysfunc-
tion, age > 70 years, coagulation disorder or treatment with drugs known to influence coagulation, dia-
betes, renal or liver disease, severe cardiovascular problems, lung disease, neurological disorders, can-
cer
Duration of illness: unspecified
Interventions Patients undergoing bilateral knee replacement surgery
Group A: surgery performed with a tourniquet (n = 56)
Group B: surgery performed without a tourniquet (n = 56)
The tourniquet was applied on a layer of cotton wool padding applied over the thigh. Both right and
leJ thighs were prepared with a tourniquet before surgery; only the limb of the TG side was elevat-
ed and exsanguinated with a rubber limb Eschmarch’s bandage. The tourniquet was then inflated to
pressure of 125 mmHg above systolic blood pressure (SBP) just before the incision. Longitudinal inci-
sions were made at the midline with the knee positioned in 90 degrees flexion, from 4 cm proximal to
the upper end of the patella up to the tibial tuberosity. The tourniquet was inflated for less than 120
minutes until wound closure was done and compressive dressing was applied. For NG knees, SBP was
maintained at a level of approximately 100 mmHg at the time of cementation with antihypertensive
drugs. Posterior stabilised knee prostheses (26 GENESIS II, Smith & Nephew, Memphis, TN, USA; 26 Van-
guard, Biomet, Warsaw, IN, USA) were used in the surgery. Periarticular injection of ropivacaine (200
mg), adrenaline hydrochloride (0.1 mg), and morphine (5 mg) was administered just before skin closure
Intravenous patient-controlled analgesia (PCA) with morphine was started postoperatively. All patients
received rivaroxaban (10 mg once a day) from the first postoperative day, for 2 weeks, as prophylaxis
against thromboembolic complications
Outcomes 1. Duration of surgery: length of every knee procedure from skin incision to wound closure
2. Pain score: pain scores were measured on a visual analogue scale (VAS) of 0 to 10 preoperatively and
on postoperative days 1, 3, 5, 7, 14, and 30
3. Range of motion: ROM was measured with a standard handheld goniometer preoperatively and on
postoperative days 7, 14, 30, and 90. Its centre of rotation was placed in line with the centre of the
knee, the fixed arm of the goniometer aligned with the greater trochanter, and the mobile arm aligned
with the lateral malleolus
4. Time to straight leg raise: the time in days to achieve the first straight leg raise of each leg was recorded
5. Swelling: this was assessed from the change in suprapatellar girth (cm). With the knee fully extended,
suprapatellar girth was measured with a standard tape measure at the superior margin of the patella
preoperatively and on postoperative days 3, 7, 14, and 30
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6. Wound healing: postoperatively, the surgical wound was examined for wound length, ooze, soakage,
erythema, skin blister, and ecchymosis
7. Deep vein thrombosis: in case of any suspicion of DVT on clinical grounds, a duplex sonography was
performed for confirmation of VTE
8. Knee Society Score: knee scoring system developed to evaluate patients post total knee replacement
surgery. Consists of a knee score and a functional score. Score ranges from 0 to 100; a score < 60 indi-
cates poor knee function, and a score of 80 to 100 indicates excellent knee function
Identification Contact details: Pei-lai Liu, PhD, Department of Orthopaedics, Qilu Hospital, Shandong University, 107
Wenhua West Road, Jinan, China 250012
Tel: 0086-531-82166542; fax: 0086-531-86927544; gklpl@163.com
No source of funding for this study identified
Notes Country: China
Language: English
Study author contacted: no
Trial registry record or protocol available: none stated or identified
Funding source/declaration of interest: no source of funding identified for this study
Adverse events:
In the tourniquet group: 4 knees had symptomatic DVT
In the non-tourniquet group: 4 knees had symptomatic DVT
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random numbers table
Allocation concealment
(selection bias)





Unclear risk Surgeon not blinded - always performed the non-tourniquet side first; not stat-
ed if patients blinded
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Unclear risk Not stated if patients blinded; therefore unclear risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)
Low risk Assessor-reported outcomes: duration of surgery, range of motion, swelling,
wound healing




Unclear risk Insufficient reporting of attrition
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
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Methods Two groups: surgery performed with a tourniquet; surgery performed without a tourniquet
Follow-up: 12 months
Study design: single-centre randomised controlled trial
Participants 26 participants in total
Male:Female: 8:18
Age, years (SD): 65.8 (9.2)
BMI (SD): 28.2 (5.6)
Inclusion criteria: patients undergoing bilateral total knee replacement surgery
Exclusion criteria: history of coagulation disorder or medications likely to influence coagulation; di-
abetes; renal or liver disease; severe cardiovascular problems and lung disease; nerve disorder; can-
cer; skin disease; history of a previous surgical procedure of the knee other than arthroscopy; apparent
keloid constitution
Duration of illness: unspecified
Interventions Patients undergoing bilateral knee replacement surgery
Group A: surgery performed with a tourniquet (n = 26)
Group B: surgery performed without a tourniquet (n = 26)
As per the surgeon’s usual practice, TKA with or without tourniquet placement was first completed on
the leJ knee, then was performed on the right side after closure. All surgeries were performed under
general anaesthesia by the same team of surgeons. A layer of cotton wool padding was applied over
both thighs, above which the tourniquet was applied. The tourniquet size was 105 cm × 7 cm. Further,
the lower limb on the side assigned to the TP group was elevated, and a rubber limb exsanguinator was
inflated to pressure of 125 mmHg above systolic blood pressure immediately before the incision was
made. Intravenous morphine for patient-controlled analgesia (PCA) was started postoperatively. All pa-
tients received rivaroxaban (10 mg 2 times daily) for 2 weeks from the first day of the operation as pro-
phylaxis against thromboembolic complications
Outcomes 1. Duration of surgery: was recorded from when the incision was made until it was closed. Measured in
minutes
2. Wound healing: measured as oozing that was classified as severe if the gauze was completely soaked
or more than 10 layers of the gauze dressing were soaked with blood or serous fluid. Oozing was clas-
sified as non-severe if fewer than 10 layers of sterile absorbent gauze were stained by serous fluid or
blood. All wounds were evaluated on postoperative day 2
3. Mean change in suprapatellar girth: measured in terms of change in suprapatellar girth (postopera-
tive girth - preoperative girth, cm). Measurement was made at the superior margin of the patella with
the knee at extension as far as possible by using a standard tape; differences between preoperative
measurements and measurements obtained on postoperative days 3, 7, 14, and 30 were calculated
4. Range of motion: measured with a standard handheld goniometer preoperatively and on postoper-
ative days 7, 14, 30, and 90. The centre of rotation was set in line with the centre of the knee, while
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the fixed arm was aligned with the greater trochanter and the mobile arm was aligned with the lateral
malleolus
5. Wound length: measured in centimetres with the knee in extension as far as possible on postoperative
day 2 while the dressing was changed after the drain was pulled out
6. Revision rate: indicating the number of patients in each group requiring revision surgery up to 1 year
postoperatively
7. MSS score: was used for an objective evaluation of the aesthetic appearance of the scar at the end of
postoperative year 1. MSS encompasses several factors, including colour, appearance, contour, dis-
tortion, and texture of the scar. All these parameters are graded on a scale of 1 to 4 points, except the
last one, which is rated as 1 for matte and 2 for shiny appearance. In addition, the overall appearance
of the incision scar was evaluated via a visual analogue scale (VAS), with a score of 0 indicating an
excellent outcome and 10 indicating the worst possible outcome
Identification Contact details: Pei-lai Liu, PhD, Department of Orthopaedics, Qilu Hospital, Shandong University, 107
Wenhua West Road, Jinan, China 250012
Tel: 0086-531-82166542; fax: 0086-531-86927544; gklpl@163.com
Notes Country: China
Language: English
Study author contacted: yes, no reply from study author
Trial registry record or protocol available: none stated or identified
Funding source/declaration of interest: no source of funding identified for this study
Adverse events: no adverse events reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random numbers table
Allocation concealment
(selection bias)





Unclear risk Insufficient information to permit judgement
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Low risk Self-reported outcomes: none
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)
Low risk Assessor-reported outcomes: duration of surgery, wound healing, mean
change in suprapatellar girth, range of motion, wound length, revision rate,




Unclear risk Insufficient reporting of attrition
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
Liu 2017 b  (Continued)
Tourniquet use for knee replacement surgery (Review)









Cochrane Database of Systematic Reviews
No protocol reported or identified





Methods Two groups: surgery performed with a tourniquet; surgery performed without a tourniquet
Follow-up: 48 hours
Study design: single-centre randomised controlled trial
Participants 20 participants in total
Male:Female: 2:8; 3:7
Age, years (range): 72.4 (64 to 83); 76.6 (65 to 84)
BMI (range): 28.3 (19.3 to 35.5); 29.5 (24 to 43.8)
Inclusion criteria: patients listed for primary total knee replacement surgery
Exclusion criteria: diabetes mellitus, presence of peripheral arterial occlusive disease (pAOD) or car-
diopulmonary diseases ruled out by clinical examination and if necessary duplex ultrasound, medical
history of thrombosis or embolism and renal insufficiency (creatinine mmol/L). Patients with severe
varus or valgus deformity > 15" or flexion contracture > 20" were excluded from the study to minimise
bias due to different soJ tissue trauma by preparation and postoperative tension of the skin
Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet (n = 10)
Group B: surgery performed without a tourniquet (n = 10)
In all cases, a cemented PFC Sigma total knee replacement (DePuy, Warsaw, IN, USA) without resur-
facing of the patella was implanted by the same surgeon (GM) through a midline incision and a medial
parapatellar approach
Outcomes 1. Postoperative endothelin-1 measurement: blood was taken preoperatively (2 mL in EDTA tube). 10
further determinations were made at time points 5, 15, and 30 minutes, and 1, 2, 3, 4, 6, 24, and 48
hours after the end of surgery or opening of the tourniquet. Blood samples were centrifuged for l0
minutes at 40°F and 2000 G within a half-hour of sampling and were frozen at -4°F until determination
2. Blood transfusion rate: defined as the number of units delivered to the patient. The higher the number
of units, the worse the outcome
3. Duration of surgery: measured in minutes
4. Change in haemoglobin: change in haemoglobin concentration between preoperative reading and
first postoperative day reading
5. Change in C-reactive protein (CRP): change in blood CRP reading between preoperative reading and
first postoperative day reading




Identification Contact information: G Matziolis, Centre for Musculoskeletal Surgery, Charite University Hospital, Schu-
mannsir, 20-21, 10117, Berlin, Germany, georg.matziolis@charite.de
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Notes Country: Germany
Language: English
Study author contacted: yes, no reply from study author
Trial registry record or protocol available: none stated or identified
Funding source/declaration of interest: no financial affiliation has been paid by third parties others
than the Center for Musculoskeletal Surgery of the Charite University Hospital
Adverse events:
In the tourniquet group: 1 patient had a wound healing disorder that required revision surgery
In the non-tourniquet group: 1 patient had nerve injury
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer generated
Allocation concealment
(selection bias)





Unclear risk Participants blinded; insufficient information to specify if surgeons were blind-
ed
However surgeons would be able to influence/alter their performance only for
intraoperative outcomes such as intraoperative blood loss, operative time,
or quality of cementation. It is unlikely that surgeons would alter their perfor-
mance to influence these outcomes for fear of damaging the overall quality
and safety of the surgery
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Low risk Self-reported outcome: nerve injury
Patients blinded; therefore low risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)




Unclear risk Insufficient reporting of attrition
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
No protocol reported or identified
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Methods Two groups: surgery performed with a tourniquet; surgery performed without a tourniquet
Follow-up: 2 years
Study design: single-centre randomised controlled trial
Participants 60 participants in total
Male:Female: 16:14; 16:14
Age, years (SD): 70 (7); 67 (9)
BMI (SD): 28 (3); 28 (3)
Inclusion criteria: patients suffering exclusively from OA, stages II to V; patients requiring knee prosthe-
sis suitable for the use of a triathlon knee system; patients understanding the conditions of the study
and willing and able to comply with scheduled postoperative clinical and radiographic evaluations and
prescribed rehabilitation; patients who signed the Ethics Committee approved informed consent form
before surgery
Exclusion criteria: previous major knee arthroplasty; significant disabling problems from the muscu-
lar-skeletal system other than the knees; obese patients with obesity severe enough to affect their abil-
ity to perform activities of daily living (BMI > 35); patients with active or suspected infection; patients
with active malignancy; patients with severe osteoporosis, Paget's disease, renal osteodystrophy; pa-
tients immunologically suppressed or receiving steroids in excess of physiological dose requirements;
patients with a neuromuscular or neurosensory deficit that would limit their ability to assess perfor-
mance of the device or that interferes with the patient's ability to limit weight-bearing or places an ex-
treme load on the implant during the healing period; pregnancy; systemic or metabolic disorders lead-
ing to progressive bone deterioration; concurrent illness such as sickle cell anaemia, SLE, or renal dis-
ease requiring dialysis
Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet (n = 30)
Group B: surgery performed without a tourniquet (n = 30)
Each patient was given preoperative antibiotics and tranexamic acid. Surgeries were performed via a
midline incision with a parapatellar medial entrance to the joint using appropriate guide instruments
according to the surgical technique supplied to the knee system. In both groups, the bony surfaces
were prepared in the same manner, were cleansed by saline pulse lavage, and were kept clean of blood
by saline-prepared medical pads. At the time of surgery, 8 tantalum markers (0.8 mm diameter; RSA
Biomedical, Umeå, Sweden) were inserted into the proximal tibial metaphysis and 5 markers were in-
serted into the polyethylene tibial insert. The tourniquet was applied during dressing and was inflat-
ed to 300 mmHg just before the start of surgery and was not deflated until the leg was sutured and
dressed. The group operated on without the use of a tourniquet was operated on with the same surgi-
cal and cementing technique. The cement used was Refobacin® Bone Cement R (Biomet Inc., Warsaw,
IN, USA). No patellar components were used in either group. Postoperatively, low-molecular-weight he-
parin was used for thromboembolic prophylaxis. Early full weight-bearing and mobilisation were simi-
lar for both groups
Outcomes 1. Duration of surgery
2. Length of hospital admission
3. Radiostereometric analysis: the RSA investigation was done within 2 to 3 days postoperatively after
full weight-bearing, then at 3 months, 1 year, and 2 years postoperatively. RSA was performed with
the patient in a supine position, with the knee of interest inside a calibration cage (Cage 10, RSA Bio-
medical, Umeå, Sweden). 3D tibial component migration was measured with UmRSA software (v6.0,
RSA Biomedical, Umeå, Sweden). The precision of the RSA system according to the double exams was
0.12 mm, 0.21 mm, and 0.14 mm for x-, y-, and z-translations, and 0.12°, 0.11°, and 0.09° for x-, y-, and
z-rotations
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4. Maximum total point motion: positive directions for translations along the orthogonal axes were
transverse (medial to lateral), longitudinal (caudal to cranial), and sagittal (posterior to anterior). Pos-
itive directions for rotations about the coordinate axes were anterior tilt (transverse axis), internal ro-
tation (longitudinal axis), and varus (sagittal axis). An increase in MTPM > 0.2 mm between first and
second year follow-up was considered as continuous migration
5. Mortality
6. Deep vein thrombosis
7. Stroke
8. Blood transfusion rate: defined as the number of units delivered to the patient. The higher the number
of units, the worse the outcome
Identification Contact information: Mats Molt, Department of Orthopaedics Hässleholm-Kristianstad Ystad, Hässle-
holm, Sjukhusorganisation, Box 351, S-281, 25 Hässleholm, Sweden
Tel.: +46 451298707, mats.molt@skane.se (M. Molt)
Notes Country: Sweden
Language: English
Study author contacted: no
Trial registry record or protocol available: clinical trial ID: NCT01604382
Funding source/declaration of interest: no funding for this study
Adverse events:
In the tourniquet group: 2 patients required re-operation; 1 patient reported instability in the index
knee at 2 years' follow-up
In the non-tourniquet group: 1 patient died due to postoperative septicaemia; 1 patient had a stroke; 1
patient had DVT
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Insufficient information to permit judgement
Allocation concealment
(selection bias)





Unclear risk Insufficient information to permit judgement
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Unclear risk Not stated if patients were blinded; therefore unclear risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)
Unclear risk Not stated if outcome assessors were blinded; therefore unclear risk of bias
Incomplete outcome data
(attrition bias)
Low risk No missing outcome data
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Methods Two groups: surgery performed with a tourniquet; surgery performed without a tourniquet
Follow-up: 7 days
Study design: single-centre randomised controlled trial
Participants 103 participants in total
Male:Female: 6:45; 9:43
Age, years (SD): 72.8 (7.3); 74.6 (7.6)
BMI (SD): 27.7 (3.4); 29.2 (3.9)
Inclusion criteria: patients undergoing total knee replacement surgery
Exclusion criteria: patients showing preoperative DVT, coagulation disorder, abnormal coagulation test
values, or receiving anticoagulants; patients who received anticoagulant therapy postoperatively ac-
cording to the judgement of the physician
Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet (n = 51)
Group B: surgery performed without a tourniquet (n = 52)
All operations were conducted by a single surgeon (S.K.). All patients received spinal and epidur-
al anaesthesia in conjunction with general anaesthesia, and the tube for the epidural continuation
was removed on the second postoperative day. Exposure of the knee was through a midline skin inci-
sion (approximately 8 to 10 cm) and a mid-vastus approach. All patients had a Scorpio non-restrictive
geometry posterior-stabilised system (Stryker Howmedica Osteonics, Allendale, NJ, USA) cemented
arthroplasty. An extramedullary guide was used for the tibia, and an intramedullary osteotomy guide
was used for the distal cut of the femur. The patella was resurfaced in all patients
In patients of group T, a pneumatic thigh tourniquet was applied, was inflated to pressure of 250
mmHg, then was deflated after skin closure. Elastic stockings were worn postoperatively by all pa-
tients. All patients were managed with a foot pump (Kendall SCD 700, Covidien, MA, USA) on both legs
to prevent DVT. Walking was permitted from the day after surgery. Two days after the operation, the
drain was removed
Outcomes 1. Duration of surgery: measured in minutes
2. Overall blood loss: the amount of intraoperative and postoperative blood loss was measured in all
cases based on suction volume and weight of the sponges
3. Deep vein thrombosis: bilateral ultrasonography of the lower extremities (iU22 Vision 2006, Philips,
Seattle, WA, USA) was performed by highly skilled physicians. Ultrasonography was scheduled preop-
eratively and 7 days postoperatively. A thrombus located in anterior tibial vein (ATV), peroneal vein
(PeV), soleal vein (SoV), posterior tibial vein (PTV), and very small tertiary vessels was defined as distal
DVT. A thrombus located in femoral vein (FV), deep femoral vein (DFV), great saphenous vein (GSV),
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small saphenous vein (SSV), and popliteal vein (PV) was defined as proximal DVT. Total DVT included
distal DVT and/or proximal DVT
4. Pulmonary embolism
Identification Contact information: Noriaki Mori, Department of Orthopaedic Surgery, Wajo Eniwa Hospital, Ko-
ganechuo 2-1-1, Eniwa City 061-1449, Japan
Tel.: +81 123 33 2333; fax: +81 123 335108; noriakki@hotmail.co.jp (N.Mori)
Notes Country: Japan
Language: English
Study author contacted: yes, no reply from author
Trial registry record or protocol available: none reported or identified
Funding source/declaration of interest: no funding for this study
Adverse events: no additional adverse events reported in the 2 groups
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random numbers table
Allocation concealment
(selection bias)





Unclear risk Insufficient information to permit judgement
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Unclear risk Not stated if patients blinded; therefore unclear risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)




Low risk No missing outcome data
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
No protocol reported or identified
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Study characteristics
Methods Three groups: surgery performed with a tourniquet for the entire procedure; surgery performed with a
tourniquet for cementing only; surgery performed without a tourniquet
Follow-up: 6 weeks
Study design: single-centre randomised controlled trial
Participants 69 participants in total
Male:Female: not stated
Age, years (range): 65.05 (52 to 81)
BMI (SD): not stated
Inclusion criteria: patients diagnosed with arthritis refractory to conservative treatment and identified
as TKA candidates
Exclusion criteria: secondary arthritis, extreme deformity, previous cardiovascular disease
Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet for the entire procedure (n = 24)
Group B: surgery performed with a tourniquet for cementing only (n = 20)
Group C: surgery performed without a tourniquet (n = 25)
Posterior cruciate retaining Genesis II (Smith & Nephew, Memphis, TN, USA) cemented knee system
and OrCem 3 low-viscosity polymethylmethacrylate (PMMA) bone cement (European Medical Contract
Manufacturing, Nijmegen, Netherlands) were used in all patients. All patients were operated under gen-
eral anaesthesia with propofol and desfluran
Outcomes 1. Blood transfusion rate: defined as the number of units delivered to the patient. The higher the number
of units, the worse the outcome
2. Pain: measured as a VAS score between 0 and 10 at 6 weeks
3. Knee Society score: knee scoring system developed to evaluate patients post total knee replacement
surgery. Consists of a knee score and a functional score. Score ranges from 0 to 100; a score < 60 indi-
cates poor knee function, and a score of 80 to 100 indicates excellent knee function
4. Cement penetration depth: measured as the depth in centimetres the cement penetrated the femur
and tibia at the 6-week radiograph
Identification Contact information: Okan Ozkunt, Department of Orthopedics and Traumatology, Acibadem Universi-
ty Atakent Hospital, Halkali/Kucukcekmece, Istanbul, 34303, Turkey, drdeto@gmail.com
Notes Country: Turkey
Language: English
Study author contacted: yes, no reply from author
Trial registry record or protocol available: none reported or identified
Funding source/declaration of interest: no funding for this study
Adverse events: no additional adverse events reported in the 2 groups
Risk of bias
Ozkunt 2018 
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Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Insufficient information to permit judgement
Allocation concealment
(selection bias)





Unclear risk Insufficient information to permit judgement
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Unclear risk Insufficient information to permit judgement
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)




Low risk No missing outcome data
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
No protocol reported or identified





Methods Two groups: surgery performed with a tourniquet; surgery performed without a tourniquet
Follow-up: 4 days
Study design: single-centre randomised controlled trial
Participants 90 participants in total
Male:Female: 21:24; 11:34
Age, years (range): 69 (47 to 85); 70.5 (50 to 90)
BMI (range): 27.8 (18.5 to 38.1); 26 (18.5 to 33.9)
Inclusion criteria: patients with primary end-stage osteoarthritis receiving unilateral total knee arthro-
plasty (TKA)
Exclusion criteria: patients receiving any anticoagulation before surgery (e.g. acetylsalicylic acid, phen-
procoumon, warfarin, clopidogrel, dabigatran, rivaroxaban, low-molecular-weight heparin) with the di-
agnosis of liver dysfunction/coagulation dysfunction or a history of peripheral arterial obstructive dis-
ease or thromboembolic events
Pfitzner 2014 
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Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet (n = 45)
Group B: surgery performed without a tourniquet (n = 45)
All patients received a cemented, posterior-stabilised primary TKA (Nexgen LPS Flex, Zimmer, Warsaw,
IN, USA) with a fixed bearing design without patellar resurfacing. A total of 40 g of bone cement (Pala-
cos R®, Heraeus, Hanau, Germany) was used with a fourth-generation cementing technique including
pulsatile lavage, vacuum mixture, double-cementing technique, and cement gun pressurisation. Every
patient received the same standardised postoperative pain medication protocol
Outcomes 1. Pain: measured as a VAS score between 0 and 10 on the second and fourth postoperative days. Pain
was measured at rest and on mobilisation
2. Overall blood loss: to determine overall blood loss, peripheral blood was taken preoperatively and on
the first postoperative day. Total blood loss was calculated using the method of Bourke and Smith to
take both obvious and hidden blood losses into account
3. Cement mantle thickness: measured as the depth in centimetres the cement penetrated the femur
and tibia at the day 4 radiograph
Identification Contact information: T Pfitzner, P von Roth, C Perka, Orthopaedic Department, Center for Muscu-




Study author contacted: yes, no reply from author
Trial registry record or protocol available: none reported or identified
Funding source/declaration of interest: no funding for this study
Adverse events: no additional adverse events reported in the 2 groups
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Insufficient information to permit judgement
Allocation concealment
(selection bias)





Unclear risk Insufficient information to permit judgement
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Unclear risk Not stated if patients were blinded; therefore unclear risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)
Unclear risk Not stated if outcome assessors were blinded; therefore unclear risk of bias
Pfitzner 2014  (Continued)
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Low risk No missing outcome data
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
No protocol reported or identified





Methods Two groups: surgery performed with a tourniquet; surgery performed without a tourniquet
Follow-up: 4 days
Study design: single-centre randomised controlled trial
Participants 72 participants in total
Male:Female: 9:27; 8:28
Age, years (SD): 72.1 (6.9); 71.5 (6.8)
BMI (SD): 28.6 (4.5); 27.9 (4.2)
Inclusion criteria: patients undergoing total knee replacement surgery for osteoarthritis
Exclusion criteria: rheumatoid arthritis, coagulopathy, uncontrolled hypertension, peripheral vascular
disease
Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet (n = 36)
Group B: surgery performed without a tourniquet (n = 36)
All patients underwent primary total knee arthroplasty with minimally invasive techniques and ce-
mented prostheses (Genesis II Total Knee System, Smith & Nephew, Memphis, TN, USA; or U2 Knee Sys-
tem, United Orthopedic, Taipei, Taiwan). All operations were performed through the medial parap-
atellar approach by experienced knee surgeons. An intramedullary guide was used for both tibial and
femoral cuts. No drainage system was used postoperatively for any patient
In the tourniquet group, the tourniquet was inflated to systolic blood pressure plus 100 mmHg and was
released after the joint capsule had been closed. A 40-mL local anaesthetic mixture (2% Iidocaine with
epinephrine, bupivacaine, and gentamicin) was injected into the joint space for pain control and as a
temporary tamponade. The wound was closed after wound irrigation and haemostasis and then was
wrapped with elastic bandages. In the non-tourniquet group, the tourniquet was wrapped around the
thigh but was not inflated during surgery
Outcomes 1. Intraoperative blood loss: measured by weighing sponges and measuring suction volume
2. Blood transfusion rate: defined as the number of units delivered to the patient. The higher the number
of units, the worse the outcome
3. Overall blood loss: calculated by multiplying estimated blood loss by the decrease in haematocrit
4. Change in haemoglobin: repeated blood tests were performed daily from days 1 to 4. The haemoglobin
concentration in the blood was recorded each day
Tai 2012 
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5. Change in haematocrit: repeated blood tests were performed daily from days 1 to 4. The haematocrit
concentration in the blood was recorded on each day
6. Serum creatine phosphokinase, myoglobin, lactate dehydrogenase, C-reactive protein: blood tests
were performed daily from days 1 to 4 postoperatively. Concentrations of these enzymes was re-
scored at each time point
7. Pain: measured on a VAS score between 0 and 10 on days 1 and 4 postoperatively
8. Duration of surgery: measured in minutes
Identification Contact information: Ta-Wei Tai, Department of Orthopaedics, National Cheng Kung University Hospi-
tal, College of Medicine, National Cheng Kung University, Tainan, Taiwan
No funding for this study
Notes Country: Taiwan
Language: English
Study author contacted: yes, no reply from author
Trial registry record or protocol available: none reported or identified
Funding source/declaration of interest: no funding for this study
Adverse events: no additional adverse events reported in the 2 groups
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Insufficient information to permit judgement
Allocation concealment
(selection bias)





Low risk Patients blinded; surgeons not blinded
However surgeons would be able to influence/alter their performance only for
intraoperative outcomes such as intraoperative blood loss, operative time,
or quality of cementation. It is unlikely that surgeons would alter their perfor-
mance to influence these outcomes for fear of damaging the overall quality
and safety of the surgery
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Low risk Self-reported outcome: pain
Patients blinded; therefore low risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)
Low risk Assessor-reported outcomes: intraoperative blood loss; overall blood loss;
blood transfusion rate; change in haemoglobin; change in haematocrit, serum
creatinine phosphokinase, myoglobin, lactate dehydrogenase, CRP, duration
of surgery




Low risk No missing outcome data
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
Tai 2012  (Continued)
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No protocol reported or identified





Methods Two groups: surgery performed with a tourniquet; surgery performed without a tourniquet
Follow-up: 10 days
Study design: single-centre randomised controlled trial
Participants 63 participants in total
Male:Female: 15:18; 11:19
Age, years (SD): 69.8 (6.7); 69.8 (9.0)
BMI (SD): 28.6 (4.5); 27.9 (4.2)
Inclusion criteria: patients undergoing total knee replacement for osteoarthritis or rheumatoid arthritis
Exclusion criteria: bilateral TKA required simultaneously or staged at less than 3-month intervals; histo-
ry of bleeding diathesis; revision TKA; history of musculoskeletal infection of the affected limb; history
of peripheral vascular disease
Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet (n = 33)
Group B: surgery performed without a tourniquet (n = 30)
Groups were similar with respect to operative procedure. Lateral release was performed in 22 patients
in the tourniquet group and in 20 in the non-tourniquet group (Table 1). One synovectomy was per-
formed in each group. All patients received a primary cemented total knee replacement with a cement-
ed polyethylene patellar replacement. In the tourniquet group, the leg was elevated and exsanguinated
(without use of an Esmarch bandage) before tourniquet inflation. The tourniquet was set at 125 to 150
mmHg above systolic blood pressure, up to a maximum value of 300 mmHg. The tourniquet was deflat-
ed after the bone cement had set, and only then was electrocautery used for haemostasis. In the non-
tourniquet group, electrocautery was used as necessary throughout the procedure
Outcomes 1. Intraoperative blood loss: recorded by the anaesthetist by method estimation (i.e. suction drainage -
irrigation volume (soaked sponges were considered equivalent to 80 mL of blood))
2. Blood transfusion rate: defined as the number of units delivered to the patient. The higher the number
of units, the worse the outcome
3. Duration of surgery: measured in minutes
4. Deep vein thrombosis
5. Infection
6. Haemaglobin level: blood haemoglobin was collected on postoperative days 1, 2, 3, 5, and 7
7. Postoperative blood loss: recorded in terms of suction volume at 36 hours after the operation
8. Overall blood loss: measures by the sum of intraoperative blood loss and postoperative drainage vol-
ume
Identification Contact information: Dr John F Rudan, Department of Surgery, Queen's University, Kingston ON K7L
3N6
Tetro 2001 
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Fax 613 549-2529, cmg@post.queensu.ca
Notes Country: Kingston
Language: English
Study author contacted: yes, no reply from author
Trial registry record or protocol available: none reported or identified
Funding source/declaration of interest: no funding for this study
Adverse events:
In the tourniquet group: 4 wound infections
In the non-tourniquet group: 1 wound infection, 1 gastrointestinal haemorrhage
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Insufficient information to permit judgement
Allocation concealment
(selection bias)





Low risk Patients 'blindly' randomised; surgeons not blinded
However surgeons would be able to influence/alter their performance only for
intraoperative outcomes such as intraoperative blood loss, operative time,
or quality of cementation. It is unlikely that surgeons would alter their perfor-
mance to influence these outcomes for fear of damaging the overall quality
and safety of the surgery
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Low risk Self-reported outcomes: DVT, infection
Patients blinded; therefore low risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)
High risk Assessor-reported outcomes:intraoperative blood loss, blood transfusion
rate, duration of surgery, haemoglobin level, postoperative blood loss, overall




Low risk No missing outcome data
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
No protocol reported or identified
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Methods Two groups: surgery performed with a tourniquet; surgery performed without a tourniquet
Follow-up: 3 months
Study design: single-centre randomised controlled trial
Participants 80 participants in total
Male:Female: 9:31; 16:24
Age, years (range): 73.65 (52 to 110); 80.25 (50 to 110)
BMI (SD): not reported
Inclusion criteria: patients undergoing primary total knee replacement surgery for osteoarthritis
Exclusion criteria: patients with diabetes, haemostasis defect, rheumatoid arthritis, previous throm-
boembolism, abnormal vascular supply to the leg, previous open knee surgery, bilateral TKA
Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet (n = 40)
Group B: surgery performed without a tourniquet (n = 40)
All operations were performed under general anaesthesia by a single surgeon or by house staB using a
standardised technique. Cefamandol 1500 mg was given intravenously at induction of anaesthesia, and
4 further doses of 750 mg were given postoperatively. Standard anticoagulant prophylaxis using enoxa-
parin was started the evening before surgery and continued until the patient was fully mobile. In group
A, the limb was first exsanguinated by elevation for 2 minutes, then the tourniquet was inflated to 350
mmHg. If the duration of tourniquet use exceeded 90 minutes, the tourniquet was released intraoper-
atively and haemostasis was completed. After 10 minutes of release, a new exsanguination was insti-
tuted. The tourniquet was not released until after the wound was closed and the compressive dressing
was applied
Outcomes 1. Duration of surgery: measured in minutes
2. Change in haemoglobin: blood concentrations recorded preoperatively and on first and tenth days
postoperatively
3. Change in haematocrit: blood concentrations recorded preoperatively and on first and tenth days
postoperatively
4. Overall blood loss: was calculated as the sum of compensated and non-compensated blood loss.
Blood concentrations were recorded preoperatively and on first and tenth days postoperatively
5. Thigh pain: study authors did not include data on pain scores in the final report. They stated that pain
scores were significantly lower in the control group when compared to the tourniquet group
6. Wound complications
7. Implant loosening: radiographic analysis was conducted at 3 months to look for lucency - a sign of
loosening
8. Time to achieve straight leg raise
9. Range of knee flexion: measured in degrees at days 5 and 10 and at 3 months
Identification Contact information: E Vandenbussche, L-D Duranthon, B Augereau, Department of Orthopaedic




Study author contacted: yes, no reply from author
Trial registry record or protocol available: none reported or identified
Vandenbussche 2001  (Continued)
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Funding source/declaration of interest: no funding for this study
Adverse events:
In the tourniquet group: 1 patient had DVT
In the non-tourniquet group: 2 patients had DVT
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Insufficient information to permit judgement
Allocation concealment
(selection bias)





Low risk Patients blinded; surgeons not blinded
However surgeons would be able to influence/alter their performance only for
intraoperative outcomes such as intraoperative blood loss, operative time,
or quality of cementation. It is unlikely that surgeons would alter their perfor-
mance to influence these outcomes for fear of damaging the overall quality
and safety of the surgery
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Low risk Self-reported outcomes: pain, complications, time to achieve straight leg raise
Patients blinded; therefore low risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)
Low risk Assessor-reported outcomes: duration of surgery, change in haemoglobin,
change in haematocrit, overall blood loss, implant loosening, range of knee
flexion




Low risk No missing outcome data
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
No protocol reported or identified





Methods Two groups: surgery performed with a tourniquet; surgery performed without a tourniquet
Follow-up: 2 days
Study design: single-centre randomised controlled trial
Participants 40 participants in total
Male:Female: 10:10; 11:9
Vertullo 2017 
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Age, years (SD): 67.85 (6.91); 65.65 (8.54)
BMI (SD): 30.43 (5.07); 31 (5.31)
Inclusion criteria: Patients with end stage knee osteoarthritis who have failed non-operative manage-
ment and are being listed for a primary total knee replacement.
Exclusion criteria: history of peripheral vascular disease that precluded tourniquet use or required a se-
mi-constrained prosthesis due to ligament instability necessitating a fixed bearing tibial component
with tibial stem
Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet (n = 20)
Group B: surgery performed without a tourniquet (n = 20)
In both groups, the knee replacement procedure was commenced with a tourniquet applied but with-
out inflation. The patient’s blood pressure was maintained hypotensive if no contraindications were
applied, else normotensive. Proximal tibial osteotomy was undertaken via a computerised navigation
system, with all resections at 90 to the tibial long axis, removing a planned 10-mm resection of the lat-
eral tibial plateau. After bone resection and preparation were undertaken, patients were randomised
to group A or B. In group A, the leg was elevated for 1 minutes, then the tourniquet was inflated to 300
mmHg for the duration of the cementing procedure. In group B, the tourniquet was not inflated
Outcomes 1. Cement penetration depth: distance in millimetres the cement penetrated the femur and the tibia on
the postoperative radiograph. This was assessed on day 2
Identification Contact information: Christopher John Vertullo, Orthopaedic Surgery & Sports Medicine Centre, 8-10
Carrara Street, Benowa, QLD, Australia, chris.vertullo@icloud.com
Notes Country: France
Language: English
Study author contacted: no
Trial registry record or protocol available: none reported or identified
Funding source/declaration of interest: no funding for this study
Adverse events: no adverse events reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer generated
Allocation concealment
(selection bias)





Unclear risk Insufficient information to permit judgement
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Low risk Self-reported outcomes: none
Vertullo 2017  (Continued)
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Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)
Low risk Assessor-reported outcomes: cement penetration depth




Low risk No missing outcome data
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
No protocol reported or identified





Methods Two groups: surgery performed with a tourniquet; surgery performed without a tourniquet
Follow-up: 4 months
Study design: single-centre randomised controlled trial
Participants 77 participants in total
Male:Female: 11:26; 14:26
Age, years (range): 72.5 (57 to 85); 71.8 (43 to 91)
BMI (SD): not reported
Inclusion criteria: patients undergoing primary total knee arthroplasty
Exclusion criteria: patients with diabetes, rheumatoid arthritis, previous thromboembolism, active ma-
lignancy, those having 1-stage bilateral surgery
Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet (n = 37)
Group B: surgery performed without a tourniquet (n = 40)
All patients had identical anaesthesia, which included premedication with temazepam and general
anaesthesia with fentanyl. No patient had spinal or epidural anaesthesia Postoperatively, all had ‘pa-
tient-controlled analgesia’ (PCA) with an infusion of morphine sulphate. All patients received intra-
venous cefuroxime (1.5 g) after induction of anaesthesia and twice postoperatively. Those in group A
had TKA under a tourniquet after the leg had been exsanguinated. Tourniquet pressure was twice the
systolic blood pressure. Patients in group B did not have a tourniquet applied to the leg. Low-dose war-
farin was given to maintain the international normalised ratio between 1.3 and 2.0, and was continued
until discharge from the hospital. Mobilisation began on removal of the drains, 48 hours after the oper-
ation
Outcomes 1. Pain: assessed as a visual analogue scale between 0 and 10; zero indicates no pain, and 10 indicates
extreme pain. Measured on week 1, on week 6, and at 4 months. Study authors did not report raw data,
instead reporting a change in pain score
2. Change in knee flexion: measured in degrees. The number of degrees the knee can flex at week 1, week
6, and 4 months
Wakankar 1999 
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3. Change in swelling of the thigh, knee, and calf: the circumference of the limb at the level of the superior
pole of the patella and at points 10 cm above and below. Measured at week 1, week 6, and 4 months
4. Deep vein thrombosis
5. Adverse events
Identification Contact information: JC D’Arcy, FRCS, Consultant Orthopaedic Surgeon, Department of Orthopaedics,
Eastbourne District General Hospital, King’s Drive, Eastbourne, East Sussex BN21 2UD, UK
Notes Country: UK
Language: English
Study author contacted: no
Trial registry record or protocol available: none reported or identified
Funding source/declaration of interest: no funding for this study
Adverse events:
In the tourniquet group: 6 patients required manipulation under anaesthesia, 1 patient had wound
leakage, 1 patient died from unrelated causes
In the non-tourniquet group: 5 patients required manipulation under anaesthesia, 2 patients died from
unrelated causes
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random numbers table
Allocation concealment
(selection bias)





Unclear risk Insufficient information to permit judgement
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Unclear risk Not stated if patients blinded; therefore unclear risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)




Low risk No missing outcome data
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
No protocol reported or identified
Other bias Low risk No other sources of bias identified
Wakankar 1999  (Continued)
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Methods Two groups: surgery performed with a tourniquet; surgery performed without a tourniquet
Follow-up: 4 weeks
Study design: single-centre randomised controlled trial
Participants 37 participants in total
Male:Female: not reported
Age, years (SD): 63.2 (8.7); 61.4 (7.4)
BMI (SD): not reported
Inclusion criteria: patients undergoing primary total knee replacement surgery
Duration of illness: unspecified
Interventions All patients under general anaesthesia using sevoflurane and propofol. Endotracheal intubation and
mechanical ventilation were employed to maintain a constant end-tidal CO2 level. The fractional in-
spired O2 concentration (33%) did not change during the operation. In the with tourniquet group, a
tourniquet was applied at approximately 100 mmHg above systolic blood pressure. The operations
were performed with autologous blood transfusion and used a postoperative blood conservation sys-
tem. Blood losses in the 2 groups were measured and compared. Heparin at 5000 U/d was postopera-
tively administered to all patients for 3 weeks
Outcomes 1. Overall blood loss: measured in millilitres
2. Postoperative blood loss: measured in millilitres using a postoperative drainage catheter
3. Deep vein thrombosis
4. Pulmonary embolism
5. Number of embolic events: measured via ultrasound. To identify the residue, it was Sudan-stained to
detect fat, and it was Giemsa-stained to detect thrombus and bone marrow. Echogenic materials were
graded as follows: Grade 0 no emboli, Grade 1 few fine emboli, Grade 2 a cascade of fine emboli or
embolic masses < 5 mm, Grade 3 fine emboli mixed with large embolic masses > 5 mm
Identification Contact information: N Kato, R Ogawa, Department of Anesthesiology, Nippon Medical School, 1-1-5
Sendagi, Bunkyo-ku, Tokyo, Japan
Notes Country: Japan
Language: English
Study author contacted: no
Trial registry record or protocol available: none reported or identified
Funding source/declaration of interest: no funding for this study reported
Adverse events:
In the tourniquet group: 1 patient had PE and 2 patients had DVT
In the non-tourniquet group: 0 patients had PE or DVT
Risk of bias
Bias Authors' judgement Support for judgement
Wauke 2002 
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Random sequence genera-
tion (selection bias)
Unclear risk Insufficient information to permit judgement
Allocation concealment
(selection bias)





Unclear risk Insufficient information to permit judgement
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Unclear risk Not stated if patients were blinded; therefore unclear risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)




Low risk No missing outcome data
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
No protocol reported or identified





Methods Two groups: surgery performed with a tourniquet; surgery performed without a tourniquet
Follow-up: 6 months
Study design: single-centre randomised controlled trial
Participants 100 participants in total
Male:Female: 22:28; 19:31
Age, years (SD): 67.58 (4.61); 68.06 (3.16)
BMI (SD): 24.10 (2.16); 23.87 (2.13)
Inclusion criteria: patients undergoing primary total knee replacement surgery for osteoarthritis
Exclusion criteria: patients < 18 years or > 85 years of age, rheumatoid arthritis, allergy to TXA, history of
thrombosis, coagulation dysfunction, uncontrolled hypertension, infection, body mass index (BMI) > 35
Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet (n = 50)
Group B: surgery performed without a tourniquet (n = 50)
Wu 2018 
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All patients were treated intravenously with 15 mg/kg TXA 10 minutes before skin incision; an addition-
al 1 g TXA was used after 3 hours. All patients were treated by a senior orthopaedic surgeon under gen-
eral anaesthesia. Drainage tubes were used in all patients and were removed 24 hours postoperatively
if blood loss was < 300 mL. Otherwise, they continued to be used until the quantity was < 50 mL
Outcomes 1. Total blood loss: in millilitres estimated using the formula of Gross et al
2. Intraoperative blood loss: measured in millilitres. The higher the score, the worse the outcome
3. Hidden blood loss: measured in millilitres. The higher the score, the worse the outcome
4. Drainage volume: measured in millilitres. The higher the score, the worse the outcome
5. Transfusion requirements: defined as the number of units delivered to the patient. The higher the
number of units, the worse the outcome
6. Maximum Hb drop: defined as the difference between preoperative Hb level and lowest postoperative
Hb level received during hospital stay and the lowest Hb level before any blood transfusion
7. Knee circumference: the circumference of the limb at the level of the superior pole of the patella and
at points 10 cm above and below. Measured on postoperative days 1, 3, and 5, and at 6 months
8. Pain: measured on a visual analogue score between 0 and 10
9. ROM: number of degrees of knee flexion. Measured on postoperative days 1, 3, and 5, and at 1 and
6 months
10.Postoperative hospital stay
11.Deep vein thrombosis (DVT) and/or pulmonary embolism (PE) events
12.Wound-related complications as second outcomes
Identification Contact information: Yuangang Wu, Department of Orthopaedics, West China Hospital, Sichuan Univer-
sity, 37 # Guoxue Road, Chengdu, 610041, People's Republic of China, wuuiangang23@163.com
Notes Country: China
Language: English
Study author contacted: no
Trial registry record or protocol available: researchregistry4423
Funding source/declaration of interest: study was funded by the Science and Technology Department
of Sichuan Province (2017FZ0056 and No. 2018HH0141), and also by the Health Department of Sichuan
Province (N0. 18ZD016)
Adverse events: no adverse events reported between the 2 groups
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer generated
Allocation concealment
(selection bias)





Low risk Participants blinded; surgeons not blinded
However surgeons would be able to influence/alter their performance only for
intraoperative outcomes such as intraoperative blood loss, operative time,
or quality of cementation. It is unlikely that surgeons would alter their perfor-
mance to influence these outcomes for fear of damaging the overall quality
and safety of the surgery
Wu 2018  (Continued)
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Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Low risk Self-reported outcomes: pain, DVT, wound-related complications
Patients blinded; therefore low risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)
High risk Assessor-reported outcomes: total blood loss, intraoperative blood loss, hid-
den blood loss, drainage volume, transfusion requirements, maximum Hb
drop, knee circumference, range of motion, length of stay




Low risk No missing outcome data
Selective reporting (re-
porting bias)
Low risk All outcome measures reported





Methods Three groups: surgery performed with a tourniquet inflated until wound closure; surgery performed
with a tourniquet inflated until components were inserted; surgery performed without a tourniquet
Follow-up: day 1
Study design: single-centre randomised controlled trial
Participants 84 participants in total
Male:Female: 6:16; 9:24; 7:22
Age, years (range): 68 (54 to 72); 64 (54 to 73); 66 (51 to 74)
BMI (SD): not reported
Inclusion criteria: patients with a diagnosis of severe primary osteoarthritis, insertion of bicompart-
mental prosthesis, absence of any known coagulation disorder
Exclusion criteria: Patients undergoing a unicondylar knee replacement or a revision knee replace-
ment. Presence of a known coagulation disorder or a patient who is routinely taking anticoagulant
medication. 
Duration of illness: unspecified
Interventions Group 1: surgery performed without a tourniquet (n = 29)
Group 2: surgery performed with a tourniquet inflated until components inserted (n = 33)
Group 3: surgery performed with a tourniquet inflated until wound closure (n = 22)
For all patients, suction drainage was used routinely and was removed after 24 hours. Low-molecu-
lar-weight heparin was administered to all patients, and no monitoring for INR was performed. Antibi-
otic prophylaxis was started just before the tourniquet was inflated with 1 g cefazolin, then was contin-
ued 3 times daily for 48 hours
Yavarikia 2010 
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Outcomes 1. Change in haemoglobin: difference between preoperative haemoglobin and day 1 postoperative
haemoglobin
2. Change in haematocrit: difference between preoperative haematocrit and day 1 postoperative
haematocrit
3. Overall blood loss: measured in miilimetres
4. Blood transfusion rate: defined as number of units delivered to the patient. The higher the number of
units, the worse the outcome
5. Duration of surgery: measured in minutes
Identification Contact information: Alireza Yavarika, Department of Orthopaedics, Ward of Orthopaedics, Besat Hos-
pital, Hamadan University of Medical Sciences, Hamadan, Iran, tel +959144122542
Notes Country: Iran
Language: English
Study author contacted: yes, no reply from study author
Trial registry record or protocol available: none reported or identified
Funding source/ declaration of interest: no source of funding reported or identified
Adverse events: no adverse events reported between the 2 groups
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Insufficient information to permit judgement
Allocation concealment
(selection bias)





Unclear risk Insufficient information to permit judgement
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Low risk Self-reported outcomes: none
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)




Unclear risk Insufficient reporting of attrition
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
No protocol reported or identified
Other bias Low risk No other sources of bias identified
Yavarikia 2010  (Continued)
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Methods Two groups: surgery performed with a tourniquet; surgery performed without a tourniquet
Follow-up: not reported
Study design: single-centre randomised controlled trial
Participants 60 participants in total
Male:Female: 8:22; 11:19
Age, years (SD): 72 (6); 71 (6)
BMI (SD): 25 (4); 26 (4)
Inclusion criteria: patients undergoing primary total knee replacement surgery for osteoarthritis or
rheumatoid arthritis
Exclusion criteria: patients with diabetes, haemorrhagic disease, Hb < 100 g/L, peripheral neurovascu-
lar disease, malignant tumour, history of vascular thrombosis, history of infection in the lower limb
Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet (n = 30)
Group B: surgery performed without a tourniquet (n = 30)
Tourniquet pressure in the tourniquet group was based on the patient’s arterial systolic pressure + 100
mmHg (1 mmHg = 0.133 kPa). The wound was closed and dressed with standard wound dressings and
compression before the tourniquet was loosening. Procedures applied in the control group were iden-
tical, but between osteotomy and bone cement insertion, the anaesthesiologist controlled blood pres-
sure at 30 to 40 mmHg to reduce bleeding. Intraoperative active bleeding was coagulated electrical-
ly. Conventional low-molecular-weight heparin and a foot pump were used postoperatively to prevent
deep vein thrombosis (DVT)
Outcomes 1. Change in haemoglobin: difference between preoperative haemoglobin and postoperative haemo-
globin
2. Change in haematocrit: difference between preoperative haematocrit and postoperative haematocrit
3. Intraoperative blood loss: was calculated as volume of liquid in the suction bottle plus increase in
gauze weight minus volume of irrigation fluid used during surgery
4. Postoperative blood loss: was principally recorded as volume of visible wound drainage fluid, includ-
ing volume of blood transfused 6 hours after surgery
5. Overall blood loss: preoperative patient blood volume (PBV) × (preoperative HCT – postoperative HCT)
6. Adverse events
Identification Contact information: Dr ZHANG Fu-jiang, Department of Orthopaedics, Tianjin Hospital, Tianjin 300211,
China
No funding for this study
Notes Country: China
Language: English
Study author contacted: no
Trial registry record or protocol available: none reported or identified
Funding source/declaration of interest: no source of funding reported or identified
Zhang 2010 
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Adverse events: no adverse events reported between the 2 groups
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random numbers table
Allocation concealment
(selection bias)





Unclear risk Insufficient information to permit judgement
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Unclear risk Not stated if patients were blinded; therefore unclear risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)




Unclear risk Insufficient reporting of attrition
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
No protocol reported or identified





Methods Two groups: surgery performed with a tourniquet; surgery performed without a tourniquet
Follow-up: 22 months
Study design: single-centre randomised controlled trial
Participants 166 participants in total
Male:Female: 12:72; 13:69
Age, years (range): 63.2 (46 to 80); 65.2 (46 to 83)
BMI: 28.1; 28.8
Inclusion criteria: unilateral primary total knee arthroplasty for knee osteoarthritis; volunteers to par-
ticipate in the study
Zhang 2016 
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Exclusion criteria: severe medical disease, peripheral vascular disease or deep venous thrombosis of
the lower extremities, abnormal coagulation function, severe internal and external valgus deformity of
the knee joint
Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet (n = 84)
Group B: surgery performed without a tourniquet (n = 82)
Surgery was performed under general anaesthesia (34 cases) or sciatic nerve combined with femoral
nerve block anaesthesia (50 cases) in the tourniquet group. Surgery under general anaesthesia (29 cas-
es) or sciatic nerve was combined with femoral nerve block anaesthesia (53 cases) in the non-tourni-
quet group. Regular intravenous infusion of antibiotics (cefuroxime or ceftriaxone or vancomycin) from
30 mmn to 48 hours after surgery. Intraoperative routine infusion, ambulation, 2 U autologous blood
or suspended red blood cells, fresh frozen plasma, blood transfusion treatment was given when the pa-
tient developed anaemia symptoms and Hb was lower than 80 g/L. Oral rivaroxaban 5 mg/d was given
to prevent thrombosis within 28 days after surgery; was combined with non-steroidal and opioid drugs
to relieve pain. Drainage tube was removed on the first day after surgery and lower limb function train-
ing was started
Outcomes 1. Pain: measured on a visual analogue scale between 0 and 10. VAS scores were used to evaluate knee
pain before and 3, 5, 14, and 28 days after surgery
2. Duration of surgery: measured in minutes
3. Intraoperative blood loss: measured in millilitres
4. Deep vein thrombosis
5. Hospital for Special Surgery knee score: knee-related score assessing pain, stability (measured as total
varus-valgus arc, extension), motion (measured as total passive arc), quadriceps strength (measured
as 10% of normal for age and gender), and subtraction for contracture or fixed varus/valgus. Score
ranges from 0 to 100. The higher the score, the better the outcome
Identification Contact information: DONG Jiyuan, dongjiyuan81301@l63.com, Department of Orthopaedics, PLA Gen-
eral Hospital, Beijing, 100853
Notes Country: China
Language: English
Study author contacted: yes, no reply from the author
Trial registry record or protocol available: none reported or identified
Funding source/declaration of interest: no source of funding reported or identified
Adverse events:
In the tourniquet group: 9 patients had DVT
In the non-tourniquet group: 2 patients had DVT
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Insufficient information to permit judgement
Allocation concealment
(selection bias)
Unclear risk Insufficient information to permit judgement
Zhang 2016  (Continued)
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Unclear risk Insufficient information to permit judgement
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Unclear risk Not stated if patients were blinded; therefore unclear risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)




Low risk No missing outcome data
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
No protocol reported or identified





Methods Two groups: surgery performed with a tourniquet; surgery performed without a tourniquet
Follow-up: not reported
Study design: single-centre randomised controlled trial
Participants 39 participants in total
Male:Female: 7:13; 5:14
Age, years (SD): 63.12 (6.79); 61.89 (7.93)
BMI: not reported
Inclusion criteria: patients undergoing total knee replacement surgery, able to provide informed con-
sent and adhere to the study protocol
Exclusion criteria: patients with a history of deep venous thrombosis of the lower extremities
Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet (n = 20)
Group B: surgery performed without a tourniquet (n = 19)
Outcomes 1. Change in D-dimer, fibrinogen, plasma viscosity, and antithrombin III: measured in blood concentra-
tion before surgery and 5 minutes after surgery
2. Change in haematocrit: measured in blood concentration before surgery and 5 minutes after surgery
3. Pain score: study authors did not mention specific values in the final report. They stated that pain
scores were significantly lower in the control group
Zhou 2011 
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Identification Contact information: Zhou Wei, Master attending physician, Department of Orthopaedics,
First People's Hospital of Pingdingshan, Pingdingshan 467000, Henan Province, China,
zhouwei666999@sina.com
No funding for this study
Notes Country: China
Language: English
Study author contacted: yes, no reply from the author
Trial registry record or protocol available: none reported or identified
Funding source/declaration of interest: no source of funding reported or identified
Adverse events: no adverse events reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computerised random number generator
Allocation concealment
(selection bias)





Unclear risk Insufficient information to permit judgement
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Unclear risk Not stated if patients were blinded; therefore unclear risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)
Low risk Assessor-reported outcomes: change in haematocrit, D-dimer, fibrinogen,
plasma viscosity, antithrombin III




Low risk No missing outcome data
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
No protocol reported or identified





Methods Two groups: surgery performed with a tourniquet; surgery performed without a tourniquet
Zhou 2017 
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Follow-up: 6 months
Study design: single-centre randomised controlled trial
Participants 140 participants in total
Male:Female: 13:59; 7:61
Age, years (SD): 66.8 (8.6); 69.1 (7.6)
BMI: 25.7 (3.4); 26.1 (4.1)
Inclusion criteria: patients with end-stage osteoarthritis or rheumatoid arthritis scheduled for unilater-
al total knee arthroplasty
Exclusion criteria: patients with prior surgery involving the femur or tibia, prior lower extremity frac-
ture, coagulopathy, uncontrolled hypertension
Duration of illness: unspecified
Interventions Group A: surgery performed with a tourniquet (n = 72)
Group B: surgery performed without a tourniquet (n = 68)
All operations were performed by the same surgeon using a Sigma fixed or rotating plant posterior-sta-
bilised total knee prosthesis (PFC, Johnson & Johnson/DePuy, Warsaw, IN, USA). All patients with con-
trolled hypotension received a general anaesthetic. Each patient received the same perioperative
treatment strategies: tranexamic acid (TXA), pain control, rehabilitation. TXA was given at initiation of
surgery and just before closure
Outcomes 1. Intraoperative blood loss: measured by weighing sponges in addition to fluid in suction tubing
2. Postoperative blood loss: amount of fluid in postoperative drainage tubing
3. Blood transfusion rate: defined as the number of units delivered to the patient. The higher the number
of units, the worse the outcome
4. Pain: measured on a VAS between 0 and 10. Measured on days 1, 3, and 5 and at weeks 3 and 12
5. HSS score: knee related score assessing pain, stability (measured as total varus-valgus arc, extension),
motion (measured as total passive arc), quadriceps strength (measured as 10% of normal for age and
gender), subtractions for contractures or fixed varus/valgus. Score ranges from 0 to 100. The higher
the score, the better the outcome. Measured at 3 and 6 months
6. Length of hospital stay: measured in days
7. Number of DVTs
8. Knee ROM: number of degrees of knee flexion. Measured on postoperative days 1, 3, and 5, at week
3, and at months 3 and 6
9. Calf swelling
Identification Contact information: correspondence: Zhouzongke2016@163.com, Department of Orthopaedics, West
China Hospital of Sichuan University, Chengdu 610041, China
Notes Country: China
Language: English
Study author contacted: no
Trial registry record or protocol available: this study was funded by Health Industry Special Scientif-
ic Research Projects of China - the safety and effectiveness evaluation of arthroplasty (grant number
201302007)
Funding source/declaration of interest: Chinese clinical trials registry number ChicTR-IOR-16007851
Adverse events:
Zhou 2017  (Continued)
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In the tourniquet group: 5 patients developed infection and 2 had DVT
In the non-tourniquet group: 3 patients developed infection
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer generated
Allocation concealment
(selection bias)





Unclear risk Insufficient information to permit judgement
Blinding of outcome as-
sessment - self-reported
outcomes (detection bias)
Unclear risk Not stated if patients were blinded; therefore unclear risk of bias
Blinding of outcome as-
sessment - assessor re-
ported outcomes (detec-
tion bias)




Low risk No missing outcome data
Selective reporting (re-
porting bias)
Low risk All outcome measures reported
Other bias Low risk No other sources of bias
Zhou 2017  (Continued)
APTT: activated partial thromboplastin time.
ASA: American Society of Anesthesiologists.
BMI: body mass index.
CRP: C-reactive protein.
DVT: deep venous thrombosis.
EDTA: ethylene diamine tetra-acetic acid.
EQ-5D: EuroQoL Group Quality of Life Questionnaire based on five dimensions.
GFR: glomerular filtration rate.
HSS: Hospital for Special Surgery.




ROM: range of motion.
RSA: radiostereometric analysis.
SD: standard deviation.
SF-12: 12-Item Short Form Survey.
TKA: total knee arthroplasty.
TXA: tranexamic acid.
VAS: visual analogue scale.
WOMAC: Western Ontario McMaster Arthritis Index.
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Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Ajnin 2020 Non-randomised study with fewer than 1000 participants
Bakker 2019 Non-randomised study with fewer than 1000 participants
Barros 2017 Non-randomised study with fewer than 1000 participants
Brin 2015 Wrong comparator
Burg 2009 Non-randomised study with fewer than 1000 participants
Dennis 2016 Wrong comparator
Dorr 2014 Commentary piece
Fakuda 2007 Non-randomised study with fewer than 1000 participants
Friedrich 1990 Wrong comparator
Harvey 1997 Wrong study design
Hasanain 2018 Non-randomised study with fewer than 1000 participants
Huang 2015 Wrong study design
Husted 2005 Wrong comparator
Jarolem 1995 Non-randomised study with fewer than 1000 participants
Kheir 2018 Non-randomised study with fewer than 1000 participants
Matziolis 2011 Non-randomised study with fewer than 1000 participants
Mourikis 2009 Supplementary piece
Mutlu 2015 Non-randomised study with fewer than 1000 participants
Nicolaiciuc 2019 Non-randomised study with fewer than 1000 participants
Nicolaiciuc 2019b Wrong study design
Nielsen 2016 Wrong comparator
Nishiguchi 2008 Non-randomised study with fewer than 1000 participants
Padala 2004 Wrong comparator
Schimizu 2016 Non-randomised study with fewer than 1000 participants
Schnettler 2017 Non-randomised study with fewer than 1000 participants
Stroh 2011 Non-randomised study with fewer than 1000 participants
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Study Reason for exclusion
Zhang 2019 Non-randomised study with fewer than 1000 participants
 
Characteristics of ongoing studies [ordered by study ID]
 
Study name Total Knee Replacement With Tourniquet or Aquamantys
Methods Double-blind randomised controlled trial
Participants Participants aged 18 to 100
Inclusion criteria: primary total knee arthroplasty
Exclusion criteria: repeat knee replacement (revision arthroplasty), bilateral knee replacements on
the same day, partial knee replacements, health or social limitations that do not allow the partici-
pant to be discharged to home on the same day or on the day after surgery
Interventions Control: surgery performed with tourniquet inflated to control bleeding
Intervention: the Aquamantys bipolar sealer is a device used during surgery to help reduce bleed-
ing in the joint. The system uses radiofrequency energy and sterile saline (salt water) to close small
blood vessels in the knee to help reduce bleeding
Outcomes Primary outcome:
Isometric quadriceps strength [Time Frame: 2 weeks]
Secondary outcomes:
1. Pain (VAS) [Time Frame: preoperative, 2 weeks, 6 weeks, 12 weeks]
2. Knee Injury Osteoarthritis Outcome Score, Joint Replacement (KOOS, JR) patient-reported out-
come score
3. Emotional health (VR-12 MCS). The Veterans Rand-12 Mental Component Score will be used to
quantify the impact of participants' emotional health on their daily activities. The VR-12 consists of
12 questions and is scored from 0 to 100, with lower scores indicating that emotional health has a
more dramatic impact on the participant's daily life
4. Knee function questionnaire [Time Frame: preoperative, 2 weeks, 6 weeks, 12 weeks]
5. Sit to stand test [Time Frame: 6 weeks, 12 weeks]
6. Opioid use [Time Frame: preoperative, 2 weeks, 6 weeks, 12 weeks]
7. Isometric quadriceps strength [Time Frame: 6 weeks, 12 weeks]
Starting date 15/08/2019
Contact information Stephen Duncan
University of Kentucky
Lexington, Kentucky, USA 40536
859-323-5533; stdunc2@uky.edu
Notes ClinicalTrials.gov Identifier NCT04016285
Duncan 2019 
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Study name The Effects of a Tourniquet in Total Knee Arthroplasty
Methods Triple-blinded randomised controlled trial
Participants Participants aged 18 and older
Inclusion criteria: knee osteoarthrosis qualifying for total knee arthroplasty
Exclusion criteria: coagulation disease, rheumatoid arthritis, peripheral vascular disease, malig-
nant disease, pregnancy, ongoing infection, not able to understand written and oral information in
Norwegian
Interventions No use of tourniquet during surgery vs use of tourniquet during surgery where cuB will be inflated
to 300 mmHg
Outcomes Primary outcome measures:
1. Mmax [Time Frame: (1) change from preoperative (baseline) to day 2 postoperative, (2) change
from preoperative to 8 weeks postoperative, (3) change from preoperative to 1 year postoperative].
EMG recordings are made using 10 mm electrodes (Ag-AgCl) attached in a bipolar configuration
over the vastus lateralis and rectus femoris
2. Nerve growth factor (NGF) [Time Frame: change from during surgery to 8 weeks postoperative].
Analysis from muscle biopsies harvested from the m vastus lateralis
3. Forgotten joint score [Time Frame: (1) change from preoperative (baseline) to day 2 postopera-
tive, (2) change from preoperative to 8 weeks postoperative, (3) change from preoperative to 1 year
postoperative]. The stair climbing test measures the time (in seconds) to ascend, turn around, and
descend a regular stairway of 11 steps. Patients are asked to perform the test as quickly as possible
Secondary outcome measures:
1. Maximal leg strength [Time Frame: (1) change from preoperative (baseline) to day 2 postopera-
tive, (2) change from preoperative to 8 weeks postoperative, (3) change from preoperative to 1 year
postoperative]. 1 RM leg strength is measured using a leg press ergometer with the participant in a
supine position (Steens Physical, Ring Mekanikk, Moelv, Norway)
2. Maximal knee extension strength [Time Frame: (1) change from preoperative (baseline) to day
2 postoperative, (2) change from preoperative to 8 weeks postoperative, (3) change from preoper-
ative to 1 year postoperative]. 1 RM knee extension is measured using knee extension equipment
(Body-Solid, Forest Park, IL, USA) with the participant in a seated position
3. Rate of force development, voluntary activation, and muscle contractility [Time Frame: (1)
change from preoperative (baseline) to day 2 postoperative, (2) change from preoperative to 8
weeks postoperative, (3) change from preoperative to 1 year postoperative]
4. Daily physical activity [Time Frame: change from day 3 to day 10 postoperative to 1 year postop-
erative (1 week measurement)]. Body-worn activity monitor
5. EuroQual 5D-L [Time Frame: preoperative, 8 weeks, 1 year postoperative]. Patient-reported out-
come measure
6. Numerical Rating Scale (NRS) [Time Frame: preoperative, from day 1 postoperative to 4 weeks
postoperative, 8 weeks, and 1 year postoperative]. Evaluating pain. the scale range from 0 (no pain)
to 10 (worst pain imaginable). Patients are asked to write down NRS values both at rest and during
activity each day for the first 4 weeks postoperatively in a home log
7. Haemoglobin values [Time Frame: preoperative, day 1 postoperative], g/dL
8. Volume of bleeding [Time Frame: during surgery and day 1 postoperative]. Total volume of
bleeding during surgery and in the drain
9. Length of hospital stay [Time Frame: from day of surgery until 10 days postoperative]. Number of
days
10. Knee circumference [Time Frame: preoperative and day 1 postoperative]. The circumference of
the knee is measured 1 cm proximal to the patellar base
11. Knee joint range of motion [Time Frame: preoperative; 1 day, 8 weeks, 1 year postoperative].
Maximal flexion and extension
Forsmo 2018 
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12. Forgotten joint score [Time Frame: preoperative; 8 weeks, 1 year postoperative]. Patient-report-
ed outcome measure
13. Gene expression analyses. RT-PCR for expression levels for VEGF, NGF, SP, CGRP, IL-6, IL-1, TNF-
alpha, Bad, Bax, Bid, Bim, Fas, Fas-ligand, Bcl-2, Mcl, and FLIP. Results will be normalised to GAPDH
expression levels [Time Frame: preoperative and 8 weeks postoperative]. Analysis from muscle
biopsies harvested from the vastus lateralis (muscle)
14. Neuronal markers, PGP, GAP-43 [Time Frame: during surgery and 8 weeks postoperative]. Analy-
sis from muscle biopsies harvested from the vastus lateralis (muscle)
15. Neuromediators, SP, CGRP, glutamate [Time Frame: during surgery and 8 weeks postoperative].
Analysis from muscle biopsies harvested from the vastus lateralis (muscle)
16. Pain receptors, glutamate receptors [Time Frame: during surgery and 8 weeks postoperative].
Analysis from muscle biopsies harvested from the vastus lateralis (muscle)
Starting date 12/09/2018
Contact information Vigdis Schnell Husby, PhD, +4773412312, vigdis.schnell.husby@ntnu.no; Siri Bjorgen Winther, PhD,
+4772573669, siri.bjorgen@ntnu.no
Notes Sponsors and Collaborators Norwegian University of Science and Technology, Zimmer Biomet,
University of British Columbia, Karolinska University Hospital, St Olav's Hospital, University Hospi-





Study name A Single-Centre, Parallel-Arm, Double-Blind Randomised Trial Evaluating the Effects of Tourniquet
Use in Total Knee Arthroplasty on Intraoperative and Postoperative Outcomes
Methods Randomised controlled trial
Participants 90 participants with osteoarthritis
Inclusion criteria: undergoing primary total knee replacement for primary osteoarthritis; > 18 years
of age; willing, able, and mentally competent to provide informed consent
Exclusion criteria: undergoing bilateral total knee replacement, neurological deficit affecting op-
erated knee, rheumatoid arthritis, preoperative knee flexion < 60 (degree of flexion required for
strength testing), varus/valgus deformity > 15, opioid tolerant (current use of oxycontin, opioid
patches, or tramadol; > 4 tabs panadeine forte per day), sulphonamide allergy (to allow parecox-
ib/celecoxib use), intolerant/allergic to oxycodone, poorly controlled diabetes (HbA1C > 8) (impact
on choice of dexamethasone as antiemetic), cognitively impaired (mini-mental state examination <
25/30), eGFR < 60 mL/min/1.73m2 (to allow parecoxib/celecoxib use)
Interventions Surgery with a tourniquet vs surgery without a tourniquet
Outcomes Primary outcome:
Isometric quadriceps strength will be measured in Newtons
Secondary outcomes:
1. Analgesic requirements will be determined from patients; hospital medication charts and aver-
age morphine equivalent daily dose calculated (mg)
2. Cement mantle quality according to the Knee Society total knee arthroplasty roentgenographic
evaluation and scoring system
3. Complications during inpatient stay as recorded in patients' hospital medical record (deep vein
thrombosis, pulmonary embolus)
4. EQ-5D-5L (quality of life)
Gill 2018 
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5. Hospital length of stay according to patients' hospital medical records
6. Intraoperative blood loss (mL) will be estimated visually by the treating surgeon
7. Isometric quadriceps strength will be measured in Newtons
8. Knee pain will be assessed using a 0 to 10 Likert scale (0 = no pain, 10 = extreme pain)
9. Operation and anaesthetic time as recorded in patients' hospital medical records
10. Oxford Knee Score (OKS) (self-reported pain and physical function)
11. Patient satisfaction assessed with a 0 to 10 visual analogue scale
12. Revision surgery as recorded in patients' hospital medical records
13. Surgeon satisfaction with intraoperative visual field, assessed using a 1 to 10 Likert scale (1 =
completely unsatisfied, 10 = completely satisfied)
14. Tourniquet inflation time as recorded in patients' hospital medical records
15. Transfusions given (units) as recorded in patients' hospital medical records
16. WOMAC (self-reported pain and physical function)
Starting date 1/10/2014
Contact information Name: Dr Stephen Gill
Address: Barwon Centre for Orthopaedic Research and Education, St John of God Hospital, Myers
Street, Geelong, Victoria, Australia 3220
Telephone: +61 3 52150902
Email: stephen.gill2@deakin.edu.au
Study registered with the Australian New Zealand Clinical Trials Registry: ACTRN12618000425291




Study name The Efficacy of Oral Tranexamic Acid on Blood Loss in Primary Total Knee Arthroplasty With or
Without Tourniquet: A Prospective, Randomized, Controlled Trial
Methods Randomised controlled trial
Participants 60 participants in total: 30 with a tourniquet vs 30 without a tourniquet
Inclusion criteria: patients with osteoarthritis of the knee
Exclusion criteria: patients with bilateral arthroplasty, allergy to TXA, history of renal failure, kidney
transplant, history of an arterial thromboembolic event such as myocardial infarction or stroke in
past years, history of hypercoagulation, haemophilia, deep vein thrombosis, pulmonary embolism
Interventions Surgery with a tourniquet vs surgery without a tourniquet
Outcomes 1. Blood loss




Contact information Name: Kang Pengde
Address: 37 Guoxuexiang, Chengdu, China
Telephone: +86 18980601953
Email: kangpd@163.com
Affiliation: West China Hospital, Sichuan University
Kange 2017 
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Study name Effect of Tourniquet on UKA
Methods Triple-blinded randomised controlled trial
Participants 30 participants
Inclusion criteria: waiting list for unicondylar knee arthroplasty
Exclusion criteria: failed upper tibial osteotomy, insufficiency of collateral or anterior cruciate lig-
aments, fixed varus or valgus deformity (not passively correctable) above 15°, flexion deformity >
15°, rheumatoid arthritis, intake of medicinal anticoagulation before surgery, liver dysfunction/co-
agulation dysfunction, peripheral arterial occlusive disease
Interventions UKA surgery with tourniquet vs UKA surgery without tourniquet
Outcomes Primary outcome measure:
Cement mantle thickness [Time Frame: 1 week]
Starting date 08/06/2015
Contact information Michael Liebensteiner, +4351250480547, Michael.liebensteiner@i-med.ac.at





Study name Tourniquet Versus No Tourniquet on Early Rehabilitation and Cement Mantle After Primary Total
Knee Arthroplasty Using a Multimodal Blood Management Protocol: A Randomized Controlled Trial
Methods Randomised controlled trial
Participants 60 participants in total
Inclusion criteria: patients aged 18 years and older, scheduled for primary TKA because of end-
stage osteoarthritis
Exclusion criteria: revisions, bilateral procedures, previous knee surgery history, flexion deformi-
ty 30°, varus/valgus deformity 30°, anaemia (< 120 g/L for female, < 130 g/L for male), contraindica-
tions for use of TXA, coagulation disorder
Interventions Surgery with a tourniquet vs surgery without a tourniquet
Outcomes 1. Total blood loss
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Contact information Name: Fuxing Pei
Address: 37 Guoxuexiang, Chengdu, China 610041
Telephone: +86 13541242147
Email: peifuxing1952@163.com
Affiliation: West China Hospital, Sichuan University




Study name Is Tourniquet Really Necessary When Multiple Uses of Intravenous and Topical Tranexamic Acid Are
Applied in Primary Total Knee Arthroplasty? A Prospective Randomised Controlled Trial
Methods Randomised controlled trial
Participants 150 participants
Inclusion criteria: aged 18 years and older, scheduled for primary TKA because of end-stage os-
teoarthritis
Exclusion criteria: revisions, bilateral procedures, previous knee surgery history, flexion deformi-
ty 30°, varus/valgus deformity 30°, anaemia (< 120 g/L for female, < 130 g/L for male), contraindica-




Interventions Group A: tourniquet + 20 mg/kg IV TXA administered 5 to 10 minutes before skin incision and 10
mg/kg TXA administered 3, 6, 12, and 24 hours later
Group B: 20 mg/kg IV TXA administered 5 to 10 minutes before skin incision and 10 mg/kg TXA ad-
ministered 3, 6, 12, and 24 hours later
Group C: only tourniquet used during surgery
Outcomes Primary outcomes:
1. Hidden blood loss
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1. Lower limb swelling ratio
2. VAS pain score





Contact information Fuxing Pei37 Guoxuexiang, Chengdu, China 610041, +8613551068719, peifuxing1951@163.com,






Study name Effects of Postoperative Limb Positions on Blood Loss and Range of Motion in Total Knee Arthro-
plasty Without Tourniquet: A Randomized Controlled Trial
Methods Randomised controlled trial
Participants 100 participants with osteoarthritis undergoing total knee replacement surgery
Inclusion criteria: with total knee replacement
Exclusion criteria: infection, anaemia, thrombosis
Interventions Surgery with a tourniquet vs surgery without a tourniquet
Outcomes 1. Blood loss
2. Range of motion
Starting date 13/02/2018
Contact information Name: Bin Shen
Address: 37 Guo Xue Xiang, Chengdu, Sichuan, China
Telephone: +86 18980601390
Email: wuyuangang23@163.com, shenbin_1971@163.com
Affiliation: West China Hospital, Sichuan University
Registration: ChiCTR1800014896




Study name Randomized Controlled Trial for Comparision of Functional Outcome in Total Knee Replacement
With Tourniquet and Without Tourniquet
Singh 2019 
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Methods Randomised controlled trial
Participants 60 participants diagnosed with osteoarthritis undergoing primary total knee replacement surgery
Inclusion criteria: diagnosed with osteoarthritis, scheduled for unilateral cemented TKA, either sex,
< 80 years of age
Exclusion criteria: severe obesity, previous operation in concerning knee, lack of informed consent,
severe cardiovascular condition, receiving general anaesthesia during surgery
Interventions Surgery with a tourniquet vs surgery without a tourniquet
Outcomes 1. Postoperative limb pain
2. Blood loss
3. Range of motion
4. Deep vein thrombosis
5. Radiolucency at bone cement interface
Starting date 01/04/2013
Contact information Name: Swapnil Singh
Address: Office of Dept of Orthopaedics, 5th floor teaching block, AIIMS New Delhi, Room 88, Hostel
7; AIIMS boys hostel; AIIMS New Delhi, 110029 South Delhi, India
Telephone: 9868397115
Email: csyadavortho@gmail.com
Affiliation: AIIMS, New Delhi




Study name After Surgery Acute Renal Failure Incidence in Total Knee Arthroplasty With and Without Tourni-
quet
Methods Double-blinded randomised controlled trial
Participants 100 participants
Inclusion criteria: knee arthrosis, requiring surgical treatment with total knee arthroplasty
Exclusion criteria: not acceptable to be in study, no signed consent form, not having blood sample
for creatinine measure
Interventions Total knee arthroplasty and use of tourniquet limb cuB at 270 mmHg vs total knee arthroplasty
with intra-articular lidocaine
Outcomes Primary outcome measures:
1. Creatinine before surgery [Time Frame: creatinine before surgery]. Blood creatinine measured in
mg/dL before surgery
2. Creatinine after surgery 1 [Time Frame: creatinine after surgery 1 at 24 hours]. Blood creatinine
measured in mg/dL at 24 hours
3. Creatinine after surgery 2 [Time Frame: creatinine after surgery 2 at 48 hours]. Blood creatinine
measured in mg/dL at 48 hours
Vasquez 2019 
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Starting date 08/01/2019
Contact information Avelino Colin Vazquez, MD





Study name Safety and Feasibility Evaluation of Tourniquets for Total Knee Replacement Study
Methods Randomised controlled trial
Participants 50 participants undergoing total knee replacement surgery
Inclusion criteria: aged 18 years and over, undergoing primary unilateral knee replacement, able
to give written informed consent and to participate fully in trial interventions and follow-up proce-
dures
Exclusion criteria: patients for whom magnetic resonance (MR) imaging is contraindicated due
to non-compliant heart pacemaker or defibrillator, non-compliant metallic foreign body (e.g. in
one or both eyes, aneurysm clips in the brain), claustrophobia (e.g. difficulty in an elevator or tele-
phone box); not suitable for a thigh tourniquet (e.g. significant peripheral vascular disease); previ-
ous participation in the SAFE-TKR trial
Interventions Surgery with a tourniquet vs surgery without a tourniquet
Outcomes Primary outcome:
1. Total volume of acute brain lesions detected on magnetic resonance (MR) brain imaging per pa-
tient, day 1 or 2 postoperatively
Secondary outcomes:
1. Montreal Cognitive Assessment (MoCA) preoperatively; on days 1, 2, and 7 postoperatively; and
at 6 and 12 months postoperatively
2. Oxford Cognitive Screen (OCS) preoperatively and on days 1, 2, and 7 postoperatively
3. Mini-mental state examination (MMSE) scores preoperatively and on days 1, 2, and 7 postopera-
tively
4. Knee pain measured using the Oxford Knee Score postoperatively at baseline, at 1 week, and at 6
and 12 months
5. Thigh pain measured using the visual analogue scale (VAS) for acute thigh pain at baseline, day 1,
day 2, and 1 week
6. Knee pain measured using the EQ-5D-5L at baseline, at 1 week, at 6 and 12 months
7. Number of symptomatic VTE events measured by questionnaire up to 12 months postoperatively
8. Surgical complication rate measured by questionnaire up to 12 months postoperatively
9. Number of intra/postoperative blood transfusions measured by patient notes up until discharge
10. Revision rate of TKR prosthesis measured by questionnaire or patient notes at 12 months
11. All-cause mortality rates measured by patient notes or by next of kin at 12 months
12. Change in haemoglobin concentration between preoperative haemoglobin and postoperative
haemoglobin
Starting date 17/02/2016
Contact information Peter Wall
University of Warwick
Wall 2016 
Tourniquet use for knee replacement surgery (Review)









Cochrane Database of Systematic Reviews












Study name Tourniquet Versus No Tourniquet on Rehabilitation After Fast-Track Total Knee Arthroplasty
Methods Randomised controlled trial
Participants 60 participants (30 in each group)
Inclusion criteria: adult patients who plan to undergo primary TKA on simultaneous bilateral knee
joints with diagnosis of osteoarthritis but not of rheumatoid arthritis
Exclusion criteria: aged > 50 or < 80 years; body mass index (BMI) > 35 kg/m2; rheumatoid arthritis;
current long-term anticoagulation therapy; abnormal coagulation function; local or systemic infec-
tion; severe deformity of the knee > 20° varus or ectropion, > 30° flexion contracture; previous open
knee surgery; disease of the blood system, cerebral infarction, cerebral haemorrhage, active malig-
nancy; peripheral vascular or nerve disease; preoperative anaemia (haemoglobin value < 100 g/L);
surgery not by project surgeon; patient refusal to participate in the study; psychiatric illness
Interventions Surgery with a tourniquet vs surgery without a tourniquet
Outcomes 1. Quadriceps strength
2. Pain score
3. Postoperative knee flexion




Contact information Name: Gang Wang
Address: 127 West Changle Road, Xi'an, Shaanxi, China
Telephone: +86 13810347690
Email: 564325747@qq.com
Affiliation: Department of Orthopaedics, Xijing Hospital, Fourth Military Medical University
Notes Funded by the Boosting Academic Program of Xijing Hospital
Wang 2016 
BMI: body mass index.
CGRP: calcitonin gene-related peptide.
eGFR: estimated glomerular filtration rate.
EQ-5D-5L: EuroQoL Group Quality of Life Questionnaire based on five-level scale.
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IL: interleukin.
NGF: nerve growth factor.
NRS: numerical rating scale.
RT-PCR: reverse transcriptase polymerase chain reaction.
TKA: total knee arthroplasty.
TNF: tumour necrosis factor.
UKA: unicompartmental knee arthroplasty.




D A T A   A N D   A N A L Y S E S
 
Comparison 1.   Surgery with a tourniquet vs surgery without a tourniquet





Statistical method Effect size
1.1 Pain at different postoperative days (visual
analogue scale 0 to 10, lower is better)
14   Mean Difference (IV, Random, 95%
CI)
Subtotals only
1.1.1 Pain: day 1 8 577 Mean Difference (IV, Random, 95%
CI)
1.25 [0.32, 2.19]




1.1.3 Pain: day 3 10 807 Mean Difference (IV, Random, 95%
CI)
0.78 [0.34, 1.23]
1.1.4 Pain: week 2 6 562 Mean Difference (IV, Random, 95%
CI)
0.32 [0.12, 0.53]




1.2 Function: patient-reported knee function at
3 months (scale 0 to 100, higher is better)




1.3 Function: patient-reported knee function at
12 months (scale 0 to 100, higher is better)




1.4 Global assessment of success: participant-re-
ported satisfaction at 3 months (based on num-
ber of participants, higher is better)
1 100 Risk Ratio (M-H, Random, 95% CI) 1.02 [0.92, 1.14]
1.5 Global assessment of success: participant-re-
ported satisfaction at 6 months (based on num-
ber of participants, higher is better)
1 100 Risk Ratio (M-H, Random, 95% CI) 1.00 [0.91, 1.10]
1.6 Health-related quality of life: SF-12 mental
component at 6 weeks (0 to 100, higher is better)




1.7 Health-related quality of life: SF-12 mental
component at 6 months (0 to 100, higher is bet-
ter)
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Statistical method Effect size
1.8 Serious adverse events 21 1799 Risk Ratio (M-H, Random, 95% CI) 1.73 [1.10, 2.73]
1.9 Serious adverse event: venous thromboem-
bolic event (VTE)
17 1575 Risk Ratio (M-H, Random, 95% CI) 1.95 [0.99, 3.82]
1.10 Serious adverse event: deep vein thrombo-
sis (DVT)
17 1602 Risk Ratio (M-H, Random, 95% CI) 2.05 [1.35, 3.13]
1.10.1 Symptomatic DVT 16 1499 Risk Ratio (M-H, Random, 95% CI) 1.83 [0.92, 3.65]
1.10.2 Asymptomatic DVT 1 103 Risk Ratio (M-H, Random, 95% CI) 2.20 [1.29, 3.74]
1.11 Serious adverse event: pulmonary em-
bolism (PE)
5 416 Risk Ratio (M-H, Random, 95% CI) 4.51 [0.49,
41.81]
1.12 Serious adverse event: infection 9 846 Risk Ratio (M-H, Random, 95% CI) 2.72 [1.15, 6.42]
1.13 Serious adverse event: re-operation 3 157 Risk Ratio (M-H, Random, 95% CI) 1.63 [0.61, 4.34]
1.14 Survival of the implant: risk of revision up to
2 years
3 214 Risk Ratio (M-H, Random, 95% CI) 1.44 [0.23, 8.92]
1.15 Blood loss: postoperative transfusion risk
(lower is better)
18 1286 Risk Ratio (M-H, Random, 95% CI) 1.20 [0.86, 1.67]
1.16 Blood loss: intraoperative (mL, lower is bet-
ter)





1.17 Blood loss: postoperative (mL, lower is bet-
ter)




1.18 Blood loss: overall blood loss (mL, lower is
better)




1.19 Blood loss: change in haemoglobin (g/dL,
lower is better)




1.20 Economic: length of hospital stay (days,
lower is better)
12 995 Mean Difference (IV, Random, 95%
CI)
0.34 [0.03, 0.64]
1.21 Economic: duration of surgery (minutes,
lower is better)




1.22 Implant stability: maximum total point mo-
tion at 8 weeks (mm, lower is better)




1.23 Implant stability: maximum total point mo-
tion at 1 year (mm, lower is better)




1.24 Implant stability: maximum total point mo-
tion at 2 years (mm, lower is better)
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Analysis 1.1.   Comparison 1: Surgery with a tourniquet vs surgery without a tourniquet,
Outcome 1: Pain at di<erent postoperative days (visual analogue scale 0 to 10, lower is better)
Study or Subgroup










Heterogeneity: Tau² = 1.61; Chi² = 124.75, df = 7 (P < 0.00001); I² = 94%
Test for overall effect: Z = 2.64 (P = 0.008)








Heterogeneity: Tau² = 0.10; Chi² = 9.65, df = 5 (P = 0.09); I² = 48%
Test for overall effect: Z = 1.82 (P = 0.07)












Heterogeneity: Tau² = 0.34; Chi² = 69.48, df = 9 (P < 0.00001); I² = 87%
Test for overall effect: Z = 3.46 (P = 0.0005)








Heterogeneity: Tau² = 0.05; Chi² = 17.93, df = 5 (P = 0.003); I² = 72%
Test for overall effect: Z = 3.05 (P = 0.002)








Heterogeneity: Tau² = 0.92; Chi² = 262.50, df = 4 (P < 0.00001); I² = 98%
Test for overall effect: Z = 0.87 (P = 0.39)





















































































































































































































































































IV, Random, 95% CI
4.00 [3.29 , 4.71]
1.65 [0.93 , 2.37]
0.15 [-0.04 , 0.34]
1.80 [0.88 , 2.72]
0.30 [-0.47 , 1.07]
1.00 [-0.97 , 2.97]
0.85 [0.25 , 1.45]
0.30 [-0.45 , 1.05]
1.25 [0.32 , 2.19]
0.14 [0.01 , 0.27]
1.43 [0.42 , 2.44]
0.40 [-0.34 , 1.14]
2.60 [-0.24 , 5.44]
0.00 [-0.67 , 0.67]
0.30 [-0.59 , 1.19]
0.37 [-0.03 , 0.76]
0.41 [-0.41 , 1.23]
-0.03 [-0.20 , 0.14]
0.90 [0.16 , 1.64]
1.30 [0.49 , 2.11]
0.80 [-1.55 , 3.15]
1.20 [-1.13 , 3.53]
0.81 [0.59 , 1.03]
1.00 [0.41 , 1.59]
0.40 [-0.46 , 1.26]
1.48 [1.00 , 1.96]
0.78 [0.34 , 1.23]
0.11 [-0.07 , 0.29]
0.45 [0.05 , 0.85]
0.40 [-0.03 , 0.83]
0.04 [-0.13 , 0.21]
0.60 [0.28 , 0.92]
0.54 [0.26 , 0.82]
0.32 [0.12 , 0.53]
0.18 [-0.02 , 0.38]
-0.64 [-1.33 , 0.05]
Not estimable
0.06 [-0.13 , 0.25]
2.06 [1.85 , 2.27]
0.12 [-0.11 , 0.35]
0.38 [-0.48 , 1.23]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours Tourniquet Favours without Tourniquet
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Analysis 1.2.   Comparison 1: Surgery with a tourniquet vs surgery without a tourniquet, Outcome







Heterogeneity: Tau² = 0.75; Chi² = 50.26, df = 3 (P < 0.00001); I² = 94%
Test for overall effect: Z = 1.41 (P = 0.16)










































IV, Random, 95% CI
0.15 [-0.34 , 0.64]
0.01 [-0.27 , 0.28]
0.02 [-0.35 , 0.39]
-3.14 [-4.00 , -2.28]
-0.64 [-1.52 , 0.25]
Std. Mean Difference
IV, Random, 95% CI




Analysis 1.3.   Comparison 1: Surgery with a tourniquet vs surgery without a tourniquet, Outcome








Heterogeneity: Tau² = 0.00; Chi² = 3.53, df = 4 (P = 0.47); I² = 0%
Test for overall effect: Z = 0.70 (P = 0.49)

















































IV, Random, 95% CI
-0.26 [-0.70 , 0.18]
-0.09 [-0.37 , 0.19]
-0.22 [-0.66 , 0.22]
-0.04 [-0.41 , 0.33]
0.19 [-0.14 , 0.52]
-0.06 [-0.22 , 0.10]
Std. Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
Favours Non Tourniquet Favours Tourniquet
 
 
Analysis 1.4.   Comparison 1: Surgery with a tourniquet vs surgery without a
tourniquet, Outcome 4: Global assessment of success: participant-reported






Test for overall effect: Z = 0.39 (P = 0.70)



















M-H, Random, 95% CI
1.02 [0.92 , 1.14]
1.02 [0.92 , 1.14]
Risk Ratio
M-H, Random, 95% CI
0.2 0.5 1 2 5
Favours Non Tourniquet Favours Tourniquet
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Analysis 1.5.   Comparison 1: Surgery with a tourniquet vs surgery without a
tourniquet, Outcome 5: Global assessment of success: participant-reported






Test for overall effect: Z = 0.00 (P = 1.00)



















M-H, Random, 95% CI
1.00 [0.91 , 1.10]
1.00 [0.91 , 1.10]
Risk Ratio
M-H, Random, 95% CI
0.2 0.5 1 2 5
Favours Non Tourniquet Favours Tourniquet
 
 
Analysis 1.6.   Comparison 1: Surgery with a tourniquet vs surgery without a tourniquet, Outcome





Test for overall effect: Z = 1.89 (P = 0.06)





















IV, Random, 95% CI
2.58 [-0.09 , 5.25]
2.58 [-0.09 , 5.25]
Mean Difference
IV, Random, 95% CI
-100 -50 0 50 100
Favours Non Tourniquet Favours Tourniquet
 
 
Analysis 1.7.   Comparison 1: Surgery with a tourniquet vs surgery without a tourniquet, Outcome





Test for overall effect: Z = 1.26 (P = 0.21)





















IV, Random, 95% CI
1.53 [-0.85 , 3.91]
1.53 [-0.85 , 3.91]
Mean Difference
IV, Random, 95% CI
-100 -50 0 50 100
Favours Non Tourniquet Favours Tourniquet
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Analysis 1.8.   Comparison 1: Surgery with a tourniquet vs

























Heterogeneity: Tau² = 0.00; Chi² = 10.35, df = 17 (P = 0.89); I² = 0%
Test for overall effect: Z = 2.35 (P = 0.02)




















































































































M-H, Random, 95% CI
11.00 [0.63 , 192.56]
5.64 [0.28 , 113.94]
1.88 [0.18 , 19.70]
0.99 [0.20 , 4.79]
3.00 [0.13 , 71.92]
1.47 [0.26 , 8.42]
3.26 [0.14 , 76.10]
5.00 [0.25 , 99.95]
3.00 [0.13 , 70.42]
1.00 [0.26 , 3.80]
3.00 [0.14 , 65.90]
0.20 [0.01 , 4.00]
Not estimable
3.64 [0.43 , 30.75]
0.50 [0.05 , 5.30]
1.26 [0.47 , 3.41]
4.75 [0.24 , 92.65]
Not estimable
Not estimable
4.39 [0.98 , 19.72]
1.57 [0.39 , 6.34]
1.73 [1.10 , 2.73]
Risk Ratio
M-H, Random, 95% CI
1
Favours tourniquet Favours without tourniquet
 
 
Analysis 1.9.   Comparison 1: Surgery with a tourniquet vs surgery without a





















Heterogeneity: Tau² = 0.00; Chi² = 8.45, df = 11 (P = 0.67); I² = 0%
Test for overall effect: Z = 1.94 (P = 0.05)






























































































M-H, Random, 95% CI
9.00 [0.50 , 161.86]
1.88 [0.18 , 19.70]
0.33 [0.01 , 8.01]
Not estimable
2.94 [0.12 , 70.50]
7.17 [0.30 , 169.67]
Not estimable
1.00 [0.26 , 3.80]
0.33 [0.01 , 7.87]
Not estimable
0.50 [0.05 , 5.30]
3.24 [0.14 , 77.06]
4.75 [0.24 , 92.65]
Not estimable
Not estimable
4.50 [1.00 , 20.21]
4.73 [0.23 , 96.70]
1.95 [0.99 , 3.82]
Risk Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours tourniquet Favours without tourniquet
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Analysis 1.10.   Comparison 1: Surgery with a tourniquet vs surgery without a





















Heterogeneity: Tau² = 0.00; Chi² = 7.78, df = 10 (P = 0.65); I² = 0%






Test for overall effect: Z = 2.90 (P = 0.004)
Total (95% CI)
Total events:
Heterogeneity: Tau² = 0.00; Chi² = 7.88, df = 11 (P = 0.72); I² = 0%
Test for overall effect: Z = 3.34 (P = 0.0008)








































































































M-H, Random, 95% CI
9.00 [0.50 , 161.86]
1.88 [0.18 , 19.70]
0.33 [0.01 , 8.01]
Not estimable
2.94 [0.12 , 70.50]
Not estimable
1.00 [0.26 , 3.80]
0.33 [0.01 , 7.87]
Not estimable
0.50 [0.05 , 5.30]
3.24 [0.14 , 77.06]
4.75 [0.24 , 92.65]
Not estimable
Not estimable
4.50 [1.00 , 20.21]
4.73 [0.23 , 96.70]
1.83 [0.92 , 3.65]
2.20 [1.29 , 3.74]
2.20 [1.29 , 3.74]
2.05 [1.35 , 3.13]
Risk Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours tourniquet Favours without tourniquet
 
 
Analysis 1.11.   Comparison 1: Surgery with a tourniquet vs surgery without









Heterogeneity: Tau² = 0.00; Chi² = 0.17, df = 1 (P = 0.68); I² = 0%
Test for overall effect: Z = 1.32 (P = 0.19)




































M-H, Random, 95% CI
Not estimable
7.17 [0.30 , 169.67]
Not estimable
2.85 [0.12 , 65.74]
Not estimable
4.51 [0.49 , 41.81]
Risk Ratio
M-H, Random, 95% CI
0.002 0.1 1 10 500
Favours Tourniquet Favours Non Tourniquet
 
 
Tourniquet use for knee replacement surgery (Review)









Cochrane Database of Systematic Reviews
Analysis 1.12.   Comparison 1: Surgery with a tourniquet vs surgery













Heterogeneity: Tau² = 0.00; Chi² = 1.66, df = 7 (P = 0.98); I² = 0%
Test for overall effect: Z = 2.29 (P = 0.02)


























































M-H, Random, 95% CI
11.00 [0.63 , 192.56]
2.97 [0.12 , 72.05]
3.00 [0.13 , 71.92]
3.00 [0.13 , 70.42]
3.00 [0.12 , 72.10]
3.00 [0.14 , 65.90]
3.64 [0.43 , 30.75]
Not estimable
1.57 [0.39 , 6.34]
2.72 [1.15 , 6.42]
Risk Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours Tourniquet Favours Non Tourniquet
 
 
Analysis 1.13.   Comparison 1: Surgery with a tourniquet vs surgery







Heterogeneity: Tau² = 0.00; Chi² = 0.88, df = 2 (P = 0.64); I² = 0%
Test for overall effect: Z = 0.98 (P = 0.33)





























M-H, Random, 95% CI
5.00 [0.25 , 99.95]
3.00 [0.14 , 65.90]
1.30 [0.43 , 3.89]
1.63 [0.61 , 4.34]
Risk Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours tourniquet Favours Non Tourniquet
 
 
Analysis 1.14.   Comparison 1: Surgery with a tourniquet vs surgery without a







Heterogeneity: Tau² = 0.00; Chi² = 1.24, df = 2 (P = 0.54); I² = 0%
Test for overall effect: Z = 0.39 (P = 0.70)





























M-H, Random, 95% CI
0.33 [0.01 , 7.81]
3.00 [0.13 , 70.42]
3.00 [0.12 , 72.10]
1.44 [0.23 , 8.92]
Risk Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours tourniquet Favours Non Tourniquet
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Analysis 1.15.   Comparison 1: Surgery with a tourniquet vs surgery without a






















Heterogeneity: Tau² = 0.11; Chi² = 20.98, df = 15 (P = 0.14); I² = 29%
Test for overall effect: Z = 1.08 (P = 0.28)






































































































M-H, Random, 95% CI
4.53 [0.53 , 38.76]
0.48 [0.18 , 1.27]
Not estimable
Not estimable
0.33 [0.11 , 1.00]
1.67 [1.11 , 2.50]
1.33 [0.33 , 5.36]
0.80 [0.37 , 1.74]
7.00 [0.41 , 120.16]
1.00 [0.17 , 5.77]
5.00 [0.25 , 99.95]
1.30 [0.40 , 4.28]
1.00 [0.15 , 6.72]
1.52 [0.63 , 3.66]
4.00 [0.47 , 34.24]
4.00 [0.46 , 34.54]
0.93 [0.55 , 1.58]
2.52 [0.70 , 9.10]
1.20 [0.86 , 1.67]
Risk Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours tourniquet Favours Non Tourniquet
 
 
Analysis 1.16.   Comparison 1: Surgery with a tourniquet vs surgery without


















Heterogeneity: Tau² = 7058.44; Chi² = 1112.19, df = 14 (P < 0.00001); I² = 99%
Test for overall effect: Z = 6.56 (P < 0.00001)























































































































IV, Random, 95% CI
-132.00 [-192.82 , -71.18]
-26.34 [-31.73 , -20.95]
-140.00 [-161.44 , -118.56]
-126.00 [-162.51 , -89.49]
-5.80 [-38.38 , 26.78]
-133.00 [-187.03 , -78.97]
-443.00 [-552.74 , -333.26]
-110.00 [-136.59 , -83.41]
-152.00 [-178.15 , -125.85]
-217.50 [-243.42 , -191.58]
-147.00 [-221.39 , -72.61]
-106.68 [-116.28 , -97.08]
-349.00 [-374.71 , -323.29]
-124.00 [-137.54 , -110.46]
-77.10 [-111.75 , -42.45]
-147.05 [-190.97 , -103.12]
Mean Difference
IV, Random, 95% CI
-500 -250 0 250 500
Favours Tourniquet Favours Non Tourniquet
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Analysis 1.17.   Comparison 1: Surgery with a tourniquet vs surgery without















Heterogeneity: Tau² = 4555.20; Chi² = 159.17, df = 11 (P < 0.00001); I² = 93%
Test for overall effect: Z = 2.56 (P = 0.01)


































































































IV, Random, 95% CI
145.00 [99.39 , 190.61]
-14.70 [-43.57 , 14.17]
645.00 [313.22 , 976.78]
115.00 [42.21 , 187.79]
98.00 [34.96 , 161.04]
21.10 [-104.98 , 147.18]
-13.76 [-29.83 , 2.31]
-133.10 [-196.14 , -70.06]
-78.10 [-231.66 , 75.46]
62.62 [48.01 , 77.23]
211.00 [138.21 , 283.79]
73.50 [31.01 , 115.99]
57.72 [13.58 , 101.87]
Mean Difference
IV, Random, 95% CI
-1000 -500 0 500 1000
Favours Tourniquet Favours non Tourniquet
 
 
Analysis 1.18.   Comparison 1: Surgery with a tourniquet vs surgery without





















Heterogeneity: Tau² = 35816.17; Chi² = 401.67, df = 17 (P < 0.00001); I² = 96%
Test for overall effect: Z = 0.18 (P = 0.86)












































































































































IV, Random, 95% CI
-5.00 [-117.61 , 107.61]
13.00 [-65.80 , 91.80]
197.11 [177.11 , 217.11]
-181.38 [-250.63 , -112.13]
106.80 [13.04 , 200.56]
770.00 [368.99 , 1171.01]
-52.00 [-244.64 , 140.64]
-79.00 [-209.04 , 51.04]
181.00 [69.24 , 292.76]
-301.00 [-382.96 , -219.04]
300.00 [193.83 , 406.17]
-120.00 [-195.18 , -44.82]
-88.00 [-238.89 , 62.89]
-322.50 [-435.11 , -209.89]
64.09 [-25.41 , 153.59]
-15.00 [-157.27 , 127.27]
70.00 [-61.00 , 201.00]
-14.70 [-71.74 , 42.34]
8.61 [-83.76 , 100.97]
Mean Difference
IV, Random, 95% CI
-1000 -500 0 500 1000
Favours Tourniquet Favours Non Tourniquet
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Analysis 1.19.   Comparison 1: Surgery with a tourniquet vs surgery without a












Heterogeneity: Tau² = 0.21; Chi² = 52.03, df = 8 (P < 0.00001); I² = 85%
Test for overall effect: Z = 0.85 (P = 0.40)













































































IV, Random, 95% CI
-0.56 [-0.96 , -0.16]
-0.20 [-0.56 , 0.16]
-0.40 [-0.74 , -0.06]
-0.40 [-1.21 , 0.41]
-1.10 [-1.62 , -0.58]
0.30 [-0.24 , 0.84]
0.19 [-0.06 , 0.44]
1.12 [0.59 , 1.65]
-0.26 [-0.53 , 0.01]
-0.14 [-0.48 , 0.19]
Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
Favours Tourniquet Favours Non Tourniquet
 
 
Analysis 1.20.   Comparison 1: Surgery with a tourniquet vs surgery without a















Heterogeneity: Tau² = 0.18; Chi² = 48.94, df = 11 (P < 0.00001); I² = 78%
Test for overall effect: Z = 2.19 (P = 0.03)


































































































IV, Random, 95% CI
0.00 [-0.62 , 0.62]
0.00 [-0.69 , 0.69]
0.00 [-0.15 , 0.15]
0.40 [-0.38 , 1.18]
2.20 [0.97 , 3.43]
0.90 [0.20 , 1.60]
-0.20 [-0.55 , 0.15]
1.60 [-0.06 , 3.26]
-0.60 [-1.22 , 0.02]
0.18 [-0.19 , 0.55]
0.86 [0.47 , 1.25]
0.80 [0.20 , 1.40]
0.34 [0.03 , 0.64]
Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
Favours Tourniquet Favours Non Tourniquet
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Analysis 1.21.   Comparison 1: Surgery with a tourniquet vs surgery without a






























Heterogeneity: Tau² = 14.38; Chi² = 141.31, df = 26 (P < 0.00001); I² = 82%
Test for overall effect: Z = 3.95 (P < 0.0001)











































































































































































































IV, Random, 95% CI
-6.00 [-19.07 , 7.07]
-4.00 [-9.91 , 1.91]
-1.30 [-4.48 , 1.88]
-1.00 [-3.40 , 1.40]
0.10 [-3.27 , 3.47]
4.00 [-0.44 , 8.44]
-0.40 [-2.54 , 1.74]
-8.00 [-21.45 , 5.45]
0.00 [-17.90 , 17.90]
3.00 [-1.75 , 7.75]
4.00 [-10.82 , 18.82]
-6.00 [-13.16 , 1.16]
-9.00 [-15.15 , -2.85]
-13.00 [-23.64 , -2.36]
-8.50 [-10.48 , -6.52]
-2.00 [-3.68 , -0.32]
-8.00 [-18.64 , 2.64]
0.00 [-6.16 , 6.16]
-2.70 [-8.39 , 2.99]
-6.30 [-11.89 , -0.71]
2.00 [-4.43 , 8.43]
-5.50 [-10.82 , -0.18]
-9.40 [-18.64 , -0.16]
-0.94 [-2.08 , 0.20]
-38.00 [-47.26 , -28.74]
-2.71 [-6.63 , 1.21]
-4.80 [-9.31 , -0.29]
-3.70 [-5.53 , -1.87]
Mean Difference
IV, Random, 95% CI
-50 -25 0 25 50
Favours Tourniquet Favours Non Tourniquet
 
 
Analysis 1.22.   Comparison 1: Surgery with a tourniquet vs surgery without a tourniquet,





Heterogeneity: Tau² = 0.00; Chi² = 0.48, df = 1 (P = 0.49); I² = 0%
Test for overall effect: Z = 1.76 (P = 0.08)




























IV, Random, 95% CI
-0.09 [-0.19 , 0.01]
-0.04 [-0.14 , 0.06]
-0.06 [-0.13 , 0.01]
Mean Difference
IV, Random, 95% CI
-1 -0.5 0 0.5 1
Favours Tourniquet Favours Non Tourniquet
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Analysis 1.23.   Comparison 1: Surgery with a tourniquet vs surgery without a tourniquet,





Heterogeneity: Tau² = 0.00; Chi² = 0.01, df = 1 (P = 0.94); I² = 0%
Test for overall effect: Z = 0.65 (P = 0.51)




























IV, Random, 95% CI
0.04 [-0.15 , 0.23]
0.05 [-0.14 , 0.24]
0.05 [-0.09 , 0.18]
Mean Difference
IV, Random, 95% CI
-1 -0.5 0 0.5 1
Favours Tourniquet Favours Non Tourniquet
 
 
Analysis 1.24.   Comparison 1: Surgery with a tourniquet vs surgery without a tourniquet,





Heterogeneity: Tau² = 0.00; Chi² = 1.50, df = 1 (P = 0.22); I² = 33%
Test for overall effect: Z = 0.86 (P = 0.39)




























IV, Random, 95% CI
0.02 [-0.07 , 0.11]
0.18 [-0.06 , 0.42]
0.06 [-0.08 , 0.19]
Mean Difference
IV, Random, 95% CI
-1 -0.5 0 0.5 1
Favours Tourniquet Favours Non Tourniquet
 
 
A D D I T I O N A L   T A B L E S
Tourniquet use for knee replacement surgery (Review)







































































































Abdel-Salem 1995 80 40 40 73 73        
Aglietti 2000 20 10 10 70 (8) 68 (4.5) 30 40 27.9 27.3
Alexandersson 2018 81 38 43 68 (7.4) 69.7 (6.4) 47 51 28.6 (3.4) 27.9 (3.5)
Ayik 2020 65 32 33 65.39 (7.25) 64.90 (6.58) 44 42 31.38 (4.72) 30.3 (7.1)
Clarke 2001 31 21 10            
Dong 2019 122 58 64 68.2 (17.1) 69.5 (15.9) 34 35    
Ejaz 2014 64 33 31 68 (8.4) 68 (7.4) 55 55 25 (2) 25 (2.5)
Ejaz 2015 62 31 31 68 (6.3) 68.2 (7.2) 52 55 25.1 (2) 25.2 (2.5)
Ejaz 2015 b 57 29 28 68.3 (8.4) 68.2 (7.8) 45 54 25.1 (2) 25.2 (2.5)
Goel 2019 199 100 99 66.0 (7.0) 65.5 (7.8) 50 48 30.9 (4.6) 31.3 (4.5)
Harston 2015 64 32 32 68 (8) 66 (8)     27.4 28.4
Huang 2017 100 50 50 66.2 (8.3) 65.1 (8.1) 36 32 25.1 (1.5) 24.2 (1.5)
Jawhar 2015 34 17 17 70.6 (6) 70.6 (6) 53 53 32.1 (5) 33.8 (5)
Jawhar 2019 99 50 49 69.3 (7.4) 68.3 ± 7.8 34 39 31.9 (6) 31.4 (5.5)
Juelsgaard 2001 30 16 14 69 64 44 29    
Kato 2002 46 22 24 65 63        
Kiss 2015 100 51 49 72.6 (7.1) 74.7 (7.4) 20 27 28.8 (3.9) 28.5 (3.3)
Kumar 2015 30 30 30 58 58 30 30    



































































































































Ledin 2012 50 25 25 70 (8) 71 (6) 67 39 29 (4.8) 28 (4.8)
Li 2008 60 30 30 71 (7) 70 (7)     24 (5) 24 (5)
Li 2009 80 40 40 71 (6) 70 (7) 28 33 27.3 (6.3) 26.8 (5.1)
Liu 2014 20 10 10 67 60 70 90 25.5 28.7
Liu 2017 52 52 52 67 (8) 67 (8)     28.1 (5.5) 28.1 (5.5)
Liu 2017 b 26 26 26 65.8 (9.2) 65.8 (9.2) 35 35 28.2 (5.6) 28.2 (5.6)
Matziolis 2015 20 10 10 72.4 76.6 80 70 28.3 29.5
Molt 2014 60 30 30 70 (7) 67 (9) 53 53 28 (3) 28 (3)
Mori 2016 103 51 52 72.8 (7.3) 74.6 (7.6) 12 17 27.7 (3.4) 29.2 (3.9)
Ozkunt 018 49 24 25 65.05 65.05        
Pfitzner 2014 90 45 45 69.3 70.5 47 24 27.8 26
Tai 2012 72 36 36 72.1 (6.9) 71.5 (6.8)     28.6 (4.5) 27.9 (4.2)
Tetro 2001 63 33 30 69.8 (6.7) 69.8 (9) 45 37    
Vandenbussche 2001 80 40 40 72.5 68.5 22.5 40    
Vertullo 2017 40 20 20 67.85 (6.91) 65.65 (8.54) 50 55 30.43 (5.07) 31 (5.31)
Wakankar 1999 77 37 40 72.5 71.8 30 35    
Wauke 2002 37 19 18 63.2 (8.7) 61.4 (7.4)        
Wu 2018 100 50 50 68.06 (3.16) 67.58 (4.61) 38 44 23.87 (2.13) 24.10 (2.16)
Yavarikia 2010 51 22 29 68 66 27 24    
Zhang 2010 60 30 30 72 (6) 71 (6) 27 37 25 (4) 26 (4)
Zhang 2016 166 84 82 84 82        



































































































































Zhou 2011 39 20 19 63.12 (6.79) 61.89 (7.93) 35 26    
Zhou 2017 140 72 68 72 68 18 10 26.1 (4.1) 25.7 (3.4)
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Outcome Bias estimate (standard error) P value
Pain 3.875 (2.168) 0.097
Intraoperative blood loss -8.732 (2.596) 0.005
Overall blood loss 5.585 (3.968) 0.178
Postoperative blood loss -0.049 (3.420) 0.989
Transfusion rate 0.47 (0.63) 0.468
Length of stay 0.219 (2.182) 0.922
Duration of surgery -2.947 (1.113) 0.014
Serious adverse events 0.567 (0.552) 0.318
Table 2.   Statistical tests for publication bias 
 
 
A P P E N D I C E S
Appendix 1. CENTRAL search strategy
Database: EBM Reviews - Cochrane Central Register of Controlled Trials <February 2020>
1 arthroplasty, replacement, knee/ (2397)
2 knee Prosthesis/ (695)
3 Tkr.ti,ab. (611)
4 exp knee/ (757)
5 Knee.ti,ab. (26815)
6 4 or 5 (26892)
7 exp arthroplasty/ (4793)
8 joint prosthesis/ (152)
9 (arthroplast$ or prosthe$ or replac$).ti,ab. (44454)
10 or/7-9 (45239)
11 6 and 10 (8683)
12 or/1-3,11 (8836)






19 12 and 18 (539)
Appendix 2. MEDLINE search strategy for RCTs
Database: Ovid MEDLINE(R) ALL <1946 to March 26, 2020>
1 arthroplasty, replacement, knee/ (23209)
2 knee Prosthesis/ (11497)
3 Tkr.ti,ab. (1965)
4 exp knee/ (14079)
5 Knee.ti,ab. (136670)
6 4 or 5 (141363)
7 exp arthroplasty/ (67501)
8 joint prosthesis/ (10183)
9 (arthroplast$ or prosthe$ or replac$).ti,ab. (553274)
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10 or/7-9 (570385)
11 6 and 10 (43440)
12 or/1-3,11 (47102)






19 12 and 18 (945)
20 randomized controlled trial.pt. (502716)
21 controlled clinical trial.pt. (93585)
22 randomized.ab. (474264)
23 placebo.ab. (206347)




28 exp animals/ not humans.sh. (4683296)
29 27 not 28 (1175436)
30 19 and 29 (340)
Appendix 3. Embase search strategy for RCTs
Database: Embase <1974 to 2020 March 27>
1 knee arthroplasty/ (15292)
2 knee prosthesis/ (8310)
3 total knee replacement/ (20943)
4 (knee adj3 (arthroplast$ or replac$ or prosthe$)).ti,ab. (41589)
5 or/1-4 (50915)










16 cross over.tw. (31934)
17 cross-over.tw. (31934)
18 placebo$.tw. (305092)
19 (doubl$ adj blind$).tw. (207633)




24 crossover procedure/ (62618)
25 double blind procedure/ (170919)
26 randomized controlled trial/ (596807)
27 single blind procedure/ (38387)
28 or/13-27 (2300219)
29 12 and 28 (411)
Appendix 4. Clinicaltrials.gov
Search performed 28th March 2020
Search terms:
Tourniquet AND Knee (42)
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Appendix 5. WHO ICTRP
Search performed 7th August 2019
Search terms:
Tourniquet AND Knee (108)
Appendix 6. MEDLINE search strategy for observational studies
Database: Ovid MEDLINE(R) ALL <1946 to March 26, 2020>
1 arthroplasty, replacement, knee/ (23209)
2 knee Prosthesis/ (11497)
3 Tkr.ti,ab. (1965)
4 exp knee/ (14079)
5 Knee.ti,ab. (136670)
6 4 or 5 (141363)
7 exp arthroplasty/ (67501)
8 joint prosthesis/ (10183)
9 (arthroplast$ or prosthe$ or replac$).ti,ab. (553274)
10 or/7-9 (570385)
11 6 and 10 (43440)
12 or/1-3,11 (47102)






19 12 and 18 (945)
20 exp animals/ not humans.sh. (4683296)
21 Cohort studies/ or comparative study/ or follow-up studies/ or prospective studies/ or risk factors/ or cohort.mp. or compared.mp. or
groups.mp. or multivariate.mp. (7434644)
22 21 not 20 (6243355)
23 19 and 22 (656)
Appendix 7. Embase search strategy for observational studies
Database: Embase <1974 to 2020 March 27>
1 knee arthroplasty/ (15292)
2 knee prosthesis/ (8310)
3 total knee replacement/ (20943)
4 (knee adj3 (arthroplast$ or replac$ or prosthe$)).ti,ab. (41589)
5 or/1-4 (50915)






12 5 and 11 (1189)
13 Clinical article/ or controlled study/ or major clinical study/ or prospective study/ or cohort.mp. or compared.mp. or groups.mp. or
multivariate.mp. (14008642)
14 exp animals/ or exp invertebrate/ or animal experiment/ or animal model/ or animal tissue/ or animal cell/ or nonhuman/ (27151487)
15 human/ or normal human/ or human cell/ (20781357)
16 14 and 15 (20718818)
17 14 not 16 (6432669)
18 (12 and 13) not 17 (879)
H I S T O R Y
Protocol first published: Issue 11, 2017
Review first published: Issue 12, 2020
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D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W
We aimed to assess non-randomised studies using the ROBINS-I tool; however, given that we identified no non-randomised studies that
met our inclusion criteria, we did not use this tool.
We did not perform subgroup analysis as we did not identify any studies that reported surgery other than primary total knee replacement.
In addition, all studies used pneumatic tourniquets for the procedure.
All studies reporting outcomes and pain used a tourniquet from initial incision through to wound closure. Only one study reporting serious
adverse events used a diBerent tourniquet technique (Tetro 2001). In this study, the tourniquet was released aJer cementation. We did
not include formal sensitivity analysis in the final report, as removing this study did not significantly aBect the results (RR 2.07, 95% CI
1.27 to 3.38).
We planned to group outcomes based on short term (up to 3 months), medium term (> 3 to 12 months), and longer term (> 12 months).
However, aJer consultation with patients and surgeons, the consensus was that earlier time points were more appropriate for pain, as
this is when the intervention was likely to have the greatest eBect. Therefore the primary endpoint for pain was day 1 postoperatively (and
in our report, SoF and pain scores were also reported for day 2, day 3, two weeks, and six weeks.
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